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Abstract 
 
FeS clusters are ancient prosthetic groups, widely diffused in almost all living beings in 
which they are involved in several fundamental metabolic pathways, including redox reactions, 
electron transfer, enzyme catalysis and many other functions. This assortment is reflected in the 
presence of several FeS clusters with different structures, from the simple rhombic 2Fe2S and cubic 
4Fe4S clusters, to the highly complex 2Fe[4Fe4S] H-cluster (metal cofactor of [FeFe]-
hydrogenases). Distinct biosynthetic pathways for the assembly of different FeS clusters exist, in 
both prokaryotic and eukaryotic microorganisms. In general, these are rather complex processes 
carried out by many proteins interacting with each other. While keeping some key peculiarities, 
these systems are highly conserved in terms of action strategy, which can be generally divided in 
two main steps: the assembly of the metal cofactor on a scaffold protein, and the subsequent 
transfer of the de novo generated FeS cluster from the scaffold to the acceptor apoprotein, which is 
eventually converted into the mature active holoprotein. Both steps require key scaffold proteins, 
that must be able to dynamically interact with the biosynthetic partners as well as with a 
combination of several chaperones and co-chaperones which participate into the final transfer of the 
prosthetic group to the recipient FeS protein. Thus, the structural features of scaffold proteins 
allowing their interactions with all the functional partners are key points. However, for many of 
these fundamental proteins a clear structure-function relationship characterization is missing, and a 
complete characterization of the whole complex multistep molecular pathways in which they are 
functionally involved need a deeper investigation. In this PhD thesis, two different FeS clusters 
biosynthetic systems have been studied: in Chapter 1), the [FeFe]-hydrogenases maturation system 
and in Chapter 2), the human mitochondrial FeS clusters biosynthetic system. 
Chapter 1) [FeFe]-hydrogenases are FeS proteins that in several prokaryotes as well as in 
unicellular green algae catalyze the reversible reduction of protons to hydrogen gas. Thus, they 
received an increasing attention for potential technological applications in the field of biological 
production of clean and renewable fuel. A specific and highly conserved biosynthetic system is 
required to assemble the complex [FeFe]-hydrogenases FeS cluster, the so-called H-cluster, which 
is composed by a 4Fe4S center linked to a 2Fe subcluster coordinated by CO and CN- ligands as 
well as to a bridging dithiolate. Despite the high complexity of this cofactor, its biosynthesis and 
transfer is carried out by only three specific proteins, working in combination with the FeS cluster 
housekeeping biogenesis machinery: HydE and HydG assemble the H-cluster on the scaffold 
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protein HydF, a small GTPase which also drives the delivery of the complete cluster to the target 
apohydrogenase. Thus, HydF plays a central double role of FeS cluster scaffold and carrier protein 
in [FeFe]-hydrogenases maturation. Although several molecular and functional data have been 
obtained since the discovery of the HydE/HydF/HydG machinery, the whole biosynthetic process is 
still not completely characterized. The crystal structure of a recombinant HydF apoprotein was 
solved in my laboratory and suggested useful molecular insights into the protein function.  On the 
other hand, several open issues remained, including the specific role of the HydF GTPase domain, 
which is essential for the [FeFe]-hydrogenase maturation and activation. 
Chapter 2). In mammals, FeS clusters are mainly present and synthetized in mitochondria. 
Their assembly is performed by a complex and highly conserved system involving several proteins. 
Among them, ISCU is the scaffold upon which FeS clusters are assembled at the so called SDU, 
which also includes the desulfurase NFS1, the accessory protein ISD11, and frataxin (FXN). FXN 
is an iron-binding protein (Fe2+ and Fe3+) whose specific role in this biosynthetic pathway is still 
controversial, as it was first proposed to be the iron donor of the process, and then an allosteric 
activator of the SDU complex. In humans, defects of both ISCU or FXN lead to diseases with 
distinct clinical phenotypes but similar cellular and biochemical features. Decreased levels of ISCU 
mitochondrial isoform caused by a point mutation of the ISCU gene lead to a rare myopathy with 
lactic acidosis (ISCU myopathy); decreased levels of FXN, due to an abnormal expansion of GAA 
trinucleotide repeat in the FXN gene, cause Friedreich‟s Ataxia (FRDA), a neurodegenerative 
disorder. Cellular hallmarks of both diseases are compromised respiration, mitochondrial iron 
overload and increased sensitivity to oxidative stress, and for both a specific therapy is still missing. 
This may be due, at least in part, to an incomplete characterization of the pathway(s) in which these 
proteins are involved, and in particular it is worth to note that FXN is a protein still looking for a 
function. 
Based on these premises, I focused the work of my PhD on these two open issues by taking 
advantage, in both cases, of a combination of biochemical and spectroscopic approaches to assess 
structural features of 1) HydF GTPase domain and 2) FXN, both alone and in binary complex with 
the scaffold ISCU. In particular, to explore the HydF protein and its structural response to GTP 
binding, in collaboration with Prof. Carbonera (Department of Chemical Sciences Padova, 
University of Padova), I exploited an advanced spectroscopic technique, EPR (Electron 
Paramagnetic Resonance), that is the ultimate technique for the study of FeS proteins; to 
characterize into detail the FXN-ISCU direct interaction, I applied the two-dimensional NMR 
(Nuclear Magnetic Resonance) technique, in collaboration with Prof. Bellanda (Department of 
Chemical Sciences, University of Padova).  
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Chapter 1). I carried out in vitro spectroscopic studies to characterize the HydF GTPase 
domain. The obtained results allowed me to conclude that HydF can be considered as a novel 
member of the K+-dependent GTPases. Thus, these proteins may have a larger spread of functions 
than supposed before. HydF could be a molecular switch undergoing significant structural 
modifications upon GTP binding, as other members of the same family. Moreover, diffuse 
conformational changes due to GTP binding were detected, and this could be pivotal for dynamic 
structural and functional interactions with the other proteins involved in [FeFe]-hydrogenase 
maturation and activation. Starting from this discovery, it will be possible to model the GTP-bound 
state of HydF, an important structural information which was missing in the X-ray structure of the 
apoprotein previously solved in our laboratory. 
Chapter 2). I performed biochemical and spectroscopic analysis of human FXN, alone and 
in complex with ISCU, that allowed me to identify in FXN the residues involved in the binding of 
Fe3+/2+ and in its interaction with ISCU, which a confirmed to be iron-dependent. Then, since many 
FXN residues that I found to be involved in the direct interaction with ISCU are mutated in patients 
with variants of FRDA, I evaluated if and how these mutations can interfere with ISCU-FXN direct 
interaction and with its capability to bind iron. I found that FRDA-related frataxin variants in which 
mutations are located in ISCU-binding region do not affect frataxin iron-binding properties, while 
impairing both the interaction with ISCU and the ability to activate the SDU complex. Other FRDA 
related frataxin variants, instead, in which mutations are located in the iron-binding region or 
between the latter and ISCU-binding region, affect, as expected, the capability of FXN to bind iron 
while not completely impairing its interaction with ISCU. Moreover, these FXN variants keep a 
partial capability to activate SDU complex. Taken together, these results open new perspectives in 
the study of the mechanisms leading to FRDA variants, and give additional hints useful to clarify 
the physiological role of FXN as well as its contribution to the pathogenesis of Friedreich‟s ataxia. 
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General introduction 
The iron-sulfur clusters 
In nature, the function of many proteins depends on cofactors. These are low-molecular-
mass compounds that bind proteins, either covalently or non-covalently, in well-defined and 
evolutionarily conserved sequence motifs. Both organic and inorganic protein cofactors exist. 
Organic cofactors include various nucleotides, vitamins and metal-organic compounds, whereas 
inorganic cofactors can be different metal ions such as magnesium (Mg2+), zinc (Zn2+), manganese 
(Mn2+), cuprous and cupric ions (Cu1+ and Cu 2+), ferrous and ferric ions (Fe2+ and Fe3+) (Beinert H. 
et al., 1997). Among the inorganic cofactors, iron-sulfur (FeS) clusters are probably the most 
ancient and versatile ones, participating in rather diverse functions such as electron 
transfer, tricarboxylic acid (TCA) cycle, aminoacid biosynthesis, bacterial and mitochondrial 
respiration, cofactor biosynthesis, ribosome assembly, regulation of protein translation, DNA 
replication and repair. It has been hypothesized that FeS clusters could be the catalysts at the very 
basis of life on our planet, in Hadean ocean floor (Martin W. and Russell M.J., 2003), where in 
particular conditions (structured iron monosulphide precipitates in a seepage site hydrothermal 
mound at a redox, pH and temperature gradient between sulphide-rich hydrothermal fluid and 
iron(II)-containing waters), redox reactions between iron sulphide minerals could have allowed 
primordial carbon fixation providing the necessary free energy and electrons (Wächtershäuser G., 
1988).  
The functions of the iron-sulfur clusters 
The importance of FeS clusters in life on earth and in its development from the primordial 
steps is underlined by their wide diffusion in almost all living beings, from prokaryotes to 
eukaryotes, from archaea to mammals. This huge diffusion reflects also in a vast variety of 
structurally and functionally different FeS clusters (see below). The most common function of FeS 
clusters is electron transfer, as they are excellent donors and acceptors of electrons. In fact, when 
bound to proteins, FeS clusters can adopt redox potentials from -500 mV to +300 mV thanks to the 
propensity of iron to switch between oxidative states +2 and +3 (Meyer J., 2008) (fig. 1), thus 
allowing the above mentioned function, for example, in bacterial and mitochondrial respiratory 
complexes I–III, photosystem I, ferredoxins and hydrogenases. Moreover, they can be involved in 
enzyme catalysis, as in the case of aconitase, in which the FeS cluster serves as a Lewis acid for the 
conversion of citrate into isocitrate (Lill R., 2009). Furthermore, FeS clusters can act as sulfur donor 
for some radical S-adenosyl-methionine (SAM) enzymes (such as biotin synthase and lipoate 
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synthase), in which one of the two clusters bound by these proteins is disassembled during the 
formation of the products (biotin and lipoic acid, respectively) (Booker S.J. et al., 2007).  
 
Figure 1. Electronic patterns in FeS clusters. Localized Fe3+ (blue), localized Fe2+ (red) sites and 
delocalized Fe2.5+ Fe2.5+ pairs (purple) are shown. The oxidation state (0, 1+, 2+ and 3+) and the total spin 
state S of each cluster is reported on the top and in the grey bar, respectively. It is worth to note the 
importance of chemical composition, geometry and coordination for the FeS cluster properties (Pandelia M.-
E. et al., 2015). 
 
An additional main role of FeS clusters is played in gene expression regulation, through 
sensing environmental or intracellular conditions. In fact, thanks to these cofactors proteins can 
sense O2, superoxides or FeS clusters themselves, as in the case of mammalian cytosolic iron 
regulatory protein 1 (IRP1). Upon iron starvation conditions, IRP1 loses the labile FeS cluster, thus 
becoming a post-transcriptional regulator that binds to particular regions, called iron-responsive 
elements (IREs), of messenger RNAs of proteins involved in iron homeostasis in the cell, 
interfering either positively (at the 3ʹ-located IREs) or negatively (at the 5ʹ-located IREs) (Kennedy 
M.C. et al., 1992). Several other enzymes involved in metabolism of bacteria and eukaryotes 
possess FeS clusters. However, the precise functional role of the metal cofactor is not always clear, 
and it is therefore possible that, at least in some proteins, the FeS cluster is simply an inheritance of 
the evolutionary process (Lill R., 2009). 
7 
 
The structures of the iron-sulfur clusters 
From the structural and chemical point of view, the simplest are the rhombic [2Fe-2S] and 
the cubane [4Fe-4S] clusters (figs. 1 and 2), which are composed by iron (Fe2+/3+) and sulphide 
(S2−) and are usually integrated into proteins through coordination of the iron ions by cysteine 
residues (Lill R., 2009). Furthermore, the variant of FeS clusters coordination represented by Rieske 
proteins is worthy of note, in which one of the two Fe atoms of the [2Fe-2S] cofactor is coordinated 
by two histidine residues rather than two cysteine residues (Rieske J.S., 1968). 
 
 
 
Figure 2. Schematic structural representation of simple and complex FeS clusters. A: rhombic [2Fe-2S] 
cluster; B: cuboidal [Fe3S4] cluster; C: cubane [4Fe-4S] cluster; D: P-cluster of nitrogenase; E: H-cluster of 
[FeFe]-hydrogenase. Depicted in bronze Fe atoms, in yellow S atoms, in gray C atoms, in blue N atoms and 
in red O atoms. The representations have been realized according to the current state of the art of FeS 
clusters, utilizing Avogadro software (Hanwell M.D. et al., 2012). 
 
[2Fe-2S] and [4Fe-4S] clusters (figs. 1 and 2, A and C) are the most widely diffused, being 
the cofactors of proteins present in many organisms and involved in different biological functions, 
ranging from plant and bacterial ferredoxins to respiratory complexes I–III of bacteria and 
mitochondria. These FeS clusters have in general high plasticity and modularity, in particular the 
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cuboidal [Fe3S4] species (figs. 1 and 2B), that allow the formation of more complex FeS clusters, as 
for example the P-cluster of nitrogenases (fig. 2D) or the heterometallic complexes found in [NiFe]-
hydrogenases (Beinert H. et al., 1997). The most complex FeS-clusters, as for examples the metal 
cofactor of [FeFe]-hydrogenases enzymes (H-cluster, fig. 2E, see also below), are involved in very 
specific purposes and are restricted to particular organisms, such as some extremophile bacteria, 
obligate anaerobic microorganisms, unicellular green algae and protists. These clusters present 
highly complicated architectures and multiple coordinations to proteins involving, in addition to the 
typical cysteine or histidine residues, alternative aminoacidic ligands such as aspartate, arginine and 
serine, or non-aminoacidic ligands as carbon monoxide (CO) and cyanide ion (CN-) (Fontecilla-
Camps J.C., 2009).  
Thus, the versatility of FeS clusters is given by the combination of the metal composition 
with their unique structures, that gives rise to distinct electronic behaviors of different irons in the 
same cluster. Likewise, aminoacidic and non-aminoacidic ligands can further modify these 
behaviors, contributing to the ubiquitous employment of FeS clusters (Pandelia M.-E. et al., 2015). 
The biogenesis of the iron-sulfur clusters 
The biosynthesis of the FeS clusters in vivo is a highly complex sequence of coordinated 
reactions, both in the case of the most complex cofactors and for clusters with simpler chemical 
geometries. The first studies on this topic have been performed in bacteria, in which three main 
different systems for the biogenesis of FeS proteins have been identified and characterized: the iron-
sulfur cluster (ISC) assembly system, responsible for the synthesis of housekeeping FeS proteins 
under normal conditions; the sulfur formation (SUF) system, that plays the same role of ISC system 
but in oxidative-stress conditions; and the nitrogen fixation (NIF) system, specifically dedicated to 
the maturation of nitrogenase (Fontecave M. & Ollagnier-de-Choudens S., 2008). Interestingly, ISC 
and SUF machineries result evolutionarily conserved in eukaryotes with FeS proteins in 
mitochondria, cytosol and the nucleus, in which these systems were likely transferred by 
endosymbiosis. In fact, proteins of the SUF system are found to be retained in plastids of plants and 
algae, whereas homologous components of ISC system are present in mitochondria (Lill R., 2009). 
Furthermore, in eukaryotes the cytosolic and nuclear FeS proteins generation needs the presence of 
an additional system, the cytosolic iron-sulfur protein assembly (CIA) machinery (Lill R. & 
Mühlenhoff U., 2008).  Related to this PhD thesis, it worth to note that the assembly of complex 
FeS clusters, such as the H-cluster of the [FeFe]-hydrogenases (see below), requires further 
dedicated maturation systems that work downstream to ISC- or SUF-dependent pathways (Shepard 
E.M., 2011).   
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In general, bacterial and eukaryotic FeS clusters biosynthetic pathways share the same 
biosynthetic rules, despite keeping differences among the various organisms. Of particular interest 
is the high level of conservation of the entire process from yeast to human, which can be divided in 
two main macro-steps: 1) the very assembly of the FeS cluster on a scaffold protein, and 2) the 
transfer of the de novo generated cofactor from the scaffold to the acceptor apoprotein, with the 
final maturation into holoprotein (Lill R., 2009) (fig. 3). Both steps are based on a dynamic 
structural and functional interaction of several proteins and cofactors, each one with an essential 
role, performing partial reactions which contribute to the whole process, either directly or as 
regulators.  
 
 
 
Figure 3. Schematic representation of the two main macro-steps of FeS-protein biogenesis. 1) De novo 
assembly of the FeS cluster on a scaffold protein with the help of sulphur, iron and electron donors; 2) 
transfer of the FeS cluster to the acceptor apoprotein, and its maturation to holoprotein. 
 
Despite these partial reactions have not been completely characterized in all known 
biosynthetic pathways, it is possible to identify some general common steps. In particular, in the 
first macro-step (the de novo assembly of FeS clusters) a pyridoxal phosphate (PLP)-dependent 
cysteine desulfurase converts cysteine to alanine, extracting the sulfur needed for the biosynthesis 
of the cluster (Johnson D.C. et al., 2005) (fig. 4).  
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Figure 4. Salient mechanistic features of the cysteine desulfurases involved in FeS clusters assembly. 
The Cys substrate (blue) bound to the PLP cofactor (red) undergoes nucleophilic attack by the thiolate anion 
of the cysteine present on the enzyme active site. 
 
After the formation of a persulphide on a conserved cysteine residue of the enzyme, this 
intermediate may be transferred to helper proteins, or directly to scaffold proteins which also assist 
the iron insertion into the bound rising cofactor (Lill R., 2009). Because of the intrinsic toxicity of 
free iron in solution, the latter step is strictly regulated: to guarantee its accurate delivery to scaffold 
proteins through appropriate interactions, specific iron donors are needed. Unfortunately, this step is 
one of the most controversial and it is still not completely clarified, particularly with regard to the 
mammals biosynthetic pathway (Maio N. & Rouault T.A., 2015). To complete the first macro-step, 
sulfur coming from cysteines must be reduced from S0 to S-2, the one present in FeS clusters. This 
step is carried out by ferredoxins or ferredoxin-like proteins/domains, depending on the system. The 
second macro-step, in which the labile FeS clusters bound to the scaffolds must be transferred to 
apoproteins, involves several transfer proteins, which are different depending on the target 
apoprotein to be maturated. These proteins are generally involved in three different tasks: to induce 
dissociation of the FeS cluster bound to the scaffold; to guarantee its accurate and specific transfer 
to the right apoprotein; and to promote correct assembly of the FeS cluster at the proper acceptor 
sites for the final conversion in holoprotein (Lill R., 2009). The role of the scaffold proteins is thus 
fundamental for the whole process: they have to be able to bind and stabilize the rising FeS cluster, 
but at the same time this binding must be labile to allow the final transfer of the mature cofactor to 
apoproteins: in fact, the scaffold FeS cluster binding sites possess highly conserved cysteines 
residues to coordinate the cluster, and one or more surrounding residues responsible for the binding 
destabilization. As an example, the human scaffold protein ISCU presents, close to the conserved 
cysteines, an aspartate residue that, if mutated in alanine, prevents the loss of the de novo 
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synthetized FeS cluster (Foster M.W. et al., 2000). Moreover, scaffolds have to interact with several 
proteins of the biosynthetic pathway, and often form oligomers that can help the stabilization of the 
FeS cluster, driving its correct assembly and the whole biosynthetic process (Fantini M. et al., 
2017). 
Bacterial and mitochondrial ISC systems 
 The evolutionary relationship between bacteria and mitochondria has a perfect example in 
the ISC system. In fact, there are evident similarities between the bacterial and mitochondrial 
components, and between the respective FeS clusters assembly mechanism. This led to the 
identification and functional characterization of several mitochondrial proteins homologous to the 
bacterial ISC system (Kispal G. et al., 1999 and Schilke B. et al., 1999). These ISC systems 
perfectly reflect the two macro-steps of the FeS proteins biogenesis (fig. 5). 
 
 
Figure 5. Schematic representation of bacterial and mitochondrial ISC systems. In green tones scaffold 
proteins, in blue tones enzymes and other accessory proteins, in red tones final acceptor proteins. In yellow 
spheres persulphide intermediates and in orange squares de novo synthetized FeS clusters. The detailed 
description of both pathways is in the respective paragraph. 
 
In this case, in the first macro-step, the de novo FeS cluster is initially and transiently assembled on 
the scaffold proteins IscU, in bacteria, and ISCU, in mitochondria. This scaffold is one of the most 
conserved proteins of these pathways, being very similar also to the scaffold of NIF system NifU; 
indeed, the mitochondrial ISCU is often called NifU-like protein. As assessed above, these proteins 
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coordinate in a labile manner the rising FeS cluster with three highly conserved cysteine residues, 
and then move the assembled cofactor to recipient apoproteins with the help of other proteins (Lill 
R., 2009). 
The assembly of the FeS cluster, as mentioned before, depends primarily on the activity of a 
desulfurase, an enzyme highly conserved in both bacterial (IscS) and mitochondrial (Nfs1) ISC 
systems. Both IscS and Nfs1 work as a homodimer, in which each monomer has two domains: one 
harboring the pyridoxal-phosphate-binding site and the other containing the active site involved in 
the sulfur release from free cysteines (Cupp-Vickery J.R. et al., 2003). Conversely to IscS, for its 
function in vivo Nfs1 needs to be in complex with the small protein Isd11, whose precise function is 
still under debate (Wiedemann N. et al., 2006). Moreover, an additional component of this complex 
has been recently identified in eukaryotes: the Acyl carrier potein (ACP), which interacts with the 
complex by binding to ISD11 (Van Vranken J.G. et al., 2016 and Cory S.A. et al., 2017). ACP 
seems to further stabilize and enhance the biosynthetic complex activity when it binds its cofactor, 
S-dodecanoyl-4‟-phosphopantetheine (4‟-PPT); for this reason it has been proposed to function as a 
metabolic sensor and regulator of the process (Van Vranken J.G. et al., 2016). The de novo FeS 
cluster biosynthesis occurs thanks to the interaction of the desulfurases IscS/Nfs1 and the scaffolds 
IscU/ISCU, and is further boosted by the interaction with a third factor: frataxin (FXN in humans, 
CyaY in bacteria and Yfh1 in yeast) (Gerber J. et al., 2003). Frataxin is highly conserved from 
bacteria to humans, and is able to bind both Fe2+ and Fe3+ (Adinolfi S. et al., 2002). For this reason, 
and for many years, it was believed to be the iron donor of the pathway; on the other hand, it has 
also been suggested to be an allosteric activator of the process, with different outcomes on the 
biosynthetic kinetics depending on the organism (Adinolfi S. et al., 2009 and Tsai C.L. & 
Barondeau D.P., 2010). In Chapter 2 frataxin and its involvement in human mitochondrial ISC 
system through the interaction with the scaffold protein ISCU will be further discussed, being the 
subjects of the second part of this PhD thesis. To date, the iron donor, and more in general the 
whole mechanism through which the FeS cluster is completed at the ISC machinery, are still not 
completely defined.  
The process needs electrons for the reduction of the sulphur extracted from free cysteines 
(S0) to the sulphide (S2−) present in FeS clusters, and eventually for the fusion of two [2Fe2S] 
clusters in a [4Fe4S] cluster by reductive coupling (Unciuleac M.C. et al., 2007). Ferrodoxins are 
involved in these passages: Fdx in bacteria, Yah1 in yeast and FDX1/2 in humans. These proteins 
interact one at a time with the complex, receiving electrons by ferrodoxin reductases and NADH, 
and providing the correct electron flow to the process (Cai K. et al., 2016 and Mühlenhoff U. et al., 
2003). 
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The release of the de novo assembled cofactor from the scaffold, its transfer to apoproteins 
and the final assembly of the FeS cluster into the latter, are the three processes taking place in the 
second macro-step of the pathway. Nowadays, there are not sufficient experimental evidences to 
characterize them step by step, but it is possible to address the overall process identifying the 
dedicated chaperone system. Mitochondria possess the Hsp70 ATPase Ssq1 and the DnaJ-like co-
chaperone Jac1, homologous to the bacterial HscA and HscB respectively (Lill R., 2009). The 
ATPase activity of Ssq1/HscA is functional for its highly specific interaction with the scaffold, in 
particular with the LPPVK motif of ISCU/IscU. (Dutkiewicz R. et al., 2004). Once the complex is 
formed, the intervention of Jac1/HscB is thought to induce a structural change in the scaffold with a 
consequent labilization of the binding of the cofactor, to facilitate cluster dissociation and transfer 
to apoproteins (Chandramouli K. et al., 2006, Andrew A.J. et al., 2006 and Bonomi F. et al., 2008). 
In mitochondria the nucleotide exchange factor Mge1 is also involved in this step, which is instead 
not necessary in bacteria because of the intrinsic lability of ADP bound to HscA (Vickery L.E. & 
Cupp-Vickery J.R. 2007). An alternative model (dashed lines in figure 5) suggests that the FeS 
cluster is moved from ISCU to the monothiol glutaredoxin GLRX5 (glutaredoxin-5), with the help 
of Ssq1 and Jac1; then, GLRX5 would work as a [2Fe2S] cluster chaperone transferring it to several 
possible acceptors (Xu X.M. & MollerS.G., 2011). Furthermore, mitochondria and bacteria have 
additional biogenesis components dedicated to the specific maturation of particular FeS proteins, 
that act in parallel to the main process in the second macro-step. The mitochondrial ISCA protein 
family (ISCA, and IBA57) and the bacterial IscA family (IscA and ErpA) are a major example, 
being specifically involved in the maturation of a subset of [4Fe4S] proteins, such as mitochondrial 
and bacterial aconitases (Gelling C. et al., 2009, Tan G. et al., 2009 and Sheftel A.D. et al., 2012). 
In humans, the dedicated cluster insertion into the diverse polypeptide chains of target FeS proteins 
is carried out by the cluster transfer proteins NFU1 and IND1 (Paul V.D. & Lill R. 2015). 
Mitochondrial ISC export and cytosolic CIA machineries 
In eukaryotic cells, and in particular in mammals, FeS clusters are mainly synthetized in 
mitochondria, and to a lesser extent also in cytosol and nucleus, where FeS proteins are present as 
in mitochondria (Rouault T.A., 2012). Consistently, extra-mitochondrial isoforms of Nfs1, Isd11 
and ISCU proteins have been identified (Maio N. & Rouault T.A., 2015). A cytosolic FeS cluster 
assembly machinery, the CIA, is highly conserved from yeast to humans, and involves nine proteins 
(in humans: NUBP1, NUBP2, NARFL, CIAO1, NDOR1, CIAPIN1, MMS19, CIA2A and CIA2B) 
(Netz D.J. et al., 2014) (fig. 6). 
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Figure 6. Schematic representation of mitochondrial ISC export and cytosolic CIA machineries. In 
purple tones mitochondrial ISC export system factors, in blue tones CIA proteins involved in the first 
biosynthetic macro-step, in green tones CIA proteins involved in the second biosynthetic macro-step and in 
red tones final acceptor proteins. In orange squares de novo synthetized FeS clusters. The detailed 
description of both pathways is in the respective paragraph. 
 
The proposed mechanism, that has been actually studied in yeast and then inferred for 
humans, begins with the mitochondrial export of a specific sulfur-containing compound which acts 
as substrate for cytosolic FeS cluster biogenesis (Lill R., 2009). The transfer of the sulfur-
containing substrate through the mitochondrial matrix and then to the CIA system would be carried 
out by the cooperation of the ABC transporter ABCB7 with the sulphydryl oxidase GFER and in 
the presence of reduced glutathione. The substrate would be then managed by the cytosolic 
monothiol glutaredoxin GLRX3 (glutaredoxin-3), upon which the formation of the [2Fe2S] cluster 
should occur. Then, GLRX3 might act as a cytoplasmic [2Fe2S] cluster trafficking protein in the 
early phase of the CIA pathway (Ciofi-Baffoni et al., 2017). The [2Fe2S] clusters might be then 
transferred to the two P-loop NTPases NUBP1 and NUBP2 that should carry on the de novo 
assembly of a [4Fe4S] cluster with the help of the diflavin reductase NDOR1, which provides 
electrons gathered from NADPH, and the FeS protein CIAPIN1. The second macro-step (i.e. the 
transfer of the de novo assembled FeS clusters to apoproteins and their maturation into 
holoproteins) is supposed to be accomplished by an iron-hydrogenase-like protein, NARFL, 
together with the CIA targeting complex formed by CIAO1, CIA2B, CIA2A and MMS19 (Maio N. 
& Rouault T.A., 2015). 
However, the composition of the protein complex for this final step seems to depend on the 
final protein acceptor: for example, MMS19, together with CIAO1 and CIA2B, would be involved 
only in the maturation of nuclear proteins linked to nucleotide and DNA metabolism, whereas for 
cytosolic aconitase only CIAO1 and CIA2A would be necessary (Stehling O. et al., 2012 and 
Stehling O. et al., 2013). 
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Bacterial and plastidial SUF systems 
The SUF system, depicted in fig. 7, is responsible for the assembly of housekeeping 
bacterial FeS proteins under oxidative stress or iron-limiting conditions. Indeed, the suf operon, 
normally repressed by the inhibitor SufR, is induced in these conditions by IscR, that in its apo form 
acts both as a repressor of the isc operon and activator of the suf operon (Ayala-Castro C. et al., 
2008). The first step of this biosynthetic system involves a desulfurase activity of the complex 
formed by SufS and SufE proteins. Although SufS acts similarly to other cysteine desulfurases such 
as bacterial IscS or NifS and mitochondrial Nfs1–Isd11, the molecular mechanism is different 
(Loiseau L. et al., 2003). In particular, SufS obtains from free cysteines a persulphide intermediate 
through the binding to a conserved cysteine, as IscS and NifS, but then transfers it to another 
conserved cysteine of SufE, which in turn will move the intermediate to the scaffold proteins. At the 
same time, SufE stimulates the activity of SufS, increasing it more than tenfold (Layer G. et al., 
2007).  
 
 
 Figure 7. Schematic representation of bacterial and plastidial SUF systems. In green tones scaffold 
proteins, in blue tones enzymes and accessory proteins, in red tones final acceptor proteins. In yellow spheres 
persulphide intermediates and in orange squares de novo synthetized FeS clusters. The detailed description of 
both pathways is in the respective paragraph. 
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For the content of this PhD thesis, it is interesting to report that SufE is structurally similar to IscU-
type scaffold proteins, despite not sharing the same scaffold functions (Liu G. et al., 2005). As for 
the other FeS cluster biosynthetic pathways, iron and electrons are finally needed to complete the de 
novo assembly of the FeS clusters. Unfortunately, also in this case the iron donor as well as the 
factor involved in electron transfer are still unknown (Lill R., 2009). 
Three different scaffolds have been identified to take part in this pathway: SufA, SufU 
(respectively IscA and IscU homologues) and SufB, which can coordinate an FeS cluster thanks to 
several conserved cysteines (Fontecave M. & Ollagnier-de-Choudens S., 2008). SufB acts in 
complex with SufC-SufD; in particular, SufC has been proposed to be the protein responsible for 
the transfer of FeS clusters from SufB to apoproteins, through its ATPase activity (Nachin L. et al., 
2003). Noteworthy SufU, likewise to IscU, in its apo form acts as an activator of SufS, although 
they have an important structural difference: the former lacks the LPPVK sequence otherwise 
present in the latter, allowing IscU to binds HscA; this reflects in differences in the final transfer 
process in SUF system, which anyway needs further studies to be completely characterized 
(Albrecht A.G. et al, 2010 and Johnson D.C. et al., 2005).  
Since this biosynthetic system has been found to be less sensitive to high oxygen 
concentrations, SUF proteins are also present in plastids of plants and algae, although they may not 
be the only proteins to support maturation of FeS proteins in these organelles (Xu X.M. & Moller S. 
G., 2008). The system, characterized in Arabidopsis thaliana, includes the bacterial homologues 
AtSufA, AtSufB, AtSufC, AtSufD, AtSufE1–3 and AtSufS, and additional plastidial proteins, i.e. 
NFU1, NFU2 and NFU3. The plastidial proteins have the same role of the bacterial homologues: 
the complex AtSufS-AtSufE has a cysteine desulfurase activity, while AtSufA, in complex with 
ATP-dependent AtSufB-AtSufC-AtSufD proteins, is a scaffold upon which FeS clusters are 
assembled and then transferred to apoproteins. Interestingly, AtSufE1-3 are also localized in 
mitochondria and enhance the activity of AtIscS, as for AtSufS. Furthermore, NFU1-3 are specific 
plastidial scaffold proteins involved in the last part of the process (Xu X.M. & Moller S. G., 2008).  
 
The NIF maturation system 
The NIF system is responsible for the biogenesis the complex FeS clusters of nitrogenases in 
bacteria, such as the P-cluster (fig. 2) and the heterometallic iron-molybdenum cofactor (FeMo-co). 
The process involves ten proteins (NifS, NifU, NifB, NifX, NifE, NifN, NifV, NifQ, NifH and 
NifY), encoded by the nif operon (Fontecilla-Camps J.C., 2009). Despite this system generates 
complex FeS cofactors, in contrast to ISC and SUF systems that produce the simpler [2Fe2S] and 
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[4Fe4S] clusters, the main biosynthetic steps are the same, at least for the first part of the pathway 
(fig. 8).  
 
 
 
Figure 8. Schematic representation of NIF maturation system. In green tones scaffold proteins, in blue 
tones enzymes, in red tones final acceptor proteins. In orange single squares substrate [4Fe4S] clusters, in 
yellow double squares NifB cofactors, in yellow spheres P-clusters, in magenta spheres FeMo-co, in white 
spheres Fe(CO)2(CN) units and in blue spheres H-clusters. The detailed description of both t pathways is in 
the respective paragraph. 
 
 
In this case, the role of cysteine desulfurase is played by NifS, that directs the assembly of the 
clusters on the scaffold NifU by providing sulfide, that is then reduced to S-2 by a domain of NifU 
itself, after the supply of Fe by an unidentified actor. The FeS cluster is then transferred to another 
scaffold, NifB. When compared to the ISC and SUF systems, additional steps are introduced for 
further modification of the cofactor. NifB is a radical S-adenosylmethionine (SAM) protein that 
utilizes de novo synthetized [4Fe4S] clusters as substrates to synthetize on its C-terminal domain 
the so called NifB cofactor, whose structure is unknown (Rubio L.M. & Ludden P.W., 2008). Then, 
the transient cofactor is transferred by NifX to the central scaffold protein NifEN for the final 
assembly process (Fontecilla-Camps J.C., 2009). At this point, the P-cluster is eventually completed 
without the help of any other factor, and transferred to the apo-NifDK (the nitrogenase enzyme) 
through NafY movement; on the contrary, FeMo-co needs the further activity of NifV and NifQ 
proteins, for the supply of R-homocitrate and molybdenum respectively, and of NifH for the final 
assembly through ATP hydrolysis (Lee C.C., 2009). 
In all these steps, the oligomeric form of the proteins involved in the pathway is functional 
to their correct activity, in particular for the scaffolds, as depicted on the scheme of fig. 8. 
The [FeFe]-hydrogenases maturation system 
Similarly to NIF, the biogenesis of the [FeFe]-hydrogenases [6Fe6S] complex cofactor (the 
H-cluster, fig. 2) requires the further modification of a simpler pre-assembled [4Fe4S] cluster: the 
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H-cluster precursor is composed by a pre-formed cubane bound through a single cysteine to a 
couple of Fe atoms that harbor CO, CN− and dithiomethylamine ligands (Peters J.W. et al., 1998, 
Nicolet Y. et al., 1999 and Chen Z. et al., 2002). Several experimental lines of evidence support the 
idea that three highly conserved specific maturation proteins. i.e. HydE, HydF and HydG (Posewitz 
M.C. et al., 2004), are required for the synthesis of the 2Fe subcluster of the H-cluster, with the 
[4Fe4S] subcluster likely being synthesized by ISC and/or SUF assembly machinery (Shepard E.M. 
et al., 2011). HydE and HydG are radical SAM proteins that perform the assembly of the [2Fe] 
subcluster, with all its ligands, on the cubane bound to the scaffold HydF. Despite the process has 
not yet been fully characterized, two stepwise pathways has been proposed for the [FeFe]-
hydrogenase (HydA) maturation (fig. 9). In the first one (panel A), HydE modifies a [2Fe2S] cluster 
on HydF by synthesis and insertion of the dithiomethylamine ligand, whose precursor is still 
unknown (Betz J.N. et al., 2015). Then, HydG catalyzes the formation of CO and CN- from 
tyrosine, which are delivered to the 2Fe subcluster.  
 
Figure 9. Schematic representation of two possible pathways for [FeFe]-hydrogenases maturation 
system. Both in A) and B) HydF protein act as a dimeric scaffold in which HydE and HydG assemble the 
[2Fe] subunit of the H-cluster, then transferred to apo HydA for the final maturation. Indicated with * the 
unknown Fe ligands during the maturation steps (Broderick J.B. et al., 2014).   
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For the content of this PhD thesis (see more in Chapter 1), it is worth noting that direct interactions 
between the radical SAM maturases and HydF have been reported (Vallese F. et al., 2012), and may 
be important for efficient delivery of the product of HydE and HydG. The assembled 2Fe subcluster 
is then transferred to HydA, resulting in its activation (Shepard E.M. et al., 2014). An alternate 
pathway is drawn in panel B of fig. 9, in which iron-bound cyanide and carbon monoxide are first 
synthesized on HydG and then delivered to HydF as Fe(CO)2(CN) units (Kuchenreuther J.M., 
2014), where HydE dithiomethylamine addition puts together the two mononuclear Fe species. Also 
in this case, for its final maturation the H-cluster has to be moved to the apo-hydrogenase, that is 
eventually converted in the active holo form. 
Interestingly, in both models HydF has been proposed to be not only the scaffold but also 
the carrier protein involved in the final transfer of the H-cluster to apo HydA (McGlynn S.E. et al., 
2008, Shepard E.M. et al., 2010 (1), Mulder D.W. et al., 2011 and Berggren G. et al., 2013). This 
biosynthetic system, and in particular the HydF scaffold protein, will be further discussed in 
Chapter 1. 
The FeS cluster scaffold proteins 
  
 
Figure 10. Cartoon structures of representative of A) U-type, B) NFU-type and C) A-type scaffold 
proteins. Where possible, the holo form is reported. A) Holo form of A. aeolicus IscU (PDBID: 2Z7E), with 
a [2Fe2S] cluster (Fe and S in orange and yellow sticks respectively) bound to the histidine (blue sticks) and 
the three conserved cysteines (red sticks) of the CX24–26 CX42–43C motif. B) Apo form of C-terminal domain 
of O. sativa NifU-like protein (PDBID: 2JNV), with its two conserved cysteines (red sticks) of the CXXC 
motif. The coordination of the [2Fe2S] cluster requires the presence of the two conserved cysteines of an 
additional monomer and thus the formation of a homodimer. C) Holo form of T. elongatus IscA (PDBID: 
1X0G), with a [2Fe2S] cluster (Fe and S in orange and yellow sticks respectively) bound to the three 
conserved cysteines (red sticks) of the CX63–65CXC motif. The fourth residue coordinating the [2Fe2S] 
cluster is a cysteine belonging to another IscA monomer (not shown) alternatively folded, composing an 
asymmetric dimer together with the first one (the cofactor is kept exposed on the surface). Images elaborated 
with PyMOL (DeLano W.L., 2002). 
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A crucial role of cluster scaffold proteins arises in all the systems described above: scaffolds 
are essential both for the de novo biosynthesis of FeS clusters and for their transfer to apoproteins. 
Three main general classes of scaffold proteins have been described: the U-type, the NFU-type and 
A-type, whose general structures are reported in fig. 10 and further discussed in the following 
paragraphs. 
U-type scaffolds 
To date, the U-type scaffold proteins, defined by the presence of three conserved cluster-
binding cysteines arranged in the CX24–26 CX42–43C motif in their primary sequence (Fontecave M. 
& Ollagnier-de-Choudens S., 2008), are the best characterized. Different scaffold proteins with 
distinct features, such as IscU/ISCU, SufU and a group of NifU proteins, belong to this class. In 
particular, when compared to IscU, SufU has a modified motif with a 18-21 amino acids insertion 
between the two last cluster-binding cysteines, and a lysine residue, instead of a histidine, 
immediately before the third cysteine residue of the motif. Moreover, as mentioned before, SufU 
lacks the LPPVK sequence that allows IscU to bind the transfer protein HscA (Johnson D.C. et al., 
2005). On the other hand, NifU shares only one of its three domains with this class of proteins. In 
fact, it is a homodimeric protein containing three conserved domains, and only the N-terminal one 
has the right characteristics to be considered an U-type scaffold. This domain possesses the three 
conserved cluster-binding cysteine residues in which FeS clusters are synthetized and bound in a 
labile way, meanwhile the C-terminal domain contains two other conserved cysteines, typical of 
NFU-type class scaffolds, that could provide an additional assembly site for the formation of these 
cofactors. Finally, the central domain harbors a “permanent” [2Fe2S] cluster bound to four 
conserved cysteine residues, and probably involved in redox reactions of the biosynthetic pathway 
(Smith A.D. et al., 2005). The peculiar three cysteines motif of these U-type scaffolds confers them 
the aptitude to bind FeS clusters stably enough to allow their assembly, keeping the capability to 
move them to the target apoproteins. These functional properties are made possible by the presence 
of the three conserved cysteines residues FeS clusters binding site and, in close proximity, of 
additional residues that destabilize the binding of the cofactor. Indeed, mutations of these 
“destabilizing” residues produce U-type scaffold proteins that stably keep in site the de novo 
synthetized FeS clusters (Foster M.W. et al., 2000 and Yuvaniyama P. et al., 2000). Moreover, it 
has been recently observed that the oligomeric state of IscU would be functional for the 
coordination of different FeS clusters. In fact, IscU monomers are usually thought to bind [2Fe2S] 
clusters, while upon dimerization the binding of a [4Fe4S] cluster can occur at the interface between 
the two monomers, to which the cluster-binding cysteines are exposed (Fantini M. et al., 2017).  
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NFU-type scaffolds 
Peculiar of the NFU-type class is the presence of two conserved cysteine residues arranged 
in the characteristic CXXC motif. As mentioned above, the C-terminal domain of NifU is a perfect 
example. In this case, the assembly of a [4Fe4S] cluster can occur at the interface of a NifU 
homodimer, through the coordination of the cofactor by the two conserved cysteine residues of each 
monomer, and the cofactor can be then rapidly transferred to the apo nitrogenase (Smith A.D. et al., 
2005). Proteins belonging to this class are usually named NFU or NFU-like proteins, and have been 
found in many organisms, from cyanobacteria to humans. NFU-type scaffold proteins typically 
have the capability of bind and transfer [2Fe2S] clusters, although human NFU and bacterial NifU 
can work with [4Fe4S] clusters (Fontecave M. & Ollagnier-de-Choudens S., 2008). As far as 
concerns the NifU protein, which has U-type and NFU-type scaffold domains, it is interesting to 
underline that both domains can work separately for in vitro maturation of target apoproteins, 
although the U-type domain seems to have a dominant function (Smith A.D. et al., 2005). 
A-type scaffolds 
A-type proteins have all the characteristics to be considered proper scaffold proteins: as U-
type scaffolds, they also contain three conserved cysteine residues, arranged in the CX63–65CXC 
motif, and experimental evidences showed that proteins belonging to this family are able to 
assemble and transfer FeS clusters. This class includes the proteins IscA/ISCA, SufA and ErpA 
(Fontecave M. & Ollagnier-de-Choudens S., 2008). However, the stoichiometry and the type of 
clusters ([2Fe2s] or [4Fe4S]) that would be bound by these proteins are still controversial. Another 
open issue is the oligomeric state of these scaffolds that allows them to bind the metal cofactor. The 
only fully resolved holo IscA is from T. elongatus (1X0G), which shows a tightly bound dimer of 
asymmetric dimers coordinating two [2Fe2S] clusters. The cofactors are bound at the interface of 
the C-terminus of both monomers of the asymmetric dimers, through the three conserved cysteines 
of one monomer and the third cysteine of the CX63–65CXC motif of the other one (Morimoto K. et 
al., 2006). This suggests that the tetramer is the functional scaffold unit of this protein, nevertheless 
it has been also proposed that cluster coordination can occur without the formation of a tetramer 
(Fantini M. et al., 2017). Moreover, the A-type proteins have been hypothesized to be potential iron 
chaperone rather than proper scaffolds (Johnson D.C. et al., 2005, Fontecave M. & Ollagnier-de-
Choudens S., 2008). Iron donors are almost totally uncharacterized for all FeS clusters biosynthetic 
pathways and this hypothesis, if confirmed, would provide new clues. Furthermore, for particular 
organisms as cyanobacteria, it has been proposed that the A-type proteins could serve as sensors of 
the FeS cluster status of the cell (Balasubramanian R., 2006). Anyway, A-type proteins appear to be 
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required only under selected conditions or in particular pathways, since their specific inactivation 
gives relatively minor effects on cellular cluster assembly (Fontecave M. & Ollagnier-de-Choudens 
S., 2008). On the other hand, this class of scaffold proteins, despite their apparent marginal role, 
needs to be better characterized to allow the proper comprehension of the whole biosynthetic 
system in which they are involved. 
Even though these three classes include a large number of scaffold proteins, other proteins 
playing the same role but characterized by different conserved structural and functional motifs 
cannot be considered to belong to them, including HydF, the scaffold protein involved in the 
biogenesis of the H-cluster of [FeFe]-hydrogenases, as assessed above. This protein is the subject of 
the first part of this PhD thesis and is described in more detail in Chapter 1.   
 Thus, scaffold proteins involved in FeS cluster biogenesis share some important features. 
First of all, it is evident that the coordination of the metal cofactor is mainly due to conserved 
cysteine residues arranged in precise motifs. Moreover, the oligomerization is clearly fundamental 
for their function, both for the coordination of the FeS cluster and for its transfer to apoproteins: this 
is achieved by modulating the stability/lability of the cluster binding. Furthermore, the cofactor is 
never buried inside the scaffold protein but exposed on its surface to be easily assembled and 
transferred. Finally, these proteins have to possess a high plasticity to specifically interact with 
many functional partners during all steps of the biosynthetic pathway. 
The structural studies of choice to investigate FeS proteins 
What emerges from several studies performed on the FeS clusters biosynthetic systems is 
that the cooperation of multiple proteins is essential for their correct activity. In particular, the 
structure of the scaffold proteins, their conformational dynamics as well as the molecular 
requirements needed for their interactions with the functional partners are key points to be further 
studied to complete the characterization of these essential biochemical pathways. These key issues 
can be addressed by a series of structural studies which, for FeS proteins, include as analytical 
techniques of choice Isothermal Titration Calorimetry (ITC), fluorescence spectroscopy, Dynamic 
Light Scattering (DLS), Circular Dichroism (CD) combined with two more advanced spectroscopic 
techniques: Electron Paramagnetic Resonance (EPR) and Nuclear Magnetic Resonance (NMR). In 
particular, EPR is historically the ultimate technique for the study of FeS proteins, allowing the 
characterization of the clusters along with their protein coordination; moreover, EPR, coupled to 
site-directed mutagenesis and spin labeling techniques, can also be exploited to perform several 
structural and conformational studies in isolated proteins and in complex systems. NMR, beside the 
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classical structural studies for which it can be utilized, is useful to examine protein interactions 
allowing to assess in detail also labile protein complexes, which would be difficult to study with 
other techniques.  
EPR spectroscopy 
The Electron Paramagnetic Resonance (EPR) is a spectroscopic technique that allows 
studying species containing unpaired electrons, as for example radicals, photoexcited triplet and 
radical pairs states and some metal complexes. The technique is widely used in biological studies 
and in particular it is one of the most applied to study proteins containing FeS clusters. Moreover, it 
also allows to examine inherently EPR-inactive species, exploiting appropriate spin labels able to 
bind to the macromolecules of interest, both in a specific and unspecific manner. The characteristic 
that makes it particularly useful for the study of proteins and complex systems is that EPR allows to 
perform structural and conformational studies, in native conditions and in solution, without the need 
of limiting steps as crystallization. 
There are many different EPR techniques, from basic to the most advanced approaches, that 
allow to obtain different information, on the observed sample. The most useful for structural studies 
are: 
 Continuous Wave EPR (CW-EPR). In this technique, the sample is irradiated with a 
fixed electromagnetic radiation at microwave frequency, while the intensity of a 
static magnetic field is continuously varied. Resonance conditions are reached when 
the energy difference between spin levels, determined by the static magnetic field 
and the characteristics of the sample, equals the energy associated to the microwave 
radiation.  
 DEER (Double Electron-Electron Resonance) or PELDOR (pulsed electron-electron 
double resonance). It is a complex pulsed EPR technique that exploits particular 
microwave pulses at two different frequencies, to measure the dipolar interaction 
between the magnetic moments of spin probe couples to determine their distance.  
 
General principles 
The principles of EPR spectroscopy are very similar to those of Nuclear Magnetic 
Resonance, however different spins are observed (electron and nuclear spin, respectively). To 
observe an EPR signal, an interaction between the electromagnetic radiation and the magnetic 
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moments associated to the electron spin of the sample, in the presence of an external magnetic field, 
must occurs. As mentioned above, the sample must have an angular momentum of the electron spin 
S not null, which generates an antiparallel magnetic dipole moment ȝ. For example, for radical 
species (S =  ½), inserted in a static and uniform magnetic field B, the spin associated magnetic 
moment ȝ interacts with the latter (Zeeman interaction), giving rise to the loss of degeneration of 
the two possible electron spin states α (+½) and ȕ (-½). The transition from a spin state to the other 
occurs if the system absorbs a quantum of energy corresponding to the energy difference between 
the two states, respecting the resonance condition (hȞ = ΔE). The resonance condition can be 
obtained either maintaining the magnetic field constant and varying the frequency or maintaining 
the frequency constant and varying the magnetic field, as in CW-EPR (fig. 11).  
 
Figure 11. Energetic levels for a system with a single isolated electron with S = ½ (α = ½ and ȕ = -½) 
as function of the applied static magnetic field B0. 
 
The two spin states α and ȕ are populated according to the Boltzmann distribution, so at 
room temperature, due to the energy difference between the two states, the one at lower energy is 
more populated when compared to the one at higher energy. Therefore, in EPR measurements the 
energy difference between α and ȕ spin states tends to increase with the external magnetic field, 
until it reaches the resonance value with the electromagnetic microwave radiation at constant 
frequency; this generates an absorption peak (registered in the EPR spectrum). In molecular 
systems, unpaired electrons can magnetically interact with some nuclei. In fact, the latter can 
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possess an angular momentum of spin (I) too, that in turn corresponds to a magnetic moment. 
Consequently, in the presence of a nuclear spin the electron spin is affected by an additional 
magnetic field generated by the nuclear magnetic moment (Fermi contact interaction), influencing 
in turn the resonance conditions. Magnetic dipole-dipole interaction between electron and nuclear 
magnetic moments is also observed in solid state or frozen samples, while it is averaged out in 
solution. 
This interaction between nuclei and electrons is named hyperfine interaction (similar to the J 
coupling in NMR), and causes the separation of the EPR resonance signal in 2nI + 1 peaks (where n 
is the number of equivalent nuclei and I is the angular momentum associated to the nuclear spin). 
For the experimental content of this PhD thesis, it worth to note that in nitroxides (chemical 
compounds containing the functional group R2NO∙), paramagnetic species widely used as spin 
labels in biological macromolecules, the unpaired electron of the NO∙ moiety is coupled to a 14N 
nucleus. In this case, the possible spin configurations are six, given by the combinations of electron 
(+ ½ and - ½) and nuclear (+1, 0 and -1, being I=1) angular momentum. According to the selection 
rules, the only permitted transitions are ΔMI = 0 e ΔMS = ± 1, that are only three of the 
abovementioned six, thus giving three peaks in the EPR spectrum (fig. 12), as expected (2nI + 1 = 
3, for a 14N nucleus having I = 1) 
 
Figure 12. Energetic levels for a constant field system with S = ½ and I = 1. Double-headed arrows 
indicate permitted transitions. On the right, the derivative of the resulting EPR signal (MI= quantum number 
for projections of nuclear spin; MS = quantum number for projections of electron spin) 
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The separation between EPR lines is determined by the hyperfine coupling (a0), that for 
species in solution contains only the Fermi contact term. If the motion in solution is slow, or in 
frozen samples, the line separation depends also on a dipolar coupling between electron and nuclear 
spin momentums. 
Spin labeling 
 As previously mentioned, to study inherently non-paramagnetic proteins by EPR, it is 
necessary to introduce EPR-active labels, the so called spin probes, in selected regions of the 
molecule of interest. This procedure is called spin labeling and can be carried out in two main ways. 
The first involves the direct incorporation of paramagnetic amino acids during the chemical 
synthesis of the protein. However, this procedure is expensive and complicated and cannot be 
applied to study large polypeptides. The most versatile and used technique is the binding of 
particular spin probes to selected residues of the protein of interest. In most cases, the thiol group of 
cysteines, naturally present on the observed protein or inserted via site-directed mutagenesis, is 
exploited to bind the spin probe through a sulfide-mediated bond. 
 
 
 
Figure 13. Representative scheme of site-directed spin labeling procedure (A) and relative spin probes 
(B).  B) Chemical structures of four common nitroxide spin labels before and after reacting with a cysteine 
residue. 1) and 2) MTSSL; 3) and 4) IAP; 5) and 6) MSL; and 7) and 8) IASL. The black ovals represent the 
labeled proteins, the green spot represents the labelled site of interest. 
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The spin probe usually consists of a nitroxide, a particular paramagnetic species that 
presents a stable unpaired electron on its NO∙ group, as mentioned above. To perform this kind of 
labeling it is necessary to have the cysteine residue only in the selected site, while replacing by site-
directed mutagenesis all the other cysteines, usually with alanine or serine residues because of their 
similar structure (Bordignon E. & Steinhoff H.J., 2007). Many nitroxide spin probes are 
commercially available, with different characteristics, such as steric hindrance, length, mobility. 
Among them, MTSSL ((1-oxyl-2,2,5,5-tetramethyl-Δ3-pyrroline-3-methyl) methanethiosulfonate), 
IAP (3-(2-iodoacetamido)-proxyl), MSL (4-maleimido-TEMPO) and IASL (4-(2-iodoacetamido)-
TEMPO) (TEMPO stands for 2,2,6,6-Tetramethylpiperidine-1-oxyl) (fig. 13B) are the most widely 
used (De Vera I.M.S. et al., 2015) because of the specific reactivity for the cysteine residues thiol 
group, the volume compactness, and the flexibility that allows labeled proteins to maintain their 
native folding (Czogalla A. et al., 2007). Moreover, these characteristics slightly vary between the 
different spin probes, allowing multiple studies on the same site with different labels. The general 
site-directed spin labeling procedure is schematized in figure 13 A. 
CW-EPR 
 These experiments are usually performed in X band, i.e. with a microwaves frequency of 
about 9 GHz. Once emitted by the generator, these waves pass through the sample and are finally 
registered by the detector. As mentioned before, in this kind of experiment the magnetic field 
varies, while the microwaves are maintained constant. As  a consequence of the radiation absorption 
by the sample, when resonance conditions are reached, the impedance changes. Thus, the 
microwaves are reflected to the detector, proportionally to the sample absorption, giving rise to the 
EPR signal. Thanks to this technique, it is possible to obtain information on the dynamic of the spin 
probes bound to the macromolecule of interest. The EPR spectra lineshape is indeed strongly 
affected by the motion of the spin probe, and therefore by its mobility and surrounding constrains. 
Nitroxides, because of the characteristics previously described, are particularly suitable for 
conformational and dynamic studies of macromolecules as proteins. Spin probes spectra become 
broader and with marked variations of the relative peaks intensity as the nitroxides lose mobility, 
differentiating more and more from the typical free spin probe spectra, characterized by three 
narrow peaks (fig. 14). 
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Figure 14. EPR spectra corresponding to different rotational correlation times. A) When the spin label 
motion is fast, the EPR spectrum has three sharp lines of approximately similar height. B), C) As the motion 
slows down, the EPR lines broaden, resulting in a decrease of their amplitudes. D) For the motionless spin 
label, a rigid limit spectrum is observed (modified from Stoll S. & Schweiger A., 2006). 
 
The mobility of the spin probe can be correlated to the rotational correlation time (τc). This 
parameter is inversely proportional to the mobility of the nitroxide, therefore the higher is the τc the 
lower is the mobility of the nitroxide and, as result, the broader and asymmetric is the spectrum, and 
vice versa (Oppenheim S.F. et al., 1996). Moreover, different spin probe conformations may be 
possible in the same macromolecule, thus giving an EPR spectrum with different overlapping 
signals, resulting in a multicomponent spectrum. If the mobility difference is large enough to 
separate the different peaks, it is possible to distinguish the components as depicted in  figure 15, 
and to quantify by spectra simulation.  
 
Figure 15. EPR spectra with different components associated to spin probes with different mobility  
(indicated with black arrows) (Vignais P.M. & Colbeau A., 2004). 
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These different CW-EPR analysis allow several structural studies of proteins, and can be 
exploited for the characterization of conformational changes of labelled proteins in solution, upon 
variations of experimental conditions or after external stimuli (addition of substrates, interaction 
with other macromolecules), as this may modify the spin probe surroundings and its dynamics, 
mobility and solvent accessibility, depending on the position of the label. 
 
DEER/PELDOR 
 This advanced EPR technique can give information on the distance among two spin probes, 
positioned in a range between 17 and 80 Å, by assessing the weak magnetic dipolar interactions 
between the two spins. It is a pulsed EPR experiment, since it exploits a particular sequence of 
microwaves pulses, at two different frequencies, to excite two different spin populations. Thus, it is 
possible to observe if and how the two spin populations affect each other through weak dipolar 
interactions. According to the intensity of these dipolar interactions, the distance measurement is 
obtained. This is possible thanks to the correlation that occurs among these interactions and the 
distance between the two interacting spins, described by the equation: 
D = f (1/r3) 
where D is the dipolar interaction, r the distance between the spins and f a function of dipole 
moments and space permeability. Technically, the DEER signal is a modulation of the spin echo 
amplitude generated by a particular sequence of pulses directed to a spin population (A) (fig. 16 A). 
This is affected by another spin population (B) which is pumped by a second microwave radiation. 
If these two populations, A and B, are close enough, and the first is influenced by the variation of 
the dipolar field generated by the second, the echo of A will be modulated upon the inversion of the 
spin B by the pump.  
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Figure 16. Example of a DEER experiment performed on a bis-labeled protein. A) (left) shape of the 
EPR spectrum in which the two different populations are excited by the pulses A and B, according to the 
sequence of the DEER experiment (right). B) the DEER signal is normalized to t = 0, with phase and 
background correction, and with the best fitting. C) The distances between the spin probes are obtained from 
the time-dependent track processing (modified from Tsvetkov Y.D. et al., 2008). 
 
In the case of a bis-labelled protein, the DEER signal is given by two components: the relaxation 
due to intermolecular interactions between unpaired spins (background signal), and periodic 
oscillations generated by intramolecular spin interactions (fig. 16 B). The distance between the spin 
probes inserted in the species under consideration can be obtained by appropriate processing from 
the frequency of the oscillations, which reflects the magnitude of the dipolar interaction between the 
two spin populations (fig. 16 C). 
NMR 
It is well known that Nuclear Magnetic Resonance (NMR) spectroscopy is a technique that, 
by exploiting the magnetic properties of certain atomic nuclei, can determine the physical and 
chemical properties of the molecules in which they are present. In fact, NMR can provide many 
detailed information about the observed molecules, including structure, dynamics, reaction state, 
and chemical environment. Thanks to its potential, this technique is mainly used by chemists and 
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biochemists to investigate the properties of organic molecules ranging from small compounds to 
large macromolecules as proteins or nucleic acids. Because of the much higher number of atoms 
present in a protein when compared to a small molecule, the basic 1-dimension (1D) NMR 
spectrum becomes more complicated, with overlapping signals difficult to interpret. Therefore, the 
study of large macromolecules is allowed by multidimensional (2, 3 or 4D) NMR experiments that 
exploit the characteristic frequency of different NMR active nuclei to split the signals in more than 
one dimension, to prevent crowded spectra (fig. 17). 
 
Figure 17. 1D, 2D and 3D NMR spectra of proteins. Crowded and hardly interpretable 1D NMR protein 
spectra (left); resolved 2D and 3D spectra of respectively 1H and 15N, and 1H, 13C and 15N labeled proteins 
(respectively center and right). 
 
In particular, NMR active 1H, 13C and 15N nuclei are usually the most frequently exploited 
for proteins investigations. Unfortunately, 13C and 15N isotopes are naturally not enough abundant 
to study proteins expressed at physiological levels, so it is necessary to enrich them with these 
isotopes. For example, to analyze proteins heterologously expressed in Escherichia coli it is 
necessary to grow bacteria in particular media in which the only C and N sources contains high 
percentage of 13C and 15N isotopes (usually 15N ammonium chloride and 13C D-glucose).  
Despite NMR is largely applied for proteins 3D structure determination, this technique can 
be also efficiently exploited to study protein-protein interactions. In particular, a 2D NMR 
technique, the Heteronuclear Single-Quantum Correlation spectroscopy (HSQC), is widely used in 
the field. HSQC assesses correlations between nuclei of two different types (usually 1H and 13C or 
1H and 15N) which are separated by one bond. This method gives a bi-dimensional spectrum with 
one peak (also called crosspeak) per pair of coupled nuclei, whose two coordinates are the chemical 
shifts of the two coupled atoms (Guéron M. & Leroy J.L., 1969). In the case of a 15N labelled 
protein, all HN couples are observed, corresponding to all the HNs of the protein backbone 
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(exception made for prolines) and the ones of some amino acids sidechains such as those of 
asparagines, glutamines, arginines, histidines (depending on the pH), and tryptophans indole ring. 
Thus, on the HSQC bi-dimensional spectrum there is a crosspeak for each HN, giving a unique 
footprint of the observed protein in that particular conditions. Moreover, since it is possible to 
assign each crosspeak to the respective amino acid on the protein primary sequence, and since the 
position and intensity of each crosspeak is strongly influenced by the chemical environment of the 
respective HN, it is possible to address the effect of any variation in this environment, as for 
example due that to the interaction with a partner, and to determine how and in which place this 
interaction takes place.  
 
Chemical shift perturbation 
 The technique applied to perform studies of protein-ligand or protein-protein interactions 
with NMR is the so called CSP (Chemical Shift Perturbation). The CSP allows, at least in principle, 
the determination of many features of these interactions, as the localization of the binding site, the 
affinity of the ligand, and/or possibly the structure of the complex in solution. This technique is 
based on the principle that CSP correlates changes in the chemical shifts of a protein when a ligand 
is added (Williamson M.P., 2013). The HSQC of 15N labeled proteins results to be the most suitable 
2D NMR experiment to perform CSP analysis. Indeed, while 13Cα and 13Cβ shifts are mainly 
influenced by through-bond effects, and 15N and 13C‟ shifts are influenced both by through-bond 
and by through-space (hydrogen bonding) interactions, 1H shifts are influenced to a large extent by 
through-space interactions; in this case, HNs result to be the best species to be analyzed to study 
interactions with this technique because it is particularly sensitive to the chemical environment. In 
particular, the observed 15N-protein is titrated with an unlabeled ligand (a small molecule or another 
macromolecule), and the system is monitored at each stage of the titration by acquiring a 2D HSQC 
spectrum (Zuiderweg E.R.P., 2002). Since chemical shift change is very sensitive to structural 
changes, and can be measured very accurately, almost any interaction can produce CSPs, thus 
allowing also the study of very weak and unstable protein-protein or protein-ligand complexes (fig. 
18). Moreover, and for the same reasons, the technique can be exploited to exclude ligand binding, 
even without a chemical shift assignment of the 2D HSQC spectrum: in this case, the absence of  
chemical shift changes can be interpreted as a lack of significant interaction. To perform this 
technique in such a reliable way, because of the system sensitivity to the environment, a 
fundamental issue is that the titration must be performed in strictly controlled experimental 
conditions. In particular, it is important to use the same buffer for protein and ligand, because even 
33 
 
very small changes in pH or salt concentration can alter protein signals, compromising the 
reliability of the experiment (Williamson M.P., 2013). 
 
Figure 18. Example of the outcome of a CSP experiment of a 15N-protein peak, and the relative 
information: ligand binding site and its mapping on the protein 3D structure, if peak assignment and 3D 
structure are available (right, upper part), and affinity of the observed protein for the ligand (right, lower 
part). On the left part, the shift of a protein peak is followed of upon the titration with a ligand (from red 
peak, no ligand, to blue peak, maximum ligand concentration of the titration).  
 
In case of fast-exchange between the protein and the ligand (relatively weak binding), the 
analysis involves the measure of the chemical shifts at each titration point to monitor how and to 
which extent each peak moves throughout the titration. The most perturbed peaks are very likely to 
map to the ligand binding site. For the correct quantification of the peaks shifts in 15N-proteins, it is 
fundamental to properly weigh 15N and 1H shifts once they have been measured, since the ppm 
scale of the two shifts is different (with 1H usually ranging between 0 and 11 ppm, while 15N 
ranging between 100 and 135 ppm). To this end, 15N shifts are usually normalized by an empirically 
determined factor (of usually 0.14 – 0.2) to 1H shifts (Williamson M.P., 2013 and Grzesiek S. et al., 
1996). Then, the average (or summed) Euclidean distance is calculated with an equation of the type 
  √        ሺ       ሻ  
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where d is the calculated distance, δH and δN are the shifts measured in 1H and 15N dimensions 
respectively, and α is the weighting factor (Williamson M.P., 2013). Then, a threshold is applied, 
according to the standard deviation of the shift for all residues and to the sensitivity of the 
experiment, to determine which shifts are significant or not (Williamson M.P., 2013). 
Furthermore, in favorable cases,  the peaks movements relative to the titration, if plotted in a 
curve in which the chemical shift varies as a function of  function of the ligand concentration, can 
be fitted, often straightforwardly, to obtain the affinity (as the value for the dissociation constant, 
Kd) of the ligand. Hence, while CSP can be used to obtain Kd values also in the absence of 
assignments, or to compare which peaks possibly move upon the addition of different ligands, this 
technique is much more powerful when the assignments are known: in this case, CSP is the only 
technique that can directly provide both the affinity and the localization of the binding site from the 
same experiments (McCoy M.A. & Wyss D. F., 2002). If the 3D structure of the observed protein is 
available, once identified the binding regions in the primary sequence, it is possible to map them in 
the whole structure; furthermore, if the 3D structure of the ligand is also available, these data can be 
exploited to obtain docking models of the complex between two interacting molecules (Williamson 
M. P., 2013). 
  
Band-Selective Optimized Flip-Angle Short-Transient Heteronuclear Multiple   
Quantum Coherence (SOFAST HMQC) 
 
 When working with proteins, a typical issue is that is not always possible to operate at high 
protein concentrations, because of loss of stability or tendency to aggregation, especially with 
complex of proteins. Moreover, high concentration of proteins, usually needed for many techniques, 
may not reflect the physiological conditions in which they usually work and interact with potential 
partners. In particular, in NMR analysis, if samples are not enough concentrated long-lasting 
measurements must be performed to obtain interpretable results, especially for titration 
experiments; these acquisition times are often not compatible with biological samples and 
instrument-time availability. For example, for typical 2D HSQC NMR experiments on 15N-proteins, 
using conventional room-temperature probes, a sample concentration of at least 300 - 400 ȝM is 
necessary to obtain exploitable results in a relative short time. A critical problem occurs when 
neither high concentrations nor long time acquisitions can be accomplished. To overcome this issue, 
a particular NMR experiment, the SOFAST HMQC (band-Selective Optimized Flip-Angle Short-
Transient Heteronuclear Multiple Quantum Coherence) can be successfully exploited. This 
technique was indeed initially developed to perform real-time investigations of dynamic events in 
proteins on the time scale of seconds, as for example to follow protein folding or reaction kinetics; 
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this requires relatively  fast acquisition times, on the time scale of seconds; thus the SOFAST-
HMQC allowed significant decreasing of experimental times while maintaining an acceptable 
sensitivity (Schanda P. & Brutscher B., 2005). However, in the same way, the technique can be 
exploited to maintain normal acquisition times (tens of minutes) while decreasing the protein 
concentrations. The SOFAST is based on HMQC, a technique which provides spectra very similar 
to HSQC but with a different pulse sequence. In particular, in the former, during the evolution time 
both 1H and 15N magnetization are allowed to evolve whereas in a HSQC only 15N magnetization 
evolves in the 15N-dimension. As a consequence, peaks result slightly broader in HMQC compared 
to HSQC, which anyway contains more pulses respect to the previous. The HMQC experiment  
results therefore to be less susceptible to losses in signal-to-noise-ratio due to non-perfect pulse 
performance (fig. 19) (Ernst R.R. et al, 1990). 
 
Figure 19. Comparison between HSQC and SOFAST-HMQC experiments to record 
1
H-
15
N 
correlation spectra of proteins. The fewer and particular pulses of SOFAST-HMQC experiment that lead 
to higher sensitivity in lower acquisition times are evidenced (modified from Schanda P. & Brutscher B., 
2005 and Ward J.M. & Skrynnikov N.R., 2012) 
 
Furthermore, in SOFAST-HMQC experiments the use of optimized flip angles allows an 
increase in the repetition rate of the experiment without losing much signal-to-noise-ratio per unit 
time (Ross A. et al., 1997). Moreover, in this experiment the sensitivity is further increased by 
enhanced 1H spin-lattice relaxation due to band-selective 1H pulses (Schanda P. & Brutscher B., 
2005). In fact, the selective manipulation of a subset of proton spins in a protein, while leaving all 
other protons unperturbed, yields significantly shortened relaxation times, resulting in a further 
increase of repetition rate (Pervushin K. et al., 2002). Therefore, in practice, the SOFAST 
experiment exploit HMQC and 1H band-selective pulses to dramatically shorten acquisition times 
while maintaining high sensitivity, thus allowing to perform both very fast experiments with high 
sample concentrations or normal timescale experiments with low sample concentrations.  
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One major issue of this technique is that, due to the band-selective pulses, which should not 
excite  water signals, the peaks with 1H chemical shifts close to water peaks have usually very low 
intensities, and thus can be lost in the final 2D NMR spectra (fig. 20). 
 
 
Figure 20. Comparison between HSQC and SOFAST HMQC spectra of the same 15N-protein. 
Highlighted in the dashed squares the protein peaks close to water ppm in 1H dimension, fading in SOFAST 
HMQC spectra. 
 
Finally, CSP performed with SOFAST HMQC can be the ideal experiment to deeply 
characterize even very weak and unstable protein-protein interactions, at relatively low 
concentration, preventing aggregation, precipitation and low-protein-stability correlated issues. 
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Aim of the thesis 
 
FeS clusters are ancient prosthetic groups, widely diffused in almost all living beings in 
which they are involved in several fundamental metabolic pathways, including redox reactions, 
electron transfer, enzyme catalysis and many other functions. According to this assortment, many 
different FeS clusters exist, from the simple rhombic [2Fe2S] and cubic [4Fe4S] clusters to the 
highly complex 2Fe[4Fe4S] H-cluster (as in [FeFe]-hydrogenases). Distinct biosynthetic pathways 
for the assembly of different FeS clusters exist, in both prokaryotic and eukaryotic microorganisms. 
In general, these are rather complex processes carried out by many proteins interacting with each 
other. Despite this variability, FeS clusters biosynthetic systems are highly conserved in terms of 
action strategy, divided in two main steps: the assembly of the FeS cluster on a scaffold protein and 
the subsequent transfer of the de novo generated cofactor from the scaffold to the acceptor 
apoprotein, which is eventually converted into the mature active holoprotein. Both steps require key 
scaffold proteins, that must be able to dynamically interact with the biosynthetic partners as well as 
with a combination of several chaperones and co-chaperones which participate into the final 
transfer of the prosthetic group to the recipient FeS protein. Thus, scaffold proteins and their 
interactions with all the functional partners are key points. However, a clear structure-function 
relationship is still an open issue for many of them, and the complex multistep molecular pathways 
in which they are functionally involved have to be further explored for a complete characterization. 
My PhD experimental work has been part of a larger project aimed at filling these gaps. Two 
distinct pathways for FeS cluster biogenesis have been addressed, with a particular focus on the 
structural features of the respective scaffold proteins, which I have investigated by a 
multidisciplinary approach ranging from basic molecular biology and biochemistry techniques to 
more specific spectroscopic approaches, such as EPR and NMR. In the work reported in Chapter 1, 
I studied the conformational dynamics of HydF, a small GTPase scaffold protein involved in the 
maturation of the [FeFe]-hydrogenases. The second part of my activity has been dedicated to the 
analysis of the human mitochondrial FeS clusters biosynthetic system (Chapter 2), investigating the 
direct interaction between the scaffold protein ISCU and frataxin, a small iron-binding protein 
whose specific function is still under debate. 
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Chapter 1 
 
The GTPase domain of [FeFe]-hydrogenase maturation protein HydF 
is a molecular switch. GTP binding triggers conformational changes, 
as revealed by Site Directed Spin Labeling and EPR spectroscopy 
 
 
 
 
 
 
 
[FeFe]-hydrogenases catalyze the reduction of protons to hydrogen at a complex 
2Fe[4Fe4S] center called H-cluster. The assembly of this active site is a multistep process involving 
three proteins, HydE, HydF and HydG. According to the current models, HydF has the key double 
role of scaffold, upon which the final H-cluster precursor is assembled, and carrier to transfer it to 
the target hydrogenase. The X-ray structure of HydF indicates that the protein is a homodimer with 
both monomers carrying two functional domains: a C-terminal FeS cluster-binding domain, where 
the precursor is assembled, and a N-terminal GTPase domain, whose exact contribution to cluster 
biogenesis and hydrogenase activation is still elusive. We previously obtained several hints 
suggesting that the binding of GTP to HydF could be involved in the interactions of this scaffold 
protein with the other maturases and with the hydrogenase itself. In this work, by means of site 
directed spin labeling coupled to EPR/PELDOR spectroscopy, we explored the conformational 
changes induced in a recombinant HydF protein by GTP binding, and provide the first clue that the 
HydF GTPase domain could be involved in the H-cluster assembly working as a molecular switch 
similarly to other known small GTPases. 
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Introduction 
 
 The maturation of [FeFe]-hydrogenases: a central role for the HydF scaffold protein  
Biohydrogen production, one of the most promising frontiers in the field of renewable 
energies, is achieved in nature by several prokaryotic and eukaryotic microorganisms through a 
general class of evolutionarily unrelated metalloenzymes called hydrogenases. Among them, 
[FeFe]- and [NiFe]-hydrogenases are the most widespread (Vignais P.M. & Billoud B., 2007). 
These proteins have different distribution, catalytic properties and molecular architectures, but they 
are both able to reversibly reduce protons to H2 by means of metal clusters with some key 
similarities, including the coordination to the polypeptide chain through four conserved cysteine 
residues and the presence of iron-bound CO and CN− ligands (Peters J.W. et al., 2015). As 
mentioned in the general introduction, in the case of [FeFe]-hydrogenases the active site (H-cluster) 
is particularly complex since it is composed of a [4Fe4S] cubane linked via a cysteine bridge to a 
2Fe subcluster comprising the CO and CN- molecules and an additional dithiomethylamine ligand 
(Peters J. W. et al., 1998, Nicolet Y. et al., 1999 and Chen Z. et al., 2002). This 2Fe subcluster 
needs a specific set of maturation proteins to be first assembled in the active form and then inserted 
into the target apo-[FeFe]-hydrogenase. Three specific conserved proteins are involved in its 
biosynthesis and delivery, i.e. HydE, HydF and HydG, discovered in the unicellular green alga 
Chlamydomonas reinhardtii and then found in all microorganisms containing a [FeFe]-hydrogenase 
(Posewitz M.C. et a., 2004). Both HydE and HydG are radical S-adenosylmethionine (SAM) 
proteins whereas HydF is a GTPase carrying a [4Fe4S] cluster binding motif (Posewitz M.C. et al., 
2004). The 3D crystal structures of all these maturases have been solved (Nicolet Y. et al., 2008 and 
2015, Cendron L. et al., 2011 and Dinis P. et al., 2015), and several in vitro and cell-free 
experiments using purified recombinant proteins have been performed to understand their functions, 
allowing to propose a two-steps model that describes a H-cluster biosynthetic pathway in which a 
2Fe precursor is assembled and chemically modified on a scaffold protein prior to the transfer to the 
apo-hydrogenase (Shepard E.M. et al., 2014 and Peters J.W. & Broderick J.B., 2012). Several 
independent experiments indicated that HydE and HydG would be responsible for the 
dithiomethylamine and CO/CN- biosynthesis respectively (Betz J. N. et al., 2015,  Kuchenreuther J. 
M. et al., 2014, Pagnier A. et al., 2016), and that HydF plays the double key role of scaffold and 
carrier of the H-cluster precursor (McGlynn S.E. et al., 2008, Shepard E.M. et al., 2010 (1), Mulder 
D.W. et al., 2011 and Berggren G. et al., 2013). Although many unresolved questions remain, the 
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most widely accepted model consists in the building of the synthon Fe(CO)2CN by HydG, with two 
synthons needed to synthesize a [2Fe]H subcluster (Kuchenreuther J.M. et al., 2014). To further 
support this hypothesis, a synthetic [2Fe] precursor has been loaded into HydF to finally yield the 
active hydrogenase (HydA) (Esselborn J. et al., 2013), suggesting a key role of HydF in the last 
steps of the H-cluster maturation and delivery.  
HydF: structural features 
As a scaffold protein, HydF must efficiently interact with the two maturation partners (i.e. 
HydE and HydG), and with the target apo-hydrogenase itself, keeping them in close proximity in 
order to get a functional unit able to follow the ordered biosynthetic pathway described in the 
proposed stepwise model, described in the general introduction. Several functional insights have 
been gained from spectroscopic analyses of the FeS cluster carrying protein in solution as well from 
the 3D structure of the apo-HydF (i.e. devoid of both GTP and FeS cluster), which has been solved 
in our laboratory (fig. 21). 
 
Figure 21. Crystal structure of HydF from Thermotoga neapolitana (PDBID: 3QQ5). The HydF dimer 
is shown as a cartoon drawing on the left and the monomer zoomed  on the right. In the dimer the two 
monomers are related by a 2-fold axis, approximately parallel to the plane of the paper in the horizontal 
direction. Cysteine side chain residues are in red; putative GTP binding regions are shown in dark blue. The 
three domains, labeled I, II, and III, are in different shades of green, and the loop connecting domains I and II 
is in brown. The side chains of the three cysteines involved in subcluster binding are shown in red (modified 
from Cendron L. et al., 2011).  
As illustrated in fig.21, HydF is a dimer in which each monomer is composed of three 
distinct domains: domain I, with the consensus sequences for the binding of GTP; domain II, 
dimerization domain; domain III, with the consensus sequences for the binding of a [4Fe4S] cluster 
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(Cendron L. et al., 2011). Domain II allows two monomers to associate through a large surface, 
giving rise to a stable, left-handed helical shaped dimer with an open and accessible surface 
enabling it to interact with potential partners. Two dimers of HydF can aggregate to form a  
tetramer (dimer of dimers), as reported in fig. 22; the dimerization of HydF dimers is mediated by 
disulphide bonds of conserved cysteine residues of the FeS cluster binding site, likely due to the 
absence of the cubane in the crystallized protein. Moreover, the cluster sites in the tetramer are 
concealed, and the open form of HydF guaranteed by the dimeric structure, where both the cluster 
and the GTP-binding site are fully accessible to the possible interactions with other maturases, is 
prevented (fig. 22).  
 
Figure 22. The structure of tetrameric HydF. A: cartoon representation of the tetramer in which one 
dimer is in green and cyan, and the other is in yellow and orange. B: van der Waals model of the tetramer. 
Cysteine residues, barely visible, are shown as red spheres, and residues potentially involved in the binding 
of GTP are shown as blue spheres red (modified from Cendron L. et al., 2011). 
 
Thus, dimer would be the functional form of HydF allowing the interaction with HydE and HydG 
for the assembly of the H-cluster. The [4Fe4S] cluster coordination sphere of HydF has been 
thoroughly investigated by spectroscopic analysis of the protein in solution, which provided several 
clues on how the H-cluster precursor is kept in-site by the scaffold during biosynthesis and 
chemical modifications by HydE and HydG; however, the exact mechanism by which the mature 
precursor is transferred from the scaffold to the hydrogenase has not been clarified (Shepard E.M. et 
al., 2010 (1), Brazzolotto X. et al., 2006, Czech I. et al., 2010 and 2011, Berto P. et al., 2012, 
Berggren G. et al., 2014 and Albertini M. et al., 2014 and 2015). A further unresolved issue is the 
specific role of the HydF GTPase moiety, which is essential for the [FeFe]-hydrogenase maturation 
and activation (King P.W. et al., 2006). 
This issue is the subject of the experimental work performed in the first part of my PhD 
program, whose results are reported and discussed in the following paragraphs. 
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The GTPase domain of HydF: looking for a structure-function relationship 
Previous experiments performed in my laboratory showed that the binding of GTP to HydF 
induces the dissociation of HydE and HydG from the scaffold (Vallese F. et al., 2012), suggesting 
that the GTPase domain could be involved in a dynamic network of interactions with the other 
maturases. Interestingly, the crystal structure of the apo-HydF protein indicated the existence of 
flexible loops in this domain (fig. 21), which could undergo structural rearrangements upon GTP 
binding. This could in turn have an impact on the capability of the holo-protein to interact with 
HydE and HydG in the maturation machinery, and to drive the proper delivery of the H-cluster 
precursor to the target hydrogenase. Before starting my PhD project, I explored this hypothesis by 
investigating the intrinsic conformational changes potentially triggered by GTP binding to a 
recombinant isolated HydF domain I (Maso L. e al., 2015). By taking advantage of the EPR 
techniques described in detail in the general introduction, nitroxide spin labeled cysteine residues 
were introduced at diagnostic positions in different elements of the protein secondary structure. 
With the aim of monitoring large rearrangement of the structure combining CW-EPR and PELDOR 
spectroscopies, either in the absence or in the presence of GTP, I analyzed the local mobility of the 
spin label at the selected sites and the distance between couples of labels, respectively. It was found 
that the binding of the nucleotide to the isolated HydF GTPase domain does not induce large 
conformational effects, at least at the level of the positions investigated. Instead, small changes in 
the distance between spin labels were observed, suggesting diffuse rearrangements upon GTP 
binding at the level of these structural elements. These results are reported in the paper by Maso L. 
e al., 2015, attached at the end of the thesis, and have been the starting point of the work discussed 
in this chapter.  
Since the presence of the other two domains may be important in producing structural 
constrains in HydF, by directing and/or amplifying the conformational changes induced at the GTP 
binding site, in my PhD project the same CW-EPR and PELDOR analysis were exploited to map 
the GTP-induced conformational changes along the entire HydF protein, in collaboration with Prof. 
Carbonera from Department of Chemical Sciences. In particular, we evaluated the possibility that 
the HydF GTPase domain functions as a molecular switch, similarly to other small GTPases (Vetter 
I.R. & Wittinghofer A., 2001 and Cherfils J. & Zeghouf M., 2013): indeed, upon GTP binding the 
protein could undergo conformational changes which should be instrumental in promoting HydF 
activity in the maturation process of hydrogenases, as previously inferred from functional studies 
(Shepard E.M. et al., 2016 and Dinis P. et al., 2016). 
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Materials and methods 
Heterologous expression and purification of HydF proteins 
The Thermotoga neapolitana hydF gene was isolated from purified genomic DNA by PCR 
amplification and subcloned in frame with a 6His-tag sequence at the N-terminus in a pET-15b 
vector (from Novagen®), as described in Cendron L. et al., 2011. Site-directed mutagenesis of the 
hydF at selected sites was performed with the QuickChange® II Site-Directed Mutagenesis Kit 
(from Agilent Technologies), using as template pET-15b/hydF recombinant plasmid and the couples 
of primers listed in table 1. The sequence of each mutant hydF gene was confirmed by DNA 
sequencing (at GATC Biotech, Germany). E. coli Rosetta (DE3) cells were transformed with the 
obtained plasmids and positive clones selected by antibiotic resistance. The expression of the wild 
type and mutant 6His-tagged HydF proteins was induced by adding 1 mM isopropyl-ȕ-
thiogalactopyranoside (IPTG) in LB medium and incubating the cells at 30 °C overnight. Proteins 
were purified starting from 0,5 to 1 L cultures and combining affinity chromatography and gel 
filtration. Briefly, cells were harvested by centrifugation, resuspended in lysis buffer (25 mM Tris-
HCl pH 8.0, 200 mM KCl supplemented with protease inhibitors 1 ȝg/ml pepstatin A, 1 ȝg/ml 
leupeptin, 1 ȝg/ml antipain, 1 mM PMSF) and lysed by French press. The supernatant fractions 
were isolated from cell debris by centrifugation and the proteins purified to homogeneity by a 
nickel affinity chromatography (HIS-Select® Nickel Affinity Gel, from Sigma-Aldrich) and a gel 
filtration chromatography using a Superdex 200 GL 10 300 column (from GE Healthcare), 
equilibrated in a buffer containing 25 mM Tris-HCl pH 8.0, 200 mM KCl, and 1 mM MgCl2 (final 
buffer). To estimate the molecular weight of the analyzed samples, the column was equilibrated in 
the same buffer and calibrated with the standards thyroglobulin (669 KDa), ferritin (440 KDa), ȕ-
amylase (200 KDa), bovine serum albumin (67 KDa), carbonic anhydrase (29 KDa) and 
cytochrome c (12 KDa). The eluted fractions containing the HydF dimer were finally pooled 
together and concentrated by centrifugal filters (Amicon Ultra Centrifugal Filter, 10000 NMWL, 
from Merck Millipore) to a volume suitable for spectroscopic analysis (see below), giving rise to a 
final concentration up to 600 ȝM, as determined spectroscopically using İ280nm = 26360 M−1cm−1. 
Purified proteins were analyzed by 12% SDS-PAGE.  
Isothermal Titration Calorimetry (ITC)  
ITC measurements were carried out at 25 °C on a MicroCal OMEGA ultrasensitive titration 
calorimeter. The titrant and sample solutions were made from the same stock buffer solution (25 
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mM Tris-HCl pH 8.0, 200 mM KCl, and 1 mM MgCl2), and both solutions were thoroughly 
degassed before each titration. The solution (75 ȝM wild type HydF protein) in the cell was stirred 
at 200 rpm to ensure rapid mixing. Typically, 7 ȝL of titrant (500 mM either GTP or GTPȖS) were 
delivered every 10 s with an adequate interval (4 min) between injections to allow complete 
equilibration. Titrations continued until no further complex formation following addition of excess 
titrant was detected. A background titration, consisting of identical titrant solution and buffer 
solution in the sample cell, was subtracted to account for heat of dilution. The data were collected 
automatically and then analyzed by the Windows-based Origin software package supplied by 
MicroCal. A one-site binding model was used. 
Circular Dichroism (CD) 
CD measurements were performed with a Jasco J-810 spectropolarimeter. Far-UV CD 
spectra were collected using cells of 0.1 cm path-length. Data were acquired at a scan speed of 20 
nm/min and at least three scans were averaged. Proteins were used at a concentration of 5 ȝM (0.2 
mg/ml), in a 0.5 mM Tris-HCl buffer, pH 8.0, containing 4 mM KCl and 20 ȝM MgCl2. 
Measurements in the presence of GTP were performed in the same samples analyzed in the absence 
of the nucleotide, adding 1 ȝL of GTP to a final concentration of 250 ȝM in 400 ȝL of total volume. 
Experiments were performed at 25 °C using a thermostated Jasco PTC-423 Peltier Cell Holder 
connected to a Jasco PTC-423S Peltier Controller. The secondary structure content of HydF was 
calculated using the CD spectrum deconvolution software CDNN (Bohm G. et al., 1992). This 
software calculates the secondary structure by comparison with a CD database of known protein 
structures.  
CW-EPR 
Samples for EPR labeled with either MTSSL or 5-MSL were obtained by adding to the 
purified protein (at a concentration of about 150 ȝM) a fivefold molar excess of spin label, either 
MTSSL or 5-MSL, dissolved in DMSO and ethanol respectively, and incubating the protein at 4 °C 
overnight in the dark. Excess of non-ligated spin label was removed from the protein by several 
cycles of dilution with final buffer (25 mM Tris-HCl, pH 8.0, 200 mM KCl and 1 mM MgCl2), and 
concentration by centrifugal filters. Twenty microliters of each sample, with a protein concentration 
of about 600 ȝM (in 25 mM Tris-HCl, pH 8.0, 200 mM KCl, and 1 mM MgCl2) were loaded into 
quartz capillaries with 0.6 mm ID and 0.84 mm OD. In GTP binding experiments, GTP (up to 10 
mM) was added to the samples and EPR measurements were performed immediately after the 
addition. EPR spectra were collected at room temperature (298 K) on an Elexsys E580-X-band 
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spectrometer (Bruker) using a Super High Sensitivity Probehead cavity. The field modulation 
frequency was set at 100 kHz, with a field-modulation amplitude of 0.5 G and the microwave power 
was 6.4 mW. Time constant was set at 40.96 ns and conversion time at 81.92 ms; data collection 
was carried out acquiring 1024 points. The center of the field was set to 351 mT and the sweep 
width to 10 mT. Simulations of the CW-EPR spectra were performed using a program based on the 
stochastic Liouville equation and adopting the MOMD model as standard for spin-labeled proteins 
(Budil D.E. et al., 1996). The overall rotational correlation time of the HydF dimer was estimated 
using the program by Barone V. et al., 2009.  
Pulse electron double resonance (PELDOR) 
Samples were exchanged with deuterated buffer. Deuterated glycerol (33% v/v) was also 
added to the samples before freezing. The final protein concentration was about 150 ȝM for all the 
samples. In the nucleotide binding experiments, GTP was added to a 10 mM final concentration. All 
the samples, loaded into quartz capillaries with 1.1 mm ID and 1.6 mm OD, were quickly frozen. Q-
band pulse EPR experiments were performed with the same EPR spectrometer used for CW-EPR 
(Elexsys E580) equipped with a Bruker EN 5107D2 resonator (microwave frequency = 33.86 GHz) 
and an Oxford CF935 cryostat. The measurements were performed at a temperature of 50 K. A 
standard four pulse sequence was applied; the microwave power was adjusted to obtain an observer 
sequence of 28/56/56 ns and a pump pulse of 56 ns. The difference between the pump and observer 
frequency was set to 80 MHz. A two-step phase cycle was applied for base-line correction, while 
deuterium nuclear modulations were suppressed using an 8 step τ cycle from a 180 ns starting value 
with 56 ns increment steps. Data on each sample were collected for about 15 hours. Distance 
distributions were extracted from PELDOR traces by using DeerAnalysis2015 (Jeschke G. et al, 
2006). 
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Table 1. List of primers used for the realization of all the reported HydF mutants 
Primer name Primer sequence 
C91S_for 5′-tctacagggcagattctggaattctcgtgac-3′ 
C91S_rev 5′-gtcacgagaattccagaatctgccctgtaga-3′ 
C302S_for 5‟-gtcatcatggaaggcagcacccacagacctc-3‟  
C302S_rev 5‟-gaggtctgtgggtgctgccttccatgatgac-3‟ 
C353S_for 5‟-cttatcatccacagcggtggatgtattctg-3‟ 
C353S_rev 5‟-cagaatacatccaccgctgtggatgataag-3‟  
C353S-C356S_for 5‟-ccacagcggtggaagtattctgaaccgttc-3‟ 
C353S-C356S_rev 5‟- gaacggttcagaatacttccaccgctgtgg-3‟ 
S35C_for 5'-gttggtcagaacgtgtgcatcgtgagcgattat-3' 
S35C_rev 5'-ataatcgctcacgatgcacacgttctgaccaac-3' 
S38C_for 5'-tgtccatcgtgtgcgattatgcgggaa-3' 
S38C_rev 5'-ttcccgcataatcgcacacgatggaca-3' 
T44C_for 5‟-agcgattatgcgggaacatgcaccgatcccgtctacaa–3‟ 
T44C_rev 5'-ttgtagacgggatcggtgcatgttcccgcataatcgct-3' 
V71C_for 5'-cctggactcgacgactgtggagaacttggaaga-3' 
V71C_rev 5'-tcttccaagttctccacagtcgtcgagtccagg-3' 
R88C-C91S_for 5′-ggcaaggtgcgtgttctactgcgcagattgtggaattctcg-3′ 
R88C-C91S_rev 5′-cgagaattccacaatctgcgcagtagaacacgcaccttgcc 3′ 
A89C-C91S_for 5'-ggagggtgttctacaggtgcgattctggaattctc-3' 
A89C-C91S_rev 5'-gagaattccagaatcgcacctgtagaacaccctcc-3' 
T164C_for 5′-gattcgacgatatcgggaagtgcatctccgaaattcttccggg-3′ 
T164C_rev 5′-cccggaagaatttcggagatgcacttcccgatatcgtcgaatc-3′ 
V261C_for 5'-tgatgtcccggaagactgcgaactcaccacctttt-3' 
V261C_rev 5'-aaaaggtggtgagttcgcagtcttccgggacatca-3' 
D340C_for 5'-ccggaaaagattttccttgtcttgaggaaatagaaaacgc-3' 
D340C_rev 5'-gcgttttctatttcctcaagacaaggaaaatcttttccgg-3' 
L341C_for 5'-ccggaaaagattttcctgattgtgaggaaatagaaaacgc-3' 
L341C_rev 5'-gcgttttctatttcctcacaatcaggaaaatcttttccgg-3' 
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Results and discussion 
Design of recombinant mutant HydF GTPase domains by in silico analysis 
An active HydF GTPase domain is essential to produce a functional [FeFe]-hydrogenase, 
both in vivo and in vitro (Posewitz M.C. et a., 2004 and King P.W. et al., 2006). Sequence analysis 
indicated that this domain contains the consensus motifs shared by all NTPases and essential to bind 
and hydrolyze GTP, i.e. the P-loop (GRRNVGKS) and G2 to G4 loops (TTT, DTPG and NKID) 
(fig. 23).  
 
Figure 23. Structural features of HydF GTPase domain.  A) apo-HydF (PDBID 3QQ5), G-domain of S. 
thermophilus FeoB (PDBID 3LX5), apo and holo binding GDP_AlF4 (PDBID 3LX8). The magnesium atom 
at the active site is shown as a green sphere, and the potassium atom as a violet sphere. The GDP_AlF4 
ligand is not shown. GTP binding residues (orange), sw1 (yellow) sw2 (green), conserved Asn (cyan) are 
highlighted. The color code is adopted from Ash M.R. et al., 2012, and maintained in the displayed structure. 
HydF sw1 is almost completely unresolved in the structure, and is not displayed. B) Aminoacid sequence of 
HydF GTPase domain, with positions of G1–G4 (orange), sw1 (yellow) and sw2 (green) indicated. G5 
(orange) corresponds to the less conserved G domain motif, that usually participates in recognition of the 
guanine base. Asp  highly conserved in K+ activated small GTPases are marked in cyan. Secondary structure 
elements are also indicated. C) Detail of the multiple sequence alignment of HydF, FeoB, RbgA, MnmE and 
TrmE GTPase domains, generated by Clustal Omega algorithm. An * indicates positions which have a 
single, fully conserved residue, a : indicates conservation between groups of strongly similar properties and a 
. indicates conservation between groups of weakly similar properties. G1 motif and conserved asparagine 
residues are highlighted with black and cyan bold characters, respectively. 
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However, the functional role of GTP binding and/or hydrolysis in the H-cluster assembly is still 
elusive. Interestingly, structural analysis identified a similarity of the HydF folding with that of 
small GTPases, such as FeoB, MnmE, RbgA and TrmE, which are well-established regulators of 
several cellular functions. These GTPases alternate between GDP-bound and GTP-bound forms, 
differing by the conformations of the so-called switch 1 (sw1) and switch 2 (sw2) regions, and of 
other, more protein dependent, structural elements (Vetter I.R. & Wittinghofer A., 2001, Cherfils J. 
& Zeghouf M., 2013 and Ash M.R. et al., 2012) (see fig. 23, panel A, where FeoB is taken as an 
example of the two different forms). In the HydF GTPase domain, the regions corresponding to 
putative sw1 and sw2, together with the GTPases consensus motifs, can be recognized (fig. 23, 
panels A and B). Moreover, according to previous experimental evidences indicating that the HydF 
GTPase activity is increased in the presence of K+ (Shepard E.M. et al., 2010 (1)), the region of 
HydF nucleotide-binding G1 motif (…GRRNVGKSSFMNALV…) contains two asparagine 
residues, namely Asn19 and Asn27, which are highly conserved in the K+ activated G-proteins (Ash 
M.R. et al., 2012), as indicated by a detail of the multiple sequence alignment reported in fig. 23, 
panel C (the complete alignment is shown in fig. 33, at the end of the chapter). In all reported 
structures of the K+ activated GTPases, the first conserved asparagine is a ligand to the potassium 
ion, which is also coordinated by three oxygen atoms from the GTP nucleotide and two backbone 
carbonyl groups from the sw1 region. In order to coordinate K+, sw1 must adopt a particular 
structure in which its „K-loop‟ lies directly over the nucleotide binding site. The GTP-bound sw1 
conformation is a unique feature of the cation dependent GTPases. Moreover, in K+-activated 
GTPases the second conserved asparagine residue forms hydrogen-bonds with the backbone of sw1, 
and contributes in positioning it in the proper conformation. Interestingly, the putative sw1 of the 
HydF GTPase domain was not resolved in the X-ray structure of the apo-protein (Cendron L. et al., 
2011), likely due to the high flexibility of this loop, which in the mentioned homologous proteins 
undergoes large conformational rearrangement upon GTP binding.  
Since the structure of HydF in the presence of either GTP or GDP is not yet available, the 
hypothesis of a structural analogy of its sw1 in the GTP-bound state with those of other K+-
activated GTPase guided the experimental design aimed to detect possible rearrangements upon 
nucleotide binding. Panel A of fig. 23 reports the details of the mentioned structural elements of the 
HydF GTPase, together with the apo- and [K+/Mg2+/GDPAlX4]-structures of the GTPase domain of 
FeoB, a membrane protein that imports Fe2+ (Kammler M. et al., 1993), taken as reference structure 
of a K+-activated GTPase. Note that the putative sw1 region of HydF (residues 31-46) is mostly 
missing, since it was unresolved in the X-ray structure, while the two conserved asparagines are 
highlighted. As reported above, sw2 is another common protein region of the GTPases, which 
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usually undergoes structural modification upon nucleotide binding/hydrolysis. This part is well 
resolved in the HydF X-ray structure and corresponds to a long loop ending with an α-helix (fig. 23, 
panel A). A similar sw2 motif was found in FeoB, as clearly seen in the structural comparison. In 
K+-activated GTPases, the structure of sw2 and its rearrangement vary in a much more protein-
dependent way with respect to sw1 (Ash M.R. et al., 2012). Thus, it is difficult to foresee the 
conformational change of this protein region upon GTP binding/hydrolysis. The same consideration 
holds for other protein segments, which may be involved in the specific interactions with other 
proteins or domains in relation to the protein function.  
The sequence homology of the HydF GTPase domain with those of proteins belonging to 
the K+ activated GTPase family is a strong indication of its possible role as a molecular switch. The 
suggested double function of HydF as scaffold and carrier of the 2Fe unit of the [FeFe]-
hydrogenase (HydA) H-cluster precursor may be facilitated by conformational changes of the 
protein during the cycle of interaction with HydG, HydE and/or HydA. Shepard and coworkers 
previously showed that the HydF-dependent GTP hydrolysis in vitro increases in the presence of 
HydE or HydG (Shepard E.M. et al., 2010 (1)), suggesting the existence of a HydF GTPase domain 
function/structure relationship driving the interactions of this scaffold with the other two maturases. 
Interestingly, Vallese et al. showed, based on Surface Plasmon Resonance experiments performed 
by injecting the nucleotide during the step of HydE and HydG dissociation from HydF, that the 
binding of GTP increases the dissociation rate (Vallese F. et al., 2012). This could be related to the 
maturation mechanism by which the displacement of an interaction partner from the scaffold 
occurs, allowing subsequent association of a different protein. Thus, it seems likely that a 
conformational switch due to the GTP binding to HydF is responsible for a fast release of the other 
two maturases. 
With the aim to evaluate the occurrence of conformational changes of HydF upon GTP 
binding, I first analyzed by circular dichroism (CD) spectroscopy a recombinant HydF protein 
(HydF Tn from Thermotoga neapolitana) expressed in E. coli (see Material and Methods section). 
Interestingly, as shown in fig. 24 the addition of GTP induces a change of the secondary structure of 
the protein corresponding to a few percent decrease of ellipticity.  
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Figure 24. Far-UV CD spectrum of HydF taken before (black) and immediately after (red) addition of 
GTP 
 
The deconvolution of the CD spectra suggested a possible change of an α-helix element into 
ȕ-strand and random coil traits (table 2). However, the technique is not very sensitive to the 
rearrangement of unstructured regions, such as loops or random portions of the protein, thus were 
performed further structural characterizations taking advantage of advanced EPR spectroscopic 
techniques. 
 
Secondary structure 
component 
WT cysteine-less 
  +GTP Δ  +GTP Δ 
α-helix 32.9 30.0 -2.9 33.0 30.4 -2.6 
Parallel ȕ 8.7 11.8 +3.1 7.8 9.8 +2.0 
Antiparallel ȕ 8.7 9.1 +0.4 8.9 9.6 +0.7 
ȕ-turn 17.0 17.6 +0.6 16.7 17.2 +0.5 
Random coil 32.8 33.8 +1.0 34.5 36.5 +2.0 
Total 100.1 102.3 +2.2 100.9 103.5 +2.6 
 
 
Table 2. Percentages of secondary structure elements obtained from the fitting of the CD spectra of 
HydFTn. Wild type (WT) and cysteine-less HydF were analyzed as such and upon the GTP binding. The 
CDNN software was exploited to perform data deconvolution (Bohm G. et al., 1992). Uncertainty on the 
reported values are estimated to be of the order of few %. 
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The same results have been obtained with wild type HydF and with a recombinant HydF in which 
all native cysteines have been mutated in serines (cysteine-less): this protein has been used as 
template to introduce cysteine residues only in specific sites, to spin-label the protein in the regions 
selected for spectroscopic analysis (see below). 
Heterologous expression, purification and site-directed spin-labeling (SDSL) of HydF 
proteins. 
To get insight into the specific regions undergoing the conformational changes suggested by 
the CD results, was made use of SDSL combined with EPR spectroscopy. This technique requires 
the introduction of a unique spin label that reports on localized regions of a protein (Berliner L.J., 
1976). All native cysteines must be eliminated in order to obtain a protein carrying a single cysteine 
introduced in the position of interest. This cysteine is then chemically modified with a sulfhydryl-
specific EPR probe. To this end, a recombinant HydF protein was expressed in E. coli in frame with 
a 6His-tag at the N-terminus, as described in details in the section Material and methods, and 
purified by combining a NiNTA affinity and a gel filtration chromatography. Due to the presence of 
cysteine residues in wild type HydF at site 91 (GTPase domain I) and sites 302, 353 and 356 (FeS 
cluster binding domain III), these native cysteines have been changed to serines by means of site-
specific mutagenesis, in order to obtain a cysteine-less mutant protein. Only in one case (mutant 
C356) a native cysteine was maintained and spin labeled itself (see below). It should be noted that 
the removal of the cysteines in the domain III, where a [4Fe4S] cluster is bound to the holo-protein, 
precludes the cluster assembly; however, since the GTPase domain is not directly affected by the 
absence of the FeS cluster, the analysis of the cysteine-less mutants are meaningful. Moreover, the 
effect of the GTP binding in the CD spectrum of the cysteine-less mutant was the same as that of 
the recombinant wild type protein giving a comparable analysis in terms of secondary structure 
composition change upon nucleotide binding (spectra reported in fig. 35 at the end of the chapter, 
deconvolution data for wild type and cysteine less-mutant are reported in  table 2).  
To provide adequate coverage of the protein structure analysis by EPR, 12 single-cysteine 
mutants were expressed, purified, modified with spin labels and compared for their EPR spectra 
taken before and after GTP addition. In this way, it was possible to obtain information concerning 
different protein regions. In particular, the spin labeling positions were selected based on the in 
silico analysis described above, to explore possible rearrangements of: 1) the switch regions (sw1: 
S35C, S38C, T44C; sw2: V71C); 2) the interface region between the GTPase domain and the 
catalytic domain (R88C, A89C, D340C, L341C); 3) the catalytic domain (C356); 4) the helix 
connecting the GTPase domain with the long loop leading to the dimerization domain (T164C); 5) 
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the long loop itself (I175C); 6) the dimerization domain (V261C). Fig. 25 reports the HydF 
structure with all these residues highlighted except for residues S35, S38 and T44, which belong to 
the unresolved loop in the X-ray structure.  
 
 
 
Figure 25. Cartoon representation of HydF monomer structure (PDBID 3QQ5). The GTP-binding 
domain is colored in light blue violet, the dimerization domain in blue and the cluster-binding domain in teal. 
The P-loop is highlighted in orange, the terminal parts of sw 1 in yellow and sw 2 in green. The residues that 
have been mutated and labeled are indicated in the structure and colored according to the effect on change 
mobility undergone upon GTP binding and detected by EPR (red, blue and grey, going from high to low 
effect). Positions S35, S38 and T44 are not highlighted, as they were not resolved in the crystallographic 
structure (Galazzo L. et al., 2017) 
 
All single mutants were labeled using the spin label MTSSL. In some cases, 3-maleimido-
proxyl (5-MSL), having a higher steric hindrance, was also used (see General introduction and 
Materials and methods in this chapter for details). Table 3 reports the labeling yields, calculated by 
spin quantification of the EPR spectrum double integrals and comparison with those of standard 
solutions of the free spin labels. 
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Mutant Yield (%) with MTSSL Yield (%) with 5-MSL 
S35C 85 60 
S38C 85 60 
T44C 80 65 
V71C 55 35 
R88C 80 20 
A89C 15 - 
T164C 75 60 
I175C 90 70 
V261C 70 - 
D340C 45 - 
L341C 45 - 
C356 55 35 
 
Table 3. Labeling yields of HydF mutants. Labeling yield for the different mutants at the cysteine 
positions were evaluated by spin quantification of the EPR spectrum double integrals and comparison with 
those of standard solutions of the free spin labels. 
 
All the spin labeled mutants showed changes of the CD spectrum upon GTP binding (data not 
shown), indicating that the introduction of the spin label was not altering the capability of the 
protein to adopt the nucleotide-induced structural changes. 
CW-EPR spectroscopy 
The combination of site-directed spin labeling (SDSL) and electron paramagnetic resonance 
(EPR) is a well-established method to determine protein dynamics and conformations (Berliner L.J., 
1976 and Klare J.P., 2013). Following protein site-directed cysteine mutagenesis, a nitroxide spin 
label binds to the mutated cysteine residue and reports on local dynamics, conformational dynamics 
of protein domains, and possibly global protein motion. The lineshape of the EPR spectrum of a 
spin label reflects its mobility and is therefore sensitive to conformational changes. Highly mobile 
spin labels, as those on the surface of a protein, have a characteristic narrow spectrum with three 
sharp peaks, whereas the reduction in mobility, due to intramolecular constrains, leads to the 
broadening of the spectrum and/or the appearance of an additional peak in the low field region 
(McHaourab H.S. et al., 1996). Thus, we recorded the EPR spectra of purified HydF proteins 
individually spin-labeled at the 12 different positions mentioned above with MTSSL and, in some 
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mutants, both with MTSSL and 5-MSL: while the latter is rigidly attached to the protein, providing 
information on the rotation of whole structural elements of the labeled protein, MTSSL is bound by 
a more flexible linkage and better describes the local environment of the target residue in the 
protein structure. Thus, different spin probes with different mobility and steric hindrance 
characteristics can allow to explore and study the same sites obtaining different information. 
Notably, the whole mobility of the spin probe is given by both the mobility of the spin probe itself 
and the mobility of the protein backbone to which is attached, plus the molecular tumbling of the 
protein in solution. In large proteins (>200 kDa) the latter is negligible, while in smaller ones this 
contribution can be relevant to the point that it can significantly influence spectral lineshape. Thus, 
to prevent this issue, it is possible to increase the solution viscosity by mean of glycerol addition, 
slowing down the molecular tumbling without affect spin probe mobility (Bordignon E. & Steinhoff 
H.J., 2007). Glycerol addition was then exploited in some of the experiments to try to underline 
spectral differences induced by GTP binding otherwise less appreciable. In effect we looked for 
mobility changes upon GTP addition to the labeled proteins, and the results are reported in figs. 26 
and 27. In particular, in all the acquired spectra we carefully analyzed the low field region (zoomed 
in the figures), in which it is possible to observe more clearly spectral variations induced by 
potential conformational changes upon GTP binding. Most of the changes detected in the EPR 
spectra of HydF are not as dramatic as one would expect for a large protein reassembly and 
reshaping. The 12 positions probed by our experiments, however, are indicative of structural 
changes taking place at different extent depending on the protein region. Furthermore, in the 
majority of the explored sites, the spin probe exhibited multiple motional states, indicating that 
either the side chains of the probes may have different motional states and/or the protein backbone 
may assume different conformations.  
In particular, significant effects are found at the level of putative sw1 and sw2, notably at 
positions 38 (sw1), 71 (sw2), and 88 (corresponding to the terminal part of sw2 and to the interface 
regione of the GTPase domain with the catalytic domain). In some cases, conformational changes 
were better evidenced using 5-MSL (fig. 27). Looking at the structural analogies common to all the 
known K+ dependent GTPases at the level of sw1, it seems likely that in HydF, after GTP addition, 
residue 38 could become very close to the K+ binding region, starting from an extended loop far 
from this site. This would be consistent with the observed reduced mobility of the backbone, as 
revealed by the 5-MSL spin label (fig. 27). The MTSSL spin probe at the same positions has a more 
complicated behavior, described by three components (fig. 26). The most immobilized component 
undergoes a reduction in intensity as well as the most mobile, while the intermediate regime 
component gains intensity.  
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Figure 26. CW-EPR spectra of the 12 investigated HydF mutants labeled with MTSSL. Spectra were 
taken before (blue) and immediately after (red) addition of GTP. For each mutant, an enlargement of the 
low-field region is shown. Spectra were taken at room temperature. (Galazzo L. et al., 2017) 
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Figure 27. CW-EPR spectra of some HydF mutants labeled with either MTSSL (50% v/v glycerol) or 
5-MTS (in the presence or in the absence of 50% v/v glycerol). Spectra were taken before (blue) and 
immediately after (red) addition of GTP. For each mutant, an enlargement of the low-field region is shown. 
Spectra were taken at room temperature (Galazzo L. et al., 2017) 
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This suggests that MTSSL, having higher flexibility compared to the 5-MSL, may adopt 
different local conformations. Since both spin probes reveal a redistribution of the components of 
the EPR spectrum upon GTP binding, a significant structural change leading to many local effects is 
clearly taking place. Residues 35 and 44 (sw1), which are very close to 38, undergo similar changes 
in terms of redistribution of components, although less pronounced. Changes of EPR lineshapes are 
observed for these two residues when 5-MSL is used as spin label and in the presence of glycerol, 
when their mobility is reduced (fig. 27). In fact, the mobility characteristics of the backbone itself 
and of the environment explored by the spin probe, combined with the molecular tumbling, can 
prevent the appearance of smaller spectral differences, which are otherwise appreciable in higher 
viscosity conditions and/or with more rigid spin probes, for example in the presence of glycerol. 
Looking at the spectra of the proteins labelled with MTSSL, it appears that residues 35 and 44 are 
both characterized by relatively high intrinsic mobility either in the presence or in the absence of 
GTP (fig. 26). For residue 44 this was expected on the basis of a possible structural analogy of 
HydF with FeoB (fig. 23) in the apo form. In that protein, when sw1 undergoes the large 
conformational change this residue moves from a loop position towards another, although different, 
loop position. Thus, its intrinsic mobility is expected to undergo only little changes. On the 
contrary, position 35 was expected to behave differently starting from the equivalent position in 
apoFeoB structure, that is a ȕ-strand which rearranges into a loop interacting with the K+ binding 
site upon GTP binding. However, it is worth noting that an unresolved sw1 region was found in the 
X-ray structure of apo MnmE (PDBID: 3GEE), and a long loop was characterizing the sw1 in the 
X-ray structure of apoTrmE (PDBID: 1XZP). Both these proteins are members of the K+ GTPase 
family and show the conserved structure of sw1 which characterize the family in the GTP-bound 
state. Thus, it is likely that also in HydF sw1 is characterized by a loop in the apo form which 
rearranges upon binding of the nucleotide into another loop, close to the K+ site. A clear structural 
rearrangement is detected at position 71, in the putative sw2 region, which, according to the X-ray 
structure, adopts a loop conformation in the apo-form of the protein. The EPR results indicate an 
immobilization of this residue upon GTP binding. Taken together, all the effects relative to residues 
35, 44, 38 and 71 strongly corroborate the hypothesis of a molecular switch role for the GTPase 
domain of HydF. 
Minor, but still detectable mobility changes were observed at positions 340 (catalytic 
domain), 164 (-helix of GTPase domain close to the loop connecting the dimerization domain) and 
175 (belonging to the long loop connecting the dimerization domain). Very little or no effects were 
detected at positions 341 (catalytic domain, region facing residue 88), 356 (catalytic domain, 
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position corresponding to [4Fe4S] cluster binding in the functional protein, and 261 (dimerization 
domain)  (figs. 26 and 27).  
As observed for other GTPases, the conformational changes may extend to additional 
portions of the molecular structure, more protein dependent, which could be relevant for specific 
protein-protein interactions and/or protein-ligand assembly (Ash M.R. et al., 2012). Since HydF 
interacts with HydE/HydG and is believed to act as a scaffold for the assembly and delivery of the 
2Fe unit of the H-cluster, it is well possible that the GTP binding either produces some effects in 
regions of the protein involved in the interaction with the other maturation proteins or induces 
modification in the catalytic domain of HydF, where the cluster precursor is bound and processed. 
In this respect, the extended change on spin mobility measured by EPR at the position 88 is very 
interesting (fig. 26), since this residue is located at the interface between the GTPase domain and 
the catalytic domain. The increase of mobility detected at this site after GTP addition may be 
related to a larger separation of the two domains induced by the nucleotide binding. A confirmation 
of this interfacial change is also proven by the effect experienced by the spin probe at site 340 
belonging to the catalytic domain and facing residue 88. The effect at site 88 was not observed in 
the previous characterization of isolated GTPase domain (Maso L. et al., 2015), because the spin 
probe was completely exposed to the solvent due to the absence of domain III. The structure and 
length of the sw2 region are more heterogeneous in the GTPases compared to those of sw1. The 
conformational change in sw2 upon nucleotide binding differs among distinct GTPases, ranging 
from small rearrangements, such as in Ras (Pai E.F. et al., 1990), to a major reorientation of helix 
a2, as in EF-Tu (Berchtold H. et al., 1993).  
Interestingly, in NFeoBLp sw2 includes a long loop region (10–14 residues) and a helix 
(a2). The unique location of a2 between the nucleotide-binding site and the GDI domain of 
NFeoBLp suggested for this helix a function of relay element transmitting the signal induced by 
nucleotide binding to the GDI and transmembrane domains (Petermann N. et al., 2010). In this way, 
nucleotide binding to the G domain in FeoB regulates ferrous iron uptake across the membrane. The 
3D structure of HydF indicates that sw2 contains a long loop constituted by 14 residues followed 
also by a helix (a2). R88 is located at the base of a2, facing domain III. Thus, an effect similar to 
that observed in FeoB proteins could take place in HydF with the conformational change of sw2 
upon nucleotide binding transmitted to the catalytic domain via a2, as suggested by the change in 
mobility experienced by the spin probe at site 340. In this respect, it is worth noting that the EPR 
spectrum of HydF [4Fe4S] cluster was found to be sensitive to GTP (Shepard E.M. et al., 2010 (1)). 
It was not possible to observe changes in the spin label mobility at position 356 where a Cys ligand 
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of the [4Fe4S] cluster is present in the wild type protein, however the lack of the cluster in the 
recombinant mutant protein may alter the response of the spin label at this site due to the absence of 
structural constrains imposed by the cluster itself in the holo-protein. HydF is characterized by a 
dimerization domain, which is directly connected to the GTPase domain through a long loop (fig. 
25). Similar long loops connecting different domains and undergoing structural rearrangements 
upon nucleotide binding are found, for instance, in the K+-dependent GTPases MnmE and TrmE 
(Meyer S. et al., 2009 and Scrima A. et al., 2005). To explore the response of the loop to the GTP 
binding in HydF, we considered the spin label at position 175. Interestingly, we found that the spin 
label bound at this site, although far away from the GTP binding site, undergoes a detectable change 
in the mobility upon nucleotide binding (fig. 27). 
Proteins acting as GTPase switches show conformational changes, induced by a cycle of 
GTP hydrolysis, with different mechanisms. Changes in protein forms can be promoted either by 
GDP binding or by GTP binding/hydrolysis (Cherfils J. & Zeghouf M., 2013). Thus, it was of 
primary importance to investigate the effects of the different nucleotides. This further 
characterization was carried out exploring the possible effects of the addition of GDP, GDP-AlF4 (a 
transition-state analogue) and GTPȖS (a non-hydrolysable GTP analogue) to a spin labeled HydF 
protein. The results are shown in fig. 28 for the MTSSL spin labeled R88C mutant, which was the 
one showing the clearest mobility change upon GTP binding. No spectral changes were observed 
upon addition of GDP and GDP-AlF4, while GTPȖS induced the same effect as GTP (note that in 
the presence of GTPȖS the spectrum showed a high fraction of free spin label, due to the release of 
MTSSL by reaction of the spin labeled protein with GTPȖS itself), thus strengthening the 
hypothesis that the trigger of the conformational change is given by the binding of the nucleotide 
rather than by its hydrolysis. Moreover, as common for many other GTPases, the conformation of 
HydF in the presence of GDP is the same as that of the apo-protein. 
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Figure 28. Effects of different nucleotides binding on the CW-EPR spectrum of labeled R88C. 
Experiments were performed in the absence of nucleotides (blue) or in the presence of non-hydrolysable 
GTP analogue (brown), GTP (red), GDP (magenta) and GDP-AlFx (violet) (Galazzo L. et al., 2017) 
 
As expected, the conformational changes were reversible once the GTP was hydrolyzed and 
left the protein binding site. Interestingly, the relaxation to the initial state was very slow compared 
to the kinetics of hydrolysis. Indeed, while the hydrolysis of the nucleotide occurs in minutes 
(Shepard E.M. et al., 2010 (1) and Vallese F. et al., 2012), detection of the EPR spectrum at 
different delay times after the GTP addition showed that only after several hours the spectrum 
returned to the lineshape preceding the nucleotide addition (fig. 29). This inertia could be due to the 
absence of some cellular effector in our in vitro experiments compared to the in vivo conditions, as 
observed for a number of GTPases needing effectors to perform the GTP/GDP cycle (Cherfils J. & 
Zeghouf M., 2013), but could even be functional to generate a rest time for the switch, allowing 
other steps of the maturation process to take place. This would fit with the previously proposed 
stepwise model of the H-cluster assembly on the HydF scaffold (Shepard E.M. et al., 2014 and 
Peters J.W. & Broderick J.B., 2012). 
 
63 
 
 
 
Figure 29. Curves of the relaxation to the initial state following addition of GTP (t = 0 h), detected as 
change of the EPR signal of spin label at site 88, at the field positions indicated by arrows in the inset. 
The dots represent respectively the percentage of recovery of the broader spectral component (grey dots) and 
of decay of the narrower spectral component (black). In the inset, the zoom of the EPR spectra (red tௗ=ௗ0ௗh; 
blue tௗ=ௗ5.5ௗh) with the positions used to obtain the kinetics shown by arrows (Galazzo L. et al., 2017) 
 
As reported in the first paragraph, functional and sequence analysis clearly indicate that 
HydF is a K+ activated GTPase (Shepard E.M. et al., 2010 (1)). Thus, the EPR experiment on R88C 
was also performed in a buffer solution without K+. The analysis of these spectra indicates that the 
absence of K+ does not preclude the conformational change induced by GTP binding, however its 
presence favors the switch of the structure (fig. 30). According to the known structures of the K+ 
activated GTPases, the cation contributes to the coordination of the sw1 upon nucleotide binding, 
thus the observed effect in HydF is in agreement with the rearrangement of sw1 and with the 
contribution to the stabilization of the switched conformation.  
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Figure 30. Top: CW-EPR spectra at room temperature of the mutant R88C in the absence (blue) and in the 
presence (red) of GTP, when potassium is not added to the buffer. Bottom: comparison between CW-EPR 
spectra of R88C in the absence of GTP and potassium (dark blue) and when 50 mM potassium is added to 
the buffer before (brown) or after (orange) the addition of GTP (Galazzo L. et al., 2017) 
 
 
 
As mentioned above, most of the sites investigated by SDSL-EPR reveal the presence of 
more than one conformation, both in the apo- and in the GTP-bound state. Moreover, we never 
observed a complete conversion of the EPR spectrum from one form to another, even in large 
excess of either GTP or GTPȖS. For instance, in the case of R88C, which proved to be the most 
sensitive to GTP addition (fig. 26), the change in the lineshape of the EPR spectrum induced by 
GTP can be assigned to a 30% population shift between the two components needed for the 
simulation of the spectra (fig. 31 and table 4), which can generally provide useful information on 
the protein backbone dynamics at the different sites. 
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Figure 31. Top: spectrum and simulation of R88C-MTSSL; bottom: spectrum and simulation of 
R88C-MTSSL with GTP; center: simulate individual components. The dashed lines help to highlight the 
main features of the two components (Galazzo L. et al., 2017) 
 
 gxx gyy gzz Axx Ayy Azz D  D S 
Broad 2.0088 2.0070 2.0030 7.9 G 5.4 G 36.2 G 11 MHz 15 ns 0°/0°/0° 0.60 
Narrow 2.0088 2.0070 2.0030 8.0 G 5.4 G 35.0 G 31 MHz 5 ns 0°/37°/0° 0.60 
 
Table 4. Parameters obtained from the fitting of the individual components of R88C 
 
More details on the simulation of CW-EPR spectra for the MTSSL-labeled R88C protein are 
reported in the supplementary information at the end of this chapter, but overall, these simulations 
suggest that the addition of GTP affects roughly a fourth of the protein at position 88. This is in 
agreement with the those obtained from Isothermal Titration Calorimetry (ITC) experiments (Fig. 
32 and table 5), showing that only 60% of the wild type recombinant HydF is able to bind GTP. 
There are different possible explanations for this experimental evidence: a) a percentage of protein 
is in a misfolded conformation, therefore only a certain amount of protein is sensitive to the 
nucleotide binding; b) HydF is always present in an equilibrium of different conformations and the 
GTP binding just shifts the equilibrium among different forms. 
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Figure 32. ITC measurements of GTPȖS binding to wild type HydF. Experimental data (circles) are 
interpolated by the curve (red) calculated with the parameters reported in the table 2 reported below (Galazzo 
L. et al., 2017) 
 
Sample titrant n ΔH (cal mol-1) ΔS (cal mol-1 deg-1) KD (μM) 
HydF GTPȖS 0.594 -2873 ± 28.36 17,9 0.96  ± 0.09 
 
Table 5. Calculated parameters for GTPȖS binding to wild type HydF monitored by ITC. Notably, the 
stoichiometry (n) results to be <1 (Galazzo et al., 2017) 
 
The presence of some unknown effectors in vivo might restrict the conformational space of 
the protein generating a limited number of conformations compared to the in vitro conditions 
adopted in these experiments. In this respect, it is interesting to note that in cell-free experiments an 
addition of cellular extract is always necessary to allow the [FeFe]-hydrogenase maturation process 
to take place (Kuchenreuther M.J. et al., 2012). Although it is difficult at this stage to discriminate 
between the a) and b) possibilities, the main result remains, showing that the GTPase domain of 
HydF may undergo conformational changes upon GTP binding. The presence of a correct cluster 
assembly and/or the interaction with other unknown effectors/maturases may well enhance the 
differences between energies of the conformations that have been detected shifting the equilibrium 
between different forms, which are however intrinsically determined by the nucleotide binding. 
Thus, for future projects, EPR experiments will be performed by using unnatural aminoacids 
carrying a spin label to avoid the substitution of native cysteine residues and allow refolding of the 
protein in the presence of the [4F-4S] cluster in the catalytic domain, with the aim of studying the 
influence of the cluster presence on the conformational equilibrium shift induced by GTP. 
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PELDOR 
Since HydF adopts a dimeric structure, which is likely its active oligomeric state (Cendron 
L. et a., 2011), with the aim to map possible large conformational changes induced by the GTP 
binding at the level of this dimeric structure, Pulse Electron DOuble Resonance (PELDOR, also 
known as DEER) experiments were also performed (Jeschke G., 2012). It is well known that this 
pulse EPR technique, based on the measure of dipole-dipole interaction between unpaired electron 
spins, has become the most widely used method for measuring distances between electron spins in 
(bio)macromolecules. The V261C HydF mutant was chosen to perform intra-dimer distance 
measurements because, based on the X-ray structure, the expected distance between spin labels 
belonging to the two moieties composing the dimer is 3.5 nm, which is in the suitable range of 
reliable distances measured by PELDOR. Moreover, according to the X-ray structure, residue 261 is 
located in a portion of the dimerization domain, that does not interfere with the folding of the ȕ-
sheet forming the dimeric structure of HydF, thus representing a good choice to detect 
conformational changes induced by GTP at the level of the dimer structure. 
The spectra of samples frozen in the absence of GTP and immediately after its addition are 
reported in fig. 33, together with the data analysis. The very good signal to noise ratio allowed to 
obtain a reliable measure of the effects. Tikhonov-derived distance distributions provided main 
values, that correspond, roughly, to those expected on the basis of the X-ray structure of the apo-
HydF protein (3.5 nm), confirming the dimer structure of the protein in solution. When GTP was 
added, some differences were detected. The distance distribution showed that about 25% of the 
shortest distance (2.8 nm) is converted into the longer (3.0 nm) in the presence of GTP. It does not 
correspond to a dramatic reassembly of the dimer, however the protein region around V216 clearly 
“feels” the switch triggered by the GTPase domain. The PELDOR experiments were also performed 
in a double spin labeled mutant (V261C-T164C) having an expected intra-monomer distance of 4.5 
nm and estimated inter-monomer distances (261–164 and 164–164) 6.2 and 7.0 nm, respectively. 
The spectra reported in fig. 33show also in this case emerging differences when GTP was added. 
Although quantitative analysis of multispin systems (four spins in this double labeled mutant) is 
quite complicated (Giannoulis A. et al., 2013), it seems clear that such differences are present not 
only in the region corresponding to the 261-261 distance, as for the single labeled mutant V261C, 
but also at the level of the other inter- and intra- monomer distances. Validation of the distance 
analysis performed with DeerAnalysis2015 is reported in fig. 36 at the end of the chapter.  
Taken together, these data give a clear indication that HydF undergoes to a protein 
rearrangement upon GTP-binding, which occurs in a region far from the GTPase domain. 
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Figure 33. PELDOR of spin labeled V261C and V26C-T164C with HydF dimer structure 
representation. Panel a. Cartoon representation of HydF dimer structure with the indication of the distance 
between the residues V261 (left) and between residues V261 (blue) and T164 (black) (right). Panel b. 
PELDOR data of mutant V261C (left) and V26C-T164C (right), in the absence (blue) and in the presence 
(red) of GTP before (upper panels) and after (middle panels) background correction, Tikhonov-derived 
distance distributions in the absence (blue) and in the presence (red) of the nucleotide, are shown in the 
bottom panels (Galazzo L. et al., 2017). 
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Conclusions 
Thanks to the obtained results, it was possible to recognize for the first time the analogies of 
HydF with the K+ dependent GTPases, in terms of sw1 and sw2 regions and conserved Asn 
residues, and establish that the HydF GTPase domain is a switch undergoing significant structural 
modifications upon GTP binding, as in other members of the same family. Starting from this 
discovery, it will be possible to model the sw1 of HydF in the GTP-bound state, an important 
structural information which was missing in the X-ray structure of the apo-protein. Although the 
predicted cation-dependent GTPases from various superfamilies (TEES, Obg-HflX, and YqeH-like) 
are all involved in ribosome biogenesis, exceptions are reported. For instance, FeoB is a membrane 
protein that imports Fe2+ (Kammler M. et al., 1993) and MnmE modifies tRNA (Yim L. et al., 
2003). Thus, HydF may represent an additional K+-activated GTPase with a novel function, 
showing that the K+ GTPases may have a larger spread of functions than supposed before. 
We also provided evidence that EPR is a suitable technique to follow the changes induced 
by GTP binding and hydrolysis in HydF and monitor the states of nucleotide cycle. The effects 
monitored at different protein sites, by using SDSL-EPR techniques, showed that the structural 
changes upon GTP binding in HydF are diffuse, and indicated that not only the GTPase domain but 
the whole protein undergoes conformational rearrangements. This is in agreement with previous 
data suggesting that GTP alters the EPR signal of the reduced [4Fe4S] cluster of HydF, and 
facilitates the dissociation of HydE and HydG from HydF. The interaction areas between the two 
maturation proteins and HydF are not known, however they likely involve extended protein regions 
not only sw1 and 2. Thus, the diffuse conformational changes detected in HydF upon GTP binding 
may well be functional to a variation of interaction with the other maturases. Experiments to 
measure these effects in the HydF-HydG and HydF-HydE spin labeled complexes will help to 
confirm this hypothesis, and are currently underway in our laboratory. Starting from the obtained 
results and with same experimental approach, we will explore at the whole maturation complex the 
structural and functional relationships between the maturases as by HydF GTP binding/hydrolysis. 
The study will also aim to the realization of a in silico model of the maturases complex formed by 
HydE, HydF and HydG, together or in couples, to allow a better characterization of this 
biotechnologically relevant pathway. 
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SUPPLEMENTARY INFORMATION 
 
Figure 34. Multiple sequence alignment (MSA) of HydF, FeoB, RbgA, MnmE and TrmE GTPase 
domain, generated by Clustal Omega algorithm (v1.2.3). An * indicates positions which have a single, 
fully conserved residue, a : indicates conservation between groups of strongly similar properties and a . 
indicates conservation between groups of weakly similar properties; dashes (-) indicates deletions. According 
to Clustal Omega, color code is: red, small, hydrophobic and aromatic residues (except for Y); blue, acidic 
residues; magenta, basic residues (except for H); green, residues with hydroxyl, sulfhydryl and amine 
groups, and G. The two highly conserved asparagine residues are underlined in the black boxes.  
 
  
  
FeoB ----------MTHALLIGNPNCGKTTLFNALTNANQR-VGNWPGVTVEKKTGEFLLGE-H  
RbgA ------MQPRPVRAVVIGFPNVGKSALINRLLNRRVVDSARRPGVTRQLRWVRIS----D  
HydF --MRLPDAGFRRYIVVAGRRNVGKSSFMNALVGQNVSIVSDYAGTTTDPVYKSMELHPIG  
MnmE --------GM--KVVIAGRPNAGKSSLLNALAGREAAIVTDIAGTTRDVLREHIHIDGM-  
TrmE SSGRLLREGI--RTVIVGKPNAGKSSLLNALLGEERAIVTEIEGTTRDTLEEELSLKDL- 
                   :: *  * **::::* * . .        *.* :     :  
  
FeoB LIEITDLPGVYSLVANAEGISQDEQIAAQSVIDLEYDCIINVIDACHL------------  
RbgA QLELLDAPGVLPSR-----LTD-----------QQAATKLAICDDIGEAAYNTQNMAAAL  
HydF PVTLVDTPGLDDV-GELGRLRVEKAR----RVFYRADCGILVTDSA-PTPYE--------  
MnmE PLHIIDTAGLREASDEVERIGIERAW----QEIEQADRVLFMVDGT-TDAV--------  
TrmE NLRVIDTAGIRETEDPVERIGVERAR----RAAEEADLIIYVVDAS-RPLDS-------- 
      : : *  *:         :              .    : : *  
  
FeoB ---ERHLYLTSQ-------LFELGKPVVVALNMMDIAEHRGISIDTEKLESLLGCSVIPI  
RbgA VDLLQHLEVKNQILPGLLPKNPLHHRYQVSIDPNQLP-----------------------  
HydF -------DDVVNL------FKEMEIPFVVVVNKIDVLGEKAEE-LKGLYESRYEAKVLLV  
MnmE --------DPAEIWPEFIARLPAKLPITVVRNKADIT--GETL---GM-SEVNGHALIRL  
TrmE --------SDEEI----LRFLPGKKALLL-LNKSDLRTIISEE---EM-KKRSGCPVLSI  
                :                :  :  ::  
  
FeoB QAHKNIGIPAL---------------------QQSLLHCSQKIKPLKLSLSVAAQQILND  
RbgA -ILT--GEDYLLKLAAERYQGDAERA---------------------------ARQLLND  
HydF SALQKKGFDDIGKTISEILPGDEEI-----------------------------------  
MnmE SARTGEGVDVLRNHLKQSMGFDTNMEGGFLARRRHL--------QAL----EQAAEHLQQ  
TrmE SARTEEGISMLSEKIREMF-F-----GGELRWNQELIICSERQRKLL----QNAGQALRE  
           *   :  
  
FeoB LENQLISKGYKNSFAYYFSRRLAEGDTLIGEKAFTESLLIKLQETEQNLDVLLADARYQK  
RbgA FRKGLLG-----AIALELPPEVSPLTDSQSDSVTQSDLMTQPEQSDQD----QSDPA---  
HydF ------------------------------------------------------------  
MnmE GKAQLLG-----AWAGELL---------------AEELRLAQQNLSEITGEFTSDDLLGR  
TrmE LCRSIEN-----GMPEDFY---------------TIDIMRAYEELGQILGERVSEDLIDE  
  
FeoB IHEIVTLVQKK  
RbgA -----------  
HydF -----------  
MnmE IFSSFCIGK— 
TrmE IFSKFCMGK-- 
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Figure 35. CD spectra of cysteine-less HydF mutant, before (blue) and after (red) GTP addition. Note 
the addition of GTP induce similar conformational transition in the two samples.  The secondary structure 
content was calculated using the CD spectrum deconvolution software CDNN, which calculates the 
secondary structure by comparison with a CD database of known protein structures. The results of the 
spectra analysis are reported in table 2. 
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Simulation of CW-EPR spectra for spin labeled R88C mutant 
The simulation of EPR spectra can provide information on the protein backbone dynamics at the 
different sites, and also a multicomponent analysis can determine the relative amounts of the 
different components in a spectrum. We performed an analysis of the EPR spectra of the MTSSL 
label at position 88 since it proved to be the most sensitive to GTP addition.  
First we analyzed the different components of the R88C-MTSSL spectrum to determine the extent 
of the changes induced by GTP. Since the experimental spectra clearly showed that only two 
components were present and that the addition of GTP likely shifted only the relative abundance, 
but not the lineshape, we were able to separate them by a properly weighed subtraction of the 
spectra with and without GTP: in fig. 30, in the center we report the simulations of the individual 
components, the parameters of the simulation are reported in table 4. The two spectral shapes were 
simulated using a program based on the stochastic Liouville equation and adopting the MOMD 
model as standard for spin labeled proteins. The starting values for the principal components of the 
g and 14N hyperfine (A) tensors of the TOAC label were obtained from fitting of the frozen solution 
spectra. The values of the magnetic (g and A) and diffusion (D) tensors, their relative orientation 
(ΩD), and the order parameter (S), were then refined by simplex fitting. The two simulated 
lineshapes were then normalized to the same number of spins and used to obtain the simulation of 
the original experimental spectra as shown in fig. 30 in the bottom part. The spectrum of the apo-
protein is simulated by equal amounts of the two components (55% broad; 45% narrow), while the 
spectrum in the presence of GTP has a predominance of the narrow component (30% broad / 70% 
narrow). Given that the simulations are not perfect, an uncertainty of ±5% in the relative amounts of 
the two components can be estimated. As regards the analysis of the backbone dynamics, the 
diffusion tensors of the two components are both isotropic, the narrow component has a slightly 
faster diffusion (lower rotational correlation time) than the broad one, and the marked change in 
spectral width can be ascribed to the tumbling around different axes. The diffusion parameters 
suggest that no marked change in the backbone dynamics takes place upon GTP addition. We also 
estimated the overall rotational correlation time of the HydF dimer; the diffusion tensor is axial with 
slightly faster rotation around the “helical” axis of the dimer: D|| = 3.65 MHz and D = 2.05 MHz, 
this corresponds to a τHydF = 1/6(D||D)1/2 = 61 ns. This value is higher than those obtained from the 
simulations, indicating that the overall tumbling of the protein should not strongly affect the 
lineshape of the EPR spectra.  
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Figure 36. Validations of the distance distributions performed with DeerAnalysis2015 for the 
investigated mutants in the absence (top) and in the presence (bottom) of GTP. The black lines represent 
the distribution with the best r.m.s.d. after the validation procedure, while grey bars indicate the full variation 
of the probability for each distance over all trials. The other lines represent the mean value of the probability 
minus (blue) or plus (red) two times the standard deviation. 
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Chapter 2 
 
Molecular and functional insights into the human frataxin-ISCU 
complex during FeS cluster assembly 
 
 
 
 
 
In mammals, FeS clusters are mainly present and synthetized in mitochondria. Their 
assembly is performed by a complex and highly conserved system involving several proteins. 
Among them, ISCU is the scaffold upon which FeS clusters are assembled at a molecular complex 
which also includes the desulfurase NFS1, the accessory protein ISD11, and frataxin (FXN). FXN is 
an iron-binding protein whose specific role in this biosynthetic pathway is still controversial, as it 
was first proposed to be the iron donor of the process, and then an allosteric activator of biogenesis 
machinery. In humans, decreased levels of FXN, due to an abnormal expansion of GAA 
trinucleotide repeat in the first intron of the FXN gene, cause Friedreich ataxia (FRDA), a 
neurodegenerative disorder in which cellular hallmarks are compromised respiration, 
mitochondrial iron overload and increased sensitivity to oxidative stress. Moreover, FRDA variants 
exist in which patients are compound heterozygous for the GAA expansion on one FXN allele and 
for a missense mutation on the other. For both FRDA pathologies, a specific therapy is still 
missing. This may be due, at least in part, to an incomplete characterization of the pathway(s) in 
which frataxin is involved, and in particular it is worth to note that this protein is still looking for a 
function. In this work, by means of two-dimensional NMR (Nuclear Magnetic Resonance) 
technique, we characterized into detail the FXN-ISCU direct interaction; moreover, we evaluated if 
and how this interaction can be affected by FRDA-associated point mutations. We found that all 
selected FXN mutations have an impact on the structural and functional properties of frataxin, 
including iron-binding, functional modulation of NSF1 desulfurase and aptitude to form a complex 
with the ISCU scaffold. Taken together, our data open new perspectives in the study of the 
mechanisms leading to FRDA variants, and give additional hints useful to clarify the physiological 
role of FXN as well its contribution to the pathogenesis of classical Friedreich’s ataxia. 
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Introduction 
 As assessed in the general introduction, FeS clusters are pivotal cofactors of several 
enzymes involved in major biochemical processes in prokaryotic and eukaryotic organisms (Beinert 
H. et al., 1997). FeS proteins are among the most important electron carriers, having a wide range of 
reduction potentials (from -700 mV to +400 mV), and thus their role is particularly critical in the 
mitochondrial respiratory chain, in which up to 12 different FeS clusters move the electrons through 
complexes I-III. Moreover, these clusters are involved in coupling of electron and proton transfer, 
substrate binding and activation, determining protein structure, regulation of gene expression and 
enzymatic activity, disulfide reduction, and iron, electron, or cluster storage. The biosynthesis of the 
FeS clusters is a highly complex and strictly coordinated process driven by phylogenetically 
unrelated molecular systems, all sharing common principles, which have been described in details 
in the general introduction. These pathways are crucial events in the overall cellular physiology, and 
in mammals their importance is supported by the fact that mutations in proteins involved in FeS 
cluster biogenesis cause an increasing number of genetic diseases, including Friedreich‟s ataxia, 
glutaredoxin 5-deficient sideroblastic anemia, ISCU myopathy and multiple mitochondrial 
dysfunction syndromes (Rouault T.A. &  Tong W.H., 2008), as reported in fig. 37. 
  
 
 
Figure 37. A general scheme for mitochondrial biogenesis of FeS clusters (ISC) in mammalian cells, 
and mutations in proteins acting at different points in the pathway. The molecular mechanism depicted 
in panels A and B has been described in details in the general introduction. Panel C, the outlined mutations 
cause diseases with markedly different phenotypes but common biochemical features and mitochondrial 
dysfunctions. Figure from Rouault T.A., 2012. 
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The basic FeS cluster assembly components reported in fig. 37 are highly expressed in 
mammalian mitochondria, where they supply these clusters for incorporation into the citric acid 
cycle enzyme aconitase and succinate dehydrogenase, and into the respiratory chain complexes I-
III. Thus, defects in the FeS cluster assembly can greatly affect the overall mitochondrial 
physiology, eventually resulting in a decreased energy production. A further common distinctive 
feature of the pathologies reported above is a severe mitochondrial iron overload associated to an 
increased sensitivity to oxidative stress, reported both in model systems and in tissues from patients 
(Rouault T.A., 2012). However, despite several important recent progresses in the field, significant 
gaps remain in the understanding of the molecular mechanisms driving the diseases caused by 
dysfunctions of the FeS cluster assembly machinery, and in fact at present there are no specific 
treatments for patients. One of the open issues is the precise role of frataxin, both in the FeS cluster 
assembly process and in the way leading to Friedreich‟s ataxia, an inherited severe mitochondrial 
disease caused by the decrease of the expression of this protein below a critical threshold. 
Human mitochondrial ISC system dysfunctions: frataxin and Friedreich’s ataxia 
As mentioned in the general introduction, frataxin (FXN) is a small protein highly conserved 
from bacteria to mammals, involved in cellular iron metabolism and in FeS clusters biogenesis 
(Adinolfi S. et al., 2002 and Gibson T.J. et al., 1996). In humans, deficiency of FXN has been 
associated to the neurodegenerative and cardiodegenerative disorder Friedreich‟s ataxia (FRDA), an 
autosomal recessive disease affecting 1/50,000 live births in the caucasian population (Campuzano 
V. et al., 1996). FRDA is characterized by a progressive gait and limb ataxia, areflexia, spasticity, 
and loss of proprioceptive sensation, while preserving cognitive functions. Patients develop 
dysarthria and usually become wheelchair dependent 15-20 years after symptoms first appear, with 
a life expectancy reduced to ~ 40-50 years and hypertrophic cardiomyopathy as the main cause of 
death. The majority of FRDA patients (>95%) are homozygous for an abnormal expansion of a 
GAA trinucleotide repeat in the first intron of the frataxin gene (FXN), which leads to a 
transcriptional silencing of FXN through heterochromatinization of the locus and to a reduced 
expression of FXN (Campuzano V. et al., 1997 and Pandolfo M., 2009). The severity of the disease 
increases with the length of the expansion, which ranges from 6-36 in healthy individuals and from 
70-1700 (most commonly 600-900) in FRDA patients (Pandolfo M., 2009), that have about 5-30% 
estimated residual frataxin levels. Indeed, constitutive deletion of FXN gene in mice causes 
embryonic lethality (Cossée M. et al., 2000), indicating that the complete loss of FXN is not 
compatible with life. A small but significant proportion of patients (i.e. 5%) are compound 
heterozygous for the GAA expansion on one FXN allele and for a mutation on the other, including 
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nonsense, missense, insertions and deletions (Cossée M. et al., 1999 and De Castro M. et al., 2000). 
To date, out of the 40 reported pathogenic variants of FXN, at least 20 point mutations have been 
described (Labuda M. et al., 1999, Gellera C. et al., 2007, Faggianelli M. et al., 2015 and Galea 
A.C. et al., 2016). It is worth noting that all clinically important mutations described in 
heterozygous FRDA patients affect highly conserved residues (Cossée M. et al., 1999). These 
patients present either the classical FRDA phenotype or an atypical, less severe clinical picture 
(Cossée M. et al., 1999 and Gellera C. et al., 2007). Contrary to the homozygous GAA expansion, 
which reduces FXN levels, these missense mutations are expected to directly affect the activity 
and/or structural properties of the expressed protein, as suggested by in vitro studies using 
recombinant mutant proteins (see below) (Correia A.R. et al., 2006 and 2008). To date, there have 
been no reports of an individual carrying two FXN point mutations, further supporting that a critical 
amount of functional FXN is essential to cell viability.  
The primary function of FXN is still under debate, and the specific contribution of its 
deficiency to the pathogenesis of both classical and atypical FRDA is unknown. Human FXN is a 
nuclearly-encoded mitochondrial protein, ubiquitously expressed at low levels, with the higher 
concentrations found in tissues strongly dependent on respiratory metabolism, such as heart, dorsal 
root ganglia sensory neurons and spinal cord (Campuzano V. et al., 1996). It is an acidic iron-
binding protein (Adinolfi S. et al., 2002), synthesized in the cytosol as a precursor of 210 
aminoacids and then imported to the mitochondrion, where it undergoes to proteolytic maturation 
by a two-step process leading to an intermediate form of 19 kDa (residues 42-210) and finally to a 
mature form of 14 kDa (residues 81-210) (Koutnikova H. et al., 1998, Condò I. et al., 2007 and 
Schmucker S. et al., 2008), which is widely accepted to be the most abundant species both in 
normal individuals and in patients. The loss of FXN results in a complex phenotype that includes 
three main biochemical features, i.e. i) deficit of FeS proteins, especially mitochondrial aconitase 
and the respiratory chain complexes (Rotig A. et al., 1997), ii) mitochondrial iron overload (Puccio 
H. et al., 2001), and iii) increased sensitivity to oxidative stress (Schulz J.B. et al., 2000). The 
decreased activity of FeS proteins in vivo supports the hypothesis of an involvement of FXN in FeS 
clusters assembly, in particular in mitochondrial ISC system (Colin F. et al., 2013, Pandey A. et al., 
2013, Stehling O. et al., 2004 and Tsai C.L. & Barondeau D.P., 2010). It worth to note that ISC is 
also essential for the biogenesis of the extra-mitochondrial FeS proteins by the CIA system 
described in the general introduction (Biederbick A. et al., 2006, Fosset C. et al., 2006 and Kispal 
G. et al., 1999), and this explains why defects of this pathway have a strong and broad impact into 
the general cellular physiology. On the other hand, the exact role of FXN is still undefined. 
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FXN function(s) in FeS cluster formation: an unresolved issue 
FXN is involved in the biogenesis of FeS clusters by mitochondrial ISC system; however,  
its precise role in this pathway it is still under debate, and several different functions have been 
proposed. The identification of structural and functional interactions of FXN with the FeS clusters 
assembly machinery led to different hypotheses on its involvement in this metabolic pathway. 
Contributions as a chaperone delivering iron to the ISC machinery or as a scavenger preventing iron 
accumulation in mitochondria, while still keeping iron biologically available for being delivered to 
key acceptors, were first hypothesized (Yoon T. & Cowan J.A., 2003, Bulteau A.-L. et al., 2004 and 
Cavadini P. et al., 2002); in this regard, it is worth noting that while cysteine is the accepted 
preferential donor of sulfur, to date nothing is known about how the largely insoluble iron gets to 
the complex. Later on, it was shown that the role of mammalian FXN goes well beyond that of an 
iron transporter, and this protein was suggested to stimulate the rate of FeS cluster assembly by 
binding the NFS1/ISD11/ISCU complex, eventually enhancing sulfide production (Colin F. et al., 
2013, Tsai C.L. & Barondeau D.P., 2010 and Bridwell-Rabb J. et al., 2014); this stimulatory effect 
would be strictly dependent on the presence of the ISCU scaffold protein (Colin F. et al., 2013). 
Intriguingly, and in stark contrast to the mammalian system, in bacteria CyaY, the homologue of 
eukaryotic FXN, was shown to slow down rather than stimulate FeS clusters assembly (Adinolfi S. 
et al., 2009). These contrasting results raised important questions concerning the molecular function 
of FXN (both in bacteria and in mammals), as well as the mechanisms by which FXN increases the 
rate of FeS cluster formation. Additional new data are necessary to clarify this issue. 
Clues on function of proteins often come from identification of interacting partners, and 
according to an involvement in the FeS clusters biogenesis human FXN was shown to interact with 
multiple core components of the ISC machinery; however, although evidence of a direct interaction 
between FXN and the desulfurase/scaffold complex has received independent confirmations, 
several questions remain unanswered, particularly as far as concerns its direct partner, which 
remains controversial as different one-to-one interactions with each component were reported 
(Gerber J. et al., 2003, Schmucker S. et al., 2011, Yoon T. & Cowan J.A., 2003, Leidgens S. et al., 
2010 and Shan Y. et al., 2007). The answer to these questions would be crucial for understanding 
FXN function and relies on its structural properties, described in the next paragraph.  
FXN: structural features 
 Sequence alignment of the frataxin family shows two distinct regions: i) a N-terminal block 
of 70-90 residues, completely absent in prokaryotes and poorly conserved also among eukaryotes 
(Huyen M.A. et al., 2001), with features typical of intrinsically unfolded proteins; ii) a C-terminus 
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comprising a block of about 100-120 aminoacids that is highly conserved in most organisms. The 
sequence identity of this region is as high as 25%, and the similarity is 40 to 70%, indicating that 
this is likely the functional portion of the protein.  
Recombinant frataxins from E. coli, S. cerevisiae and H. sapiens have been extensively 
studied. The structure of the conserved C-terminal domain of the human protein was the first to be 
characterized both by NMR and crystallography, together with the crystal structure of the E. coli 
ortholog CyaY (Musco G. et al., 2000 and Dhe-Paganon S. et al., 2000).  The N-terminal eukaryotic 
tail of the human protein (residues 81-92) was shown to be intrinsically unfolded and highly 
flexible. The conserved C-terminal domain folds in a mixed, compact αȕ sandwich, with two α-
helixes packing against an antiparallel ȕ-sheet (fig. 38). 
 
Figure 38. Crystal structure of human frataxin (PDBID: 1EKG). On the left, cartoon representation of 
mature human frataxin with its compact αȕ sandwich structure, in which the long α-helix on the left is the N-
terminal one. On the right, surface representation of frataxin in the same orientation in which acidic and 
basic domains are underlined in red and in blue, respectively. Note the high concentration of acidic domains 
corresponding to the α1/ȕ1 N-terminal of frataxin (mostly red colored surface in the α1/ȕ1 region). 
 
When first solved, this fold was recognized as novel and, despite its simplicity, it still 
remains unique. Knowledge of the frataxin structure allowed rationalizing the role of its conserved 
residues. As a general rule, in proteins conserved buried residues are usually important parts of the 
hydrophobic core, and any variation might destabilize the fold; on the contrary, conserved residues 
exposed on the surface are usually involved in protein function. In the frataxin family, the semi-
conserved negatively charged residues cluster together with the surface-exposed, conserved 
residues on the first helix and on the ȕ-sheet (Musco G. et al., 2000). 
The highly acidic N-terminal domain, corresponding to the first α-helix together with the 
first ȕ-strand (α1/ȕ1 region, residues 81-130) (fig. 38), confers to frataxin the iron-binding capacity. 
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Different constructs of human frataxin were reported to bind 6-7 Fe2+ or Fe3+ per monomer (see also 
below), but with largely discrepant dissociation constants (Yoon T. & Cowan J.A., 2003, Huang J., 
et al., 2008). The iron-binding surface was identified by NMR analysis, which indicated that the 
primary binding site involves a negatively charged ridge. Binding is prevalently electrostatic in 
nature and does not involve cysteines and/or histidines, which are otherwise found in most iron-
binding proteins. This iron-binding capacity led to the first functional hypothesis on frataxin, which 
was put forward as a ferritin-like scavenger that keeps iron in a bio-available form. However, as 
reported in the previous paragraph, independent evidences suggest that this is not the major function 
of frataxin. 
Several residues of the whole ȕ-sheet external surface are highly conserved, and have been 
claimed to be critical for specific interactions between human FXN and other FeS cluster assembly 
proteins (Schmucker S. et al., 2011 and Dhe-Paganon S. et al., 2000). As assessed above, many 
known missense point mutations associated with compound heterozygous FRDA patients map to 
FXN conserved residues: several are buried in the protein core, consistent with a requirement for 
maintenance of a compact structure, whereas other are located either in the N-terminal anionic 
patch or within the flat, conserved external surface of the ȕ-sheet (Cossée M. et al., 1999), strongly 
supporting the hypothesis that these surfaces are critical for FXN function. Some of these mutant 
FXN variants have been considered in this part of my PhD thesis, and are further described in the 
following. 
Human FXN clinical mutants 
To date, more than 40 different mutations in FXN gene have been described in FRDA 
patients (Human Gene Mutation Database, Cardiff, UK) (see Galea C.A. et al., 2016 for a 
comprehensive state of the art of FXN mutations/FRDA clinical outcome). Among them, several 
lead to a decrease of frataxin resulting from misfolded and/or degraded protein or abrogated 
function, and result in “classical” FRDA; other are associated to a less severe disease or to an 
atypical clinical phenotype (Cossée M. et al., 1999 and De Castro M. et al., 2000) and, since they 
likely cause only partial defects in frataxin function, they could provide additional insights into the 
physiological role of this protein. 
Previous in vitro studies using several recombinant FXN clinical mutants indicated that 
these proteins retain a native fold under physiological conditions but have reduced thermodynamic 
stabilities (Correia A.R. et al., 2006 and 2008). Unfolding is reversible, which rules out the 
possibility of the formation of insoluble aggregates. Mutants also differ by protein dynamics, 
propensities toward aggregation and tendency toward proteolytic digestion. These results suggest 
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that the development of FRDA in heterozygous patients may result from the combined effect of 
reduced protein folding efficiency and accelerated degradation in vivo, which in turn lead to lower 
frataxin concentrations. In addition, some of the mutations have been suggested to affect the 
binding capacity of frataxin to components of the FeS cluster assembly machinery (Schmucker S. et 
al., 2011), and/or the capability to stimulate the NFS1 cysteine desulfurase activity on the ISCU 
scaffold (Bridwell-Rabb J. et al., 2011 and Tsai C.L. et al., 2011). 
 Examining FXN clinical mutations in the context of frataxin structure-function relationships 
may increase the understanding of frataxin biology, FRDA pathology, and underlying disease 
mechanisms: for compound heterozygous individuals carrying a FXN mutation that significantly 
affects protein folding, stability and/or function, but does not lead to complete loss of frataxin 
activity, this could be crucial not only as a resource for investigating the FRDA disease 
pathogenesis but also to promote novel treatment approaches. Disease-associated frataxin mutations 
can impair protein function in two main ways: by affecting the stability, leading to aggregation or 
rapid degradation in vivo and/or, when occurring at the protein surface, by modifying the capability 
to interact with other proteins. Several prediction tools may be used to determine the effect of 
mutations on protein stability, but they are actually limited by the availability of reliable three-
dimensional structures or experimental thermodynamic data. For human frataxin, both for the wild 
type and several mutant variants, crystal structures are available (Dhe-Paganon S. et al., 2000 and 
Bridwell-Rabb J. et al., 2011). On the other hand, residues involved in the binding to various 
components of the FeS cluster assembly machinery have been identified only for bacterial and yeast 
homologs of human frataxin and, by taking advantage of the high degree of homology between 
frataxin proteins from different species, they have been inferred to be involved also in the binding 
of human frataxin to components of ISC machinery. However, despite having the same fold and 
similar functional sequences, differences must be taken into account when looking for specific 
structure-function relationships. 
Based on these premises, in the second part of my PhD project, in collaboration with Prof. 
Bellanda from the Department of Chemical Sciences of the Padova University, I explored by 
Nuclear Magnetic Resonance the interface where human FXN binds to the ISCU scaffold protein at 
the FeS cluster biogenesis machinery, both with the wild type protein and with some clinically 
relevant mutant proteins associated to compound heterozygous FRDA patients, in order to gain 
additional molecular insights into the role of FXN in mitochondrial FeS clusters biosynthesis, and 
possibly in the molecular mechanisms leading to FRDA. 
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Materials and methods 
Heterologous expression and purification of human ISCU, FXN  and NSF1/ISD11 proteins 
Human ISCU2 cDNA cloned into a pENTR223.1 vector was purchased from MyBioSource, Inc. 
(San Diego, CA, USA) and used as template to amplify the sequence corresponding to the mature 
ISCU2 variant, i.e. without mitochondrial targeting sequence. The PCR product was sub-cloned 
into a pCR-Blunt II-TOPO vector. The fragment of interest was then directionally sub-cloned into a 
pETDuet-1 expression vector in frame with a sequence coding for a 6his-tag. The identity of the 
insert was confirmed by DNA sequencing (at GATC Biotech, Germany). A plasmid containing 
human wild type mature FXN, i.e. pET-9b/FXN(90-210) (Roman E.A. et al., 2012) was generously 
provided by Dr. Javier Santos from the University of Buenos Aires. FXN mutants were obtained 
through site-directed mutagenesis with the QuickChange® II Site-Directed Mutagenesis Kit (from 
Agilent Technologies), using as template the pET-9b/FXN(90-210) plasmid and the couples of 
primers listed below in table 6. The sequence of each mutant FXN gene was confirmed by DNA 
sequencing (at GATC Biotech, Germany). 
Table 6. List of primers used for the realization of mature ISCU2 and FXN mutants 
Primer name Primer sequence 
FwISCU 5‟-gaattcttatcacaagaaggttgttgat-3‟ 
RevISCU 5‟-aagctttcatttcttctctgcctctcc-3‟ 
FwD122Y 5‟-gccatacacgtttgagtactatgatgtctcctttgg-3‟ 
RevD122Y 5‟-ccaaaggagacatcatagtactcaaacgtgtatggc-3‟ 
FwG130V 5‟-gtctcctttgggagtgttgtcttaactgtcaaactg-3‟ 
RevG130V 5‟-cagtttgacagttaagacaacactcccaaaggagac-3‟ 
FwN146K 5‟-aggaacctatgtgatcaagaagcagacgccaaaca-3‟ 
RevN146K 5‟-tgtttggcgtctgcttcttgatcacataggttcct-3‟ 
FwW155R 5‟-gccaaacaagcaaatcaggctatcttctccatcca-3‟ 
RevW155R 5‟-tggatggagaagatagcctgatttgcttgtttggc-3‟ 
 
Sequences coding for mature mouse NFS1 and ISD11 proteins were cloned into the two multi-
cloning sites (NFS1 MCS1, in frame with a N-terminus 6his-tag, and ISD11 in MCS2 ) of a 
pETDuet-1 vector. For the expression of all proteins, E. coli BL21 (DE3) cells were transformed 
with the plasmids of interest and positive clones selected by antibiotic resistance. Bacteria cultures 
were grown at 37°C and 180 rpm in Luria-Bertani Broth, pH 7.5 (except for 15N/13C labeled 
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proteins, see below in the paragraph describing NMR). For the expression of ISCU protein, 
induction was performed at OD௘600=0.5 by addition of 1.0 mM isopropyl-ȕ-thiogalactopyranoside 
(IPTG), and carried out over-night at 25°C and 180 rpm. For the expression of FXN (wild type and 
mutant proteins), induction was performed at OD௘600=௘0.7 by addition of 1.0 mM IPTG. All bacterial 
cultures, except for the one expressing FXN mutant G130V, were harvested after 3.5h of induction 
at 37°C and 180 rpm. For FXN mutant G130V, instead, it was necessary to perform induction at 
18°C and 180 rpm over-night, to prevent high levels of protein aggregation. The expression of 
NFS1/ISD11 complex was induced at OD600=0.7 by addition of 1.0 mM IPTG, carried out over-
night at 16°C and 180 rpm. At the end of inductions, bacteria were centrifuged at 6000 rpm at 4°C 
and the pellet was stored at –20°C until cell disruption with French press (within a month).  
Recombinant ISCU-6his was purified starting from 1 to 1.5 L cultures by combining affinity 
NiNTA chromatography and size exclusion chromatography (SEC). Briefly, frozen harvested cells 
were thawed in ice, resuspended in lysis buffer (20 mM Tris-HCl pH 8.0, 50 mM NaCl and 20 mM 
imidazole) supplemented with protease inhibitors (1 ȝg/ml pepstatin A, 1 ȝg/ml leupeptin, 1 ȝg/ml 
antipain, 1 mM PMSF), and lysed by French press. The supernatant fractions were isolated from 
cell debris by centrifugation and the proteins purified to homogeneity by double chromatography, 
starting from affinity chromatography (HIS-Select® Nickel Affinity Gel, from Sigma-Aldrich). 
Fractions eluted in the first chromatographic step, obtained with subsequent elutions with lysis 
buffer added with growing imidazole concentrations (from 50 to 500 mM), were evaluated by SDS-
PAGE. ISCU containing fractions were pooled together and incubated 1h in ice with 10 mM EDTA 
to eliminate any residual metal. Then, a gel filtration chromatography was performed using a 
Superose 12 10/300 GL (from GE Healthcare), equilibrated in final buffer (25 mM Tris-HCl pH 
7.0, 50 mM KCl, and 1 mM DTT). The eluted fractions containing ISCU (both dimeric and 
monomeric) were finally pooled together and concentrated by centrifugal filters (Amicon Ultra 
Centrifugal Filter, 3000 NMWL, from Merck Millipore), obtaining a final concentration up to 200 
ȝM, as determined spectroscopically using İ280nm = 10220 M−1cm−1. Since at the concentration 
exploited for the NMR analysis ISCU was almost totally present in its dimeric form, its addition in 
these experiments was performed taking into account this oligomeric state: e.g. to add 1 ISCU 
equivalent to 40 M of FXN, 80 M of ISCU monomer (40 uM of dimer) was added. The identity 
of the protein was confirmed by Western Blotting analysis (not shown in the results) using a 
primary rabbit antibody anti-human ISCU (LSBio, LifeSpan Biosciences, Inc.), a secondary goat 
anti-rabbit IgG conjugated with horseradish peroxidase (Sigma-Aldrich), and the ECL 
SuperSignalTM West Pico Chemiluminescent Substrate (ThermoScientific) for final detection on 
HYPERFILMTM (GE Healthcare Life Sciences). 
85 
 
Purification of wild type and mutant FXN proteins was carried out starting from 0,5 to 1L 
cultures and exploiting two subsequent chromatographic steps: anion exchange chromatography and 
SEC. In particular, after cell disruption with French press in lysis buffer (20 mM Tris-HCl, 1 mM 
EDTA, pH 7.0) supplemented with protease inhibitors (1 ȝg/ml pepstatin A, 1 ȝg/ml leupeptin, 1 
ȝg/ml antipain, 1 mM PMSF), soluble and insoluble fractions were separated by centrifugation. The 
soluble fraction, after 1h incubation with 10 mM EDTA, was carefully loaded onto a column 
packed with a weak anion exchanger resin (DEAE Sepharose Fast Flow, GE Healthcare), and eluted 
with a 300 mL linear gradient, from 0.0 to 1.0 M NaCl, in buffer 20 mM Tris-HCl, 1 mM EDTA, 
pH 7.0. Subsequently, fractions with FXN (identified by SDS-PAGE) were loaded onto a 
preparative HiLoad 16/600 Superdex 200 pg column (GE Healthcare), previously equilibrated with 
final buffer (25 mM Tris-HCl pH 7.0, 50 mM KCl, and 1 mM DTT). SEC fractions corresponding 
to FXN (wild type and mutant, both present exclusively as monomeric proteins) were finally pooled 
together and concentrated by centrifugal filters (Amicon Ultra Centrifugal Filter, 3000 NMWL, 
from Merck Millipore), obtaining a final concentration up to 1 mM, as determined spectroscopically 
using İ280nm = 26930 M−1cm−1 for wild type FXN and mutants G130V and N146K, İ280nm = 28420 
M−1cm−1 for mutant D122Y and İ280nm = 21430 M−1cm−1 for mutant W155R. The identity of the 
protein was confirmed by Western Blotting analysis (not shown in the results) using a primary 
rabbit antibody anti-human FXN (Proteintech), a secondary goat anti-rabbit IgG conjugated with 
horseradish peroxidase (Sigma-Aldrich), and the ECL SuperSignalTM West Pico Chemiluminescent 
Substrate (ThermoScientific) for final detection on HYPERFILMTM (GE Healthcare Life Sciences). 
The NFS1/ISD11 complex was purified starting from 1 L cultures, and performing a single 
step of affinity chromatography, exploiting NFS1 N-terminus His-tag. Briefly, frozen harvested 
cells were thawed in ice and resuspended in lysis buffer (50 mM Tris-HCl, 300 mM NaCl, pH 8.0), 
and lysed by multiple cycles of sonication. The soluble fraction of lysate, separated from the 
insoluble fraction through centrifugation, was loaded into a column for nickel affinity 
chromatography (HIS-Select® Nickel Affinity Gel, from Sigma-Aldrich). After several washes of 
the column with lysis buffer and lysis buffer supplemented with growing imidazole concentrations 
(20-50 mM), NFS1/ISD11 complex was eluted with elution buffer (50 mM Tris-HCl, 300 mM 
NaCl, 500 mM imidazole, pH 8.0). Fractions containing NFS1/ISD11 proteins were identified by 
SDS-PAGE and pooled together. Finally the proteins pool was supplemented with pyridoxal 
phosphate 10 mM (PLP) and 1 mM DTT, and subsequently dialyzed over-night against dialysis 
buffer (50 mM Tris-HCl, 200 mM NaCl, 1 mM DTT, pH 8.0), with a 10 kDa cut-off membrane. 
Finally, protein concentrations were spectroscopically estimated using an İ280nm= 42670 M-1cm-1. 
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To estimate the molecular weight of the analyzed samples during SEC, the columns were 
equilibrated in the same final buffer and calibrated with the standards thyroglobulin (669 kDa), 
ferritin (440 KkDa), ȕ-amylase (200 kDa), bovine serum albumin (67 kDa), carbonic anhydrase (29 
kDa) and cytochrome c (12 kDa). All proteins, after the final purification step, were analyzed by 
SDS-PAGE. Notably, for NMR experiments the utilized final buffer of ISCU and FXN proteins 
was used exactly from the same stock, to avoid possible perturbations due to buffer differences. 
Circular Dichroism (CD)  
CD measurements were performed with a Jasco J-810 spectropolarimeter. Far-UV CD 
spectra were collected using cells of 0.1 cm path-length. Data were acquired at a scan speed of 20 
nm/min and at least three scans were averaged. Proteins were used at a concentration of 0.2 mg/ml, 
in a 2.5 mM Tris-HCl pH 7.0, 5 mM KCl buffer. Experiments were performed at 25 °C using a 
thermostated Jasco PTC-423 Peltier Cell Holder connected to a Jasco PTC-423S Peltier Controller. 
The secondary structure content of all analyzed proteins was calculated using the CD spectrum 
deconvolution software CDNN (a software that calculates the secondary structure by comparison 
with a CD database of known protein structures) (Bohm G. et al., 1992), and then compared with 
the one present in literature to confirm their correct folding state.  
Fluorescence Measurements  
Fluorescence measurements were exploited to perform the quantitation of Fe3+ binding to 
wild type and mutant FXN proteins. The tryptophan fluorescence of human FXN solution was 
measured in 400 ȝL quartz cuvettes at room temperature with a Cary Eclipse Fluorescence 
Spectrophotometer (Agilent). Excitation wavelength was 291 nm and emission data were collected 
in the range of 300–450 nm. For ferric ion binding, spectra were obtained on a 24 ȝM solution of 
FXN (wild type or mutant) and ferric ion was titrated from a stock solution of 14 ȝM FeCl3 over the 
concentration range shown. Protein and iron samples were prepared in buffer 25 mM Tris-HCl pH 
7.0, 50 mM KCl, and 1 mM DTT. The quenching of tryptophan fluorescence induced by the 
binding of ferric ions was followed at maximum fluorescence emission wavelength: 341 nm for 
wild type FXN and all its mutants, except for mutant W155R, whose maximum fluorescence 
emission wavelength was 314 nm. The resulting data were used to describe iron binding capability 
of wild type FXN and mutant, as previously described by Yoon T. & Cowan J.A., 2003. Briefly, 
quenching of tryptophan fluorescence induced by the binding of ferric ions was used to calculate 
the fraction of binding sites occupied, fa: 
fa = (y - yf) / (yb - yf) 
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where y is the fluorescence intensity at a given concentration of ferric ions and yb and yf are the 
intensities when the binding sites are fully occupied and unoccupied, respectively. The 
stoichiometry, n, and apparent dissociation constant, Kd, were then obtained from the intercept and 
slope of a linear regression of the data transformed as described by Winzor D.J. & Sawyer W.H., 
1995, in terms of: 
Cs / fa = n Ca + Kd / (1 - fa) 
where Cs is the total concentration of metal ions and Ca is the total concentration of wild-type or 
mutant FXN. 
Nuclear Magnetic Resonance (NMR) spectroscopy 
FXN wild type and mutant 15N-labeled and 15N/13C-double labeled proteins were isolated 
from E. coli cultures expressing the protein of interest, grown in M9 minimal media supplemented 
with 15N NH4Cl/
13C D-Glucose, in the same conditions described above. When Fe2+ was used, all 
samples were prepared with N2 purged buffer (25 mM Tris-HCl pH 7.0, 50 mM KCl, and 1 mM 
DTT) under an anaerobic glove box (MBRAUN MB-200B) saturated with N2. 
15N labeled FXN 
wild type and mutant proteins had a final concentration of 45 ȝM, unlabeled dimeric ISCU, when 
present, was at 40 ȝM. Fe2+ stock solution was freshly prepared before each experiment, dissolving 
(NH4)2Fe(SO4)2·6H2O in the buffer described above, into the anaerobic glove box. Fe
3+ solution 
was prepared dissolving FeCl3 in the same buffer. Both iron stock solutions had a concentration of 
14 mM. Samples “FXN wild type/mutant + Fe” (1:4 FXN:Fe ratio) and “FXN wild type/mutant + 
Fe + ISCU” (1:4:1 FXN:Fe:ISCU ratio) were prepared starting from a common stock of FXN wild 
type/mutant + Fe, and then diluted to the right final concentration either with buffer alone or with 
buffer + ISCU, in order to obtain the same FXN/Fe ratio in all experiments. 10% D2O was added to 
all samples, which were then transferred in anaerobic conditions in Shigemi NMR tubes and sealed 
with appropriate rubber septa that secured air-tightness throughout the duration of the experiments. 
Before and after NMR experiments, pH of all samples was strictly controlled, and, in particular 
after addition of Fe3+, it was necessary to adjust it with NaOH 1M. 
All NMR experiments were acquired at 298K on a Bruker DMX 600 MHz spectrometer 
with room temperature probes. SOFAST HMQC (band-Selective Optimized Flip-Angle Short-
Transient Heteronuclear Multiple Quantum Coherence) (Shanda S. & Brutcher P., 2005) was used 
to monitor the effect of iron and ISCU on 15N labeled FXN wild type/mutants. Resonance 
assignment for the amides groups of FXN was achieved by comparison with data available for 
human FXN in the BMRB database (http://www.bmrb.wisc.edu; accession code: 4342) and 
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confirmed by HNCA, HN(CO)CA, HNCO, HN(CA)CO, HNCACB and HN(CO)CACB 3D 
heteronuclear experiments, using a sample of 1 mM protein in the same buffer described above. 
Spectra were analyzed with NMRFAM-Sparky 1.4 (Lee W. et al., 2015) and CARA (Keller 
R., 2004). Normalized chemical shifts were calculated using the following the equation:  
Δį = ((įHN) 2 + (įN / 5) 2 ) 0.5 
Residues that underwent significant chemical shift perturbations were mapped on the human FXN 
crystal structure (PDBID: 1EKG) using the program PyMOL (DeLano W.L., 2002). 
Cysteine desulfurase activity measurements 
The enzymatic catalysis of cysteine to alanine by NFS1/ISD11 (SD) complex was measured 
by the production of sulfide, using slight modifications of the assay described by Leimkühler and 
co-workers (Marelja Z. et al., 2008). Briefly, sulfide quantification was performed by a colorimetric 
reaction in which the latter is used to generate methylene blue. For the assay, a total volume of 0.4 
ml was employed, containing 1 ȝM of NFS1/ISD11, 3 ȝM FXN and 3 ȝM  ISCU. The samples 
were also supplemented with 10 ȝM PLP, 2 mM DTT and 10 µM Fe2+ at final concentrations. 
Argon-purged 50 mM Tris-HCl, 200 mM NaCl, pH 8.0 was used as a the reaction buffer. To initiate 
the reaction, 1 mM cysteine was added and the sample was incubated at room temperature. As 
sulfide production is linear during the first 40 minutes (data not shown), 30 minutes were employed 
to generate sufficient product for the detection. The assays were stopped by the addition of 50 ȝL of 
20 mM N,N-dimethyl p-phenylenediamine in 7.2 N HCl and 50 ȝL of 30 mM FeCl3 in 1.2 N HCl. 
After letting the reaction proceed for 20 minutes, the samples were centrifuged for 5 minutes at 
12000 x g. Then, the absorbance at 670 nm was measured. The same assay was performed for each 
frataxin variant, in the same concentration as the wild type. In this case, the desulfurase activity was 
normalized to the activity of the wild type protein. 
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Results and discussion 
Molecular characterization of human  FXN-ISCU interaction 
Frataxin involvement in the human mitochondrial FeS cluster biosynthesis is widely 
accepted, mainly based on its structural and functional interactions with the FeS cluster biosynthetic 
complex NFS1/ISD11/ISCU (Adinolfi S. et al., 2002). However, the molecular details of the 
interaction of the human FXN with this machinery are still not completely defined. Despite the high 
degree of conservation of the proteins involved in this biosynthetic system in prokaryotes and 
eukaryotes, the respective mechanisms of action present some important differences. For example, 
as already mentioned, in eukaryotes FXN stimulates the biosynthetic process, likely acting as an 
allosteric effector of the NFS1 desulfurase enzyme, whereas in prokaryotes the effect is the opposite 
(Gakh O. et al., 2010, Prischi F. et al., 2010, Tsai C.L. & Barondeau D.P., 2010 and Iannuzzi C. et 
al., 2011). Functional differences were also found when comparing human and yeast FXN proteins, 
especially as far as concerns the iron-binding capacity: human FXN can bind up to 7 iron atoms 
while the yeast orthologue Yfh1 only 2 (Yoon T. & Cowan J.A., 2003 and Cook J.D. et al., 2006). 
These distinct behaviors and/or discrepancies indicate that interactions between FXN and 
orthologues of ISC components may be partially unique for the system under investigation, so 
caution is needed when inferring structural and functional information on the human complex, for 
which a detailed characterization is still incomplete. 
Probably the most effective way of exploring a protein complex in vitro is by delimiting the 
system to a minimal and well-controlled number of components. In this part of my PhD work, I 
have dissected the interaction between frataxin (wild type and several mutant variants) and the 
ISCU scaffold, to gain new information on the structure of their binary complex. 
Heterologous expression and purification of recombinant human FXN and ISCU 
proteins 
In order to identify the FXN aminoacids belonging to the ISCU-binding interface, I 
performed a two-dimensional NMR analysis using a recombinant human FXN marked with 15N and 
an unlabeled human ISCU. Both proteins lack the N-terminal mitochondrial targeting sequences 
and have been purified to homogeneity by the double-steps chromatography approaches described 
in Materials and methods. Far-UV circular dichroism analysis of both proteins showed a secondary 
structure content compatible with properly folded / species (fig. 39). These purified proteins have 
been used to explore their interaction by means of NMR. 
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Figure 39. Purification of recombinant human FXN and ISCU proteins. Panel A, left, recombinant 
human FXN purification steps evaluated with SDS-PAGE. AEC lane shows FXN containing fractions after 
Anionic Exchange Chromatography, SEC lane shows purified FXN after Size Exclusion Chromatography. 
Panel B, left, recombinant human ISCU purification steps evaluated with SDS-PAGE. AC lane shows ISCU 
containing fractions after Affinity Chromatography, SEC lane shows purified ISCU after Size Exclusion 
Chromatography. Right panels A and B, Far-UV circular dichroism spectra of the relative purified protein. 
Both spectra shows a secondary structure content compatible with properly folded α/ȕ species, as quantified 
by CDNN spectra deconvolution, whose data are reported in table 9, in supplementary information section. 
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2D NMR analysis of FXN 
Fluorimetry and isothermal titration calorimetry (ITC) analysis previously showed that 
human frataxin is able to form a direct complex with ISCU with sub-micromolar binding affinities 
and that this binding is iron-dependent (Yoon T. & Cowan J.A., 2003 and Huang J. et al., 2008). 
Thus, as first experiment I mapped the iron-binding sites on FXN by means of chemical shift 
perturbation analysis. Both Fe2+ and Fe3+ titrations were performed by using SOFAST HMQC 
NMR spectra to monitor perturbations on a 15N labeled FXN protein. The spectra are reported at the 
end of the chapter, together with the NMR spectrum of FXN with the peaks assignment (figs. 51 
and 52). FXN can bind up to 7 iron ions, however a FXN:iron ratio of 1:4 was used in these 
experiments since it had been previously shown that only the first iron equivalent is essential for 
ISCU binding (Huang J. et al., 2008). Fig. 40 shows the normalized chemical shift changes, 
calculated as described in Materials and methods. As expected, upon addition of both Fe2+ (in 
anaerobic conditions) or Fe3+ positions and/or intensities of peaks in NMR spectra of FXN (reported 
at the end of the chapter, fig. 52) resulted to be perturbed. The perturbed peaks mostly correspond to 
residues of the N-terminal α1/ȕ1 acidic region, which has been previously shown to be the FXN Fe-
binding region, as described above (Nair M. et al., 2004 and Huang J., et al., 2008). Interestingly, 
although the iron-binding region resulted to be substantially the same for Fe2+ and Fe3+, ferrous ion 
generally induces larger perturbations (larger shifts or higher intensity decrease of the peaks), 
except for residues 119, 120, 137 and 140 that are more shifted in the presence of the ferric ion, 
suggesting a slightly different binding mode for iron in the two oxidative states (fig. 40, panel A).  
Addition of unlabeled ISCU to FXN was then performed either in the absence or in the 
presence of iron (Fe2+ or Fe3+), and the SOFAST HMQC NMR spectra were acquired to map the 
residues potentially affected by binding of FXN to ISCU. In the absence of iron, ISCU addition did 
not significantly perturb FXN NMR spectra (see fig 53 in the supplementary information at the end 
of the chapter), confirming that the direct interaction between the two proteins, if any, is iron-
dependent. Instead, when iron (either Fe2+ or Fe3+) was bound to FXN, significant and reproducible 
shifts were detected in FXN NMR spectra upon addition of ISCU to the sample, as depicted in fig. 
41, which reports the results obtained with Fe2+-bound FXN. The NMR spectrum is reported at the 
end of the chapter (fig. 54). Residues perturbed by ISCU addition were located both in the α1/ȕ1 
acidic region already perturbed by iron binding, and in the adjacent ȕ-sheet surface. Thus, we 
confirmed the iron-dependent direct interaction between FXN and ISCU, and we identified in 
human frataxin two regions affected by the binding to the ISCU scaffold: some peaks map in the 
iron-binding region (highlighted in red in fig. 41) and several others in additional flanking region 
(highlighted in blue in fig. 41). 
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Figure 40. Mapping the iron (Fe
2+/3+
) binding sites of human FXN by NMR chemical shift 
perturbation. Reproducible FXN + Fe spectra were collected at a 1:4 FXN to iron stoichiometric ratio. 
Panel A: normalized chemical shift changes for FXN with and without Fe2+ (up) and Fe3+ (down). The red 
line represents the threshold calculated as one standard deviation of the shifts. Residues indicated with an * 
were considered significantly perturbed because of the strong decrease of signal intensity rather than a shift 
(see fig. 57, supplementary information). A schematic representation of FXN secondary structure is inserted 
in frame with residues sequence number to facilitate the interpretation of the figure. Panel B: regions 
identified on the apo-FXN structure (PDBID: 1EKG) are relative to residues with normalized chemical shift 
values greater than the above mentioned  threshold (0.01 ppm); pink when perturbed by Fe2+ and purple 
when perturbed by Fe3+; these residues are underlined in FXN sequence in Panel C (upper sequence for Fe2+ 
and lower sequence for Fe3+). 
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Figure 41. Mapping the ISCU binding sites of human Fe
2+
-bound FXN by NMR chemical shift 
perturbation. Reproducible FXN + Fe2+ + ISCU spectra were collected at a 1:4:1 FXN to iron to ISCU 
dimer stoichiometric ratio. Panel A: normalized chemical shift changes for Fe2+-bound FXN with and 
without ISCU. The red line represents the threshold calculated as one standard deviation of the shifts. 
Residues indicated with an * were considered significantly perturbed not because of the shift but because of 
the strong decrease of signal intensity. Panel B: regions identified on the apo-FXN structure (PDBID: 
1EKG) are relative to residues with normalized chemical shift values greater than the threshold (0.01); red, 
when residues were already perturbed by Fe2+ and further perturbed by ISCU addition, blue when perturbed 
by ISCU in the adiacent -sheet region; these residues are underlined in FXN sequence in Panel C, where 
black arrows indicate residues mutated in sporadic FRDA compound heterozygotes. 
 
These results are compatible, even though not completely superimposable, with NMR data 
previously obtained by Cook and coworkers with the yeast orthologues Yfh1 (of FXN) and Isu1 (of 
ISCU) (Cook J.D. et al., 2010). Most of the residues perturbed by ISCU binding are indeed 
conserved (fig. 42), supporting their importance for FXN function(s).  
94 
 
 
Figure 42. Comparison between human FXN ISCU-binding residues and Yfh1 Isu1-binding residues. 
Panel A: multiple sequence alignment (MSA) of frataxin orthologues human FXN, S. cerevisiae Yfh1 and E. 
coli CyaY, generated by Clustal Omega algorithm. An * indicates positions which have a single, fully 
conserved residue, a : indicates conservation between groups of strongly similar properties and a . indicates 
conservation between groups of weakly similar properties. FXN ISCU-binding residues and Yfh1 Isu1-
binding residues (Cook J.D. et al., 2010) are underlined in blue and green respectively. Panel B: comparison 
between FXN ISCU-binding region and Yfh1 Isu1-binding region, mapped respectively in blue on the apo-
human FXN structure (PDBID: 1EKG) and in green on the apo-yeast frataxin solution structure (PDBID: 
2GA5). 
 
This confirms that, despite some peculiarities, the process is highly conserved between yeast and 
humans. 
Interestingly, several residues which we found to be involved in FXN-ISCU interaction 
(marked with an arrow in fig. 41) are mutated in FRDA heterozygous patients (Galea C.A. et al., 
2016), suggesting that these missense mutations could impair the binding event. We thus 
investigated if and how some of these pathological mutations interfere with FXN-ISCU interaction, 
be means of the same two-dimensional analysis described above (i.e. using FXN mutants marked 
with 15N and an unlabeled human ISCU). 
95 
 
Characterization of clinically relevant FXN variants 
 Four variants were selected to investigate the capability of pathological FXN mutants found 
in FRDA patients to form a binary complex with ISCU: D122Y (residue located in the middle of 
the iron-binding region), G130V (residue located in the border between iron-binding and the 
putative ISCU-binding region), N146K and W155R (residues located in the middle of the putative 
ISCU-binding region) (fig. 43). 
 
Figure 43. Mapping of the four FRDA-associated FXN mutations investigated in this work on the apo-
FXN structure (PDBID: 1EKG). FXN regions affected by ISCU binding are colored in blue while residues 
affected only by Fe2+ binding are indicated in magenta. Red spheres identify residue D122 (FRDA mutation: 
D122Y), yellow spheres residue G130 (FRDA mutation: G130V), green spheres residue N146 (FRDA 
mutation: N146K) and orange spheres residue W155 (FRDA mutation: W155R) 
 
Residue D122 is localized at the very beginning of the 1 strand and is an integral part of the turn 
connecting 1 to 1: being in a turn, this residue could influence the folding process. Moreover, 
since this aminoacid is one of the highly conserved acidic residues of the 1/1 region, its mutation 
into tyrosine, a hydrophobic residue, may interfere with the acidic path responsible for the iron 
binding capacity of FXN. G130 is in the tight turn formed by G128, S129 and G130 itself, between 
strands 1 and 2: its mutation into a valine may disturb the turn conformation, resulting in a severe 
local strain. W155 is an exposed and highly conserved residue with an orientation constrained by a 
hydrogen bond between the indole ring nitrogen and the side chain oxygen of residue Q153, as well 
as by van der Waals interactions with the side chains of N146, Q148, and R165. The latter, in 
particular, is a positively charged residue packed against W155 and the mutation of the tryptophan 
to an arginine results in a repulsive interaction arising from two spatially contiguous positively 
charged residues. Indeed, the crystallographic structure of the FXN mutant W155R exhibited a 
significant side-chain reorganization compared to native FXN, with a rotation of the mutated 
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residue to fill a cavity on the surface of FXN and a ∼1.5 Å translation of the Q148-N151 ȕ-turn 
between the third and fourth ȕ-strand (Tsai C.L. et al., 2011). Finally, N146 side chain nitrogen 
forms a hydrogen bond to the backbone carbonyl of K147: changes due to the N146K mutation 
include the loss of this hydrogen bond and localized alterations in the electrostatic and molecular 
surface of FXN. However, the crystal structure of FXN mutant N146K exhibited backbone and side 
chain conformations similar to those of native FXN (Bridwell-Rabb J. et al., 2014). 
Heterologous expression and purification of recombinant human FXN variants 
The selected point mutations were inserted into the wild type FXN coding sequence by site-
specific mutagenesis (as described in details in Material and methods), and the obtained 
recombinant plasmids were used to transform BL21 E. coli cells, in which protein expression was 
finally induced as previously described. All mutant proteins were expressed at the same extent as 
the wild type protein (not shown) and were almost completely found in the soluble fraction after 
cell lysis, except for G130V mutant, which showed a higher tendency towards aggregation (fig. 44). 
 
 
 
 
 
Figure 44. Effect of the four studied FXN clinical mutations on the protein aggregation propensity. 
Top panel: SDS-PAGE gels obtained from E. coli lysates expressing in the same conditions FXN mutants 
(MW = 13.6 kDa). FXN identity was confirmed by western blot analysis (not shown). For each protein 
variant, the electrophoretic separations of total protein in both the insoluble (i) and soluble (s) fractions are 
shown. Bottom panel: semi-quantitative analysis of the relative proportion of FXN present in the soluble 
and insoluble fractions, obtained from densitometric analysis of gel bands. Data represent the mean of three 
replicates ± S.D. 
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Interestingly, although G130V mutation is predicted to have little effect on protein stability, 
previously published experimental data indicated that this FXN variant has a lower stability (i.e. Tm 
= 43,2 ± 0.1 °C) when compared to the wild type protein (Tm = 66.3 ± 0.1 °C) (Correia A.R. et al., 
2008). Moreover, modeling analysis indicates that the G130V mutation may result in loss of main-
chain hydrogen bond between residues G130 and K147. K147 lies within the frataxin -sheet that 
forms a binding surface for ISCU, based on our NMR analysis. Thus, it is likely that the loss of this 
hydrogen bond may disrupt this -sheet, leading to a decrease in frataxin stability (fig. 44) and 
possibly affecting its binding to ISCU. On the other hand, mutation of the other frataxin residues 
considered in our study were predicted to have a low-to-moderate effect on protein stability 
(Correia A.R. et al., 2006 and Correia A.R. et al., 2008), which is in accordance with the results 
reported in fig. 44, but could significantly attenuate protein binding, based on the FXN/ISCU 
interface described by our NMR analysis. 
To test these hypotheses, the four mutant FXN proteins were purified, labeled and subjected 
to same 2D-NMR analysis described above for the wild type protein to evaluate their capability to 
form an iron-dependent binary complex with the scaffold ISCU. 
Spectroscopic analysis of FXN variants 
The NMR spectra of the four clinical FNX variants (reported in fig. 45) were found to be 
compatible with folded species and partially superimposable to that of the wild type protein. 
Accordingly, it was possible to easily assign most of the resonances. The quantification of the shifts 
allowed to identify the regions most perturbed by the mutations. 
The NMR spectra of the four clinical FNX variants, when compared with the wild type, 
reflected local rearrangements surrounding the mutation, which is particularly evident for the 
mutant D122Y, that lacks assignments for some peaks of residues adjacent to the mutation (fig. 45, 
red arrows) because of very large shifts when compared to the wild type protein. In fact, mutation 
D122Y induced strong perturbations in several residues facing it, making impossible to confidently 
assign them to the right residue (fig. 45, red arrows). Perturbed regions included residues of the 
terminal part of α1 and the beginning of 1 together with the loop connecting them, the loop 
between 1 and 2, and the beginning of α2 (fig. 45). In agreement with the crystal structure of 
mutant N146K obtained by Bridwell-Rabb and coworkers, that shows backbone and side chain 
conformations similar to those of native FXN (Bridwell-Rabb J. et al., 2014), this mutation 
perturbed only few residues adjacent to it, mostly belonging to (where mutation is located) 
andstrands (fig. 45).  
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Figure 45. NMR spectra comparison of wild type frataxin (red spectra) and mutants (blue spectra), 
and relative normalized chemical shift changes. The red line represents the threshold value calculated as 
one standard deviation of the shifts (0.05). Black arrows indicate in wild type frataxin spectra the peak of the 
mutated residue (two in the case of Trp 155: backbone HN and indolic ring HN). Red arrows indicate peaks 
of wild type FXN spectra that could not be identified in D122Y spectra because of very large shifts. Regions 
mapped on the apo-FXN structure (PDBID: 1EKG), in which mutated residues are represented in spheres, 
are relative to residues with normalized chemical shift values greater than the threshold. 
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The mutation of tryptophan 155 in arginine, instead, induced a significant perturbation in several 
residues, in a wide region surrounding the mutation that includes residues of α1 and the whole -
sheet (except , as shown in fig. 45. These results are compatible with the W155R crystal 
structure, previously solved by Tsai and coworkers, which showed a significant side-chain 
reorganization surrounding the mutation, compared to native FXN (Tsai C.L. et al., 2011). 
Similarly, mutation G130V induced a diffused perturbation in residues ranging from α1 to 4, all 
around the mutation, as can be appreciated in fig. 45.  
Since the interaction of the wild type frataxin with ISCU relies on the iron-binding to FXN, 
we then explored by NMR the N-terminal acidic region of the four clinical variants after addition of 
Fe2+. The results are reported in fig. 46, which shows the normalized chemical shift changes (NMR 
spectra are shown at the end of the chapter, in fig. 55). When compared to the wild type protein 
(reported in the upper part of fig. 46), FXN variants showed different behaviors in the presence of 
Fe2+. The iron-binding region of mutants N146K and W155R resulted to be almost identical to that 
of the wild type, suggesting that these two mutations do not significantly impact on Fe-binding 
capacity of FXN. Instead, mutant G130V has a slightly more extended iron-binding region, with 
additional perturbed residues surrounding the α1/ȕ1 acidic region involved in Fe-binding in the wild 
type protein (indicated with black arrows in fig. 46). The increased perturbation observed in its 
NMR spectrum upon addition of iron could reflect the lower conformational stability already 
observed in this mutant (Correia A.R. et al., 2008), as discussed above. Surprisingly, mutant D122Y 
does not present striking differences in the iron-binding region when compared to the wild type. 
However, it must be underlined that residues 120, 121 and 122 itself, which turned out to be 
perturbed after iron addition to the wild type protein (fig. 40), were not assigned in this mutant 
because of their large resonance shift; thus, possible differences in this region that potentially affect 
the capability of D122Y mutant FXN to bind iron could not be tracked. Notably, residue L156, 
located in the middle of the 4 sheet, was found to be significantly perturbed after addition of Fe2+ 
to D122Y mutant. However, since some peaks of residues facing Y122 are missing into the 
assignment, as mentioned above, this perturbation could be related to one of these unassigned, 
strongly shifted residues that could overlay L156.  
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Figure 46. NMR chemical shift analysis of residues affected by Fe2+ binding to FXN variants. Spectra 
were collected at a 1:4 FXN mutant protein to iron stoichiometric ratio. Normalized chemical shift changes 
are reported for FXN with Fe2+. The red line represents the threshold value calculated as one standard 
deviation of the shifts (0.01). Residues indicated with an * were considered significantly perturbed not 
because of the shift but because of the strong decrease of signal intensity. Black arrows indicate in G130V 
graph, additional Fe-perturbed residues surrounding the α1/ȕ1 acidic region, involved in Fe-binding in the 
wild type protein. On the right of the respective graphs, regions identified on the apo-FXN structure 
(PDBID: 1EKG), in which mutated residues are represented in spheres, are relative to residues with 
normalized chemical shift values greater than the threshold (0.01). In the upper part of the figure are reported 
regions perturbed by Fe2+ addition in wild type frataxin in the same conditions, to facilitate the comparison 
with mutants. 
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The different effects observed upon iron addition to the distinct FXN mutants, when 
compared to wild type protein, prompted us to further investigate this issue by addressing the 
impact of the selected mutations in the frataxin iron-binding properties. As reported in the 
introduction, human frataxin has been previously shown to bind six to seven irons, although with a 
low affinities (Yoon T. & Cowan J.A., 2003). Wild type human frataxin contains three tryptophan 
residues and two of them are conserved across a variety of species, including W155. Thus, iron-
binding capacity was quantified by evaluating the tryptophan fluorescence quenching upon addition 
of Fe3+ to wild type and mutant FXN proteins. Following excitation at 291 nm, the variation of 
emission intensity was analyzed by means of the procedure of Winzor and Sawyer, described in 
details in Materials and methods (Winzor D.J. & Sawyer W.H., 1995). The quenching of tryptophan 
fluorescence induced by the addition of ferric ions was followed at a 341 nm wavelength with all 
proteins except for the W155R mutant, for which emission wavelength was 314 nm. The absence of 
one of the three tryptophan residues of frataxin, in fact, significantly affected W155R emission 
spectra. The mutation removed the most solvent-exposed tryptophan, while maintaining the two 
buried trypthophans, resulting in an emission spectrum whose maximum was shifted at lower 
wavelengths. The results of these measurements are reported in fig. 47 and summarized in table 7. 
Wild type FXN resulted to have an overall higher affinity for Fe3+ when compared to all 
mutants, with iron-binding parameters compatible with those previously published by Yoon and 
Cowan (i.e., iron-binding stoichiometry 6.4 and Kd 11.7 ȝM). In particular, in the experimental 
conditions used for our titrations, mutant D122Y showed the lowest affinity (ten times lower 
respect to the wild type), while mutants G130V, N146K and W155R have similar affinities, in each 
case lower respect to the wild type protein (see table 7). For mutants D122Y, G130V and W155R 
these data are in accordance with those obtained by Correia and coworkers (Correia A.R. et al., 
2006 and Correia A.R. et al., 2008), whereas the iron-binding properties of the N146K mutant had 
never been investigated before. Taken together, these data indicate that the four mutations selected 
for this study impair the capability of frataxin to bind iron, as assessed either by different 
stoichiometries and/or apparent binding affinities: instead of the 6-7 iron equivalents found for the 
wild type protein, D122Y mutant is able to bind 4 irons per molecule and G130V resulted to be able 
to bind 5 equivalents, whereas N146K and W155Y mutants showed a stoichiometry similar to that 
of the wild type FXN, although with a  reduced Fe-binding affinity.  
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Figure 47. Iron-binding analysis of human wild type and mutant frataxin proteins. Panel A: spectra 
showing the quenching of natural Trp fluorescence, following titration with ferric ion. Fluorescence spectra 
is different of mutant W155R, in which only two of the three wild-type tryptophans are present. Panel B: 
binding curve generated from analysis of the fluorescence quenching measurements following the method of 
Winzor (Winzor D.J. & Sawyer W.H., 1995). Fitted parameters (stoichiometry and apparent binding affinity) 
are summarized in table 7.  
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FXN mutant n Kd (μM) 
wild-type 6.3 12.9 ± 0.9 
D122Y 4.35 156.8 ± 1.6 
G130V 5.4 27.5 ± 1.1 
N146K 5.8 31.1 ± 0.8 
W155R 6.2 23.6 ± 0.7 
 
Table 7. Fe-binding parameters of wild type and mutant FXN proteins. Data were obtained by 
processing of iron-induced quenching of tryptophan fluorescence, as described in details in Materials and 
methods. 
 
Notably, in the work previously published by Correia and colleagues the W155R mutant protein 
precipitated above an iron/frataxin ratio of 2:1 (Correia A.R. et al., 2006). This may be due to the 
different experimental conditions used in our work, including different protein resuspension buffers 
(i.e. Tris-HCl/KCl instead of PBS) and slightly different protein constructs (i.e. untagged 90-210 
frataxin instead of 6his- or GST-91-210 frataxins with TEV-sites for tag-cleavage, requiring 
additional steps in protein purification protocols). In the titrations reported in fig. 47 up to 9 
equivalents were added to frataxin; the addition a further equivalent to the wild type protein turned 
out to induce sample precipitation, which was observed at higher iron concentrations with all FXN 
variants. This could be explained by the higher apparent binding affinity of wild type FXN when 
compared to the mutant proteins (table 7): at the same protein and iron concentrations, the 
equilibrium between free and FXN-bound iron would be shifted to the free form in variants respect 
to the wild-type protein, thus allowing to keep them in solution at higher iron concentrations.   
Interestingly, all mutants appear to have the same fluorescence quenching after the addition 
of 1 Fe3+ equivalent (point at ~25 ȝM Fe3+ in the graph of fig. 47, panel B). Thus, it is tempting to 
speculate that a first, higher affinity iron-binding site would be present in wild type frataxin as well 
as in all mutant proteins investigated in this work (including D122Y, for which lower stoichiometry 
and affinity were found under the same experimental conditions), and that the difference in the 
overall affinity could be due to perturbations of a second, lower affinity site.  
2D NMR analysis of the binary complex between frataxin variants and ISCU 
Addition of unlabeled ISCU to 15N labeled FXN protein was performed in the presence of 
iron (Fe2+) in 1:4 molar ratio, and the SOFAST HMQC NMR spectra were acquired to map the 
residues potentially affected by binding of FXN mutants to ISCU. The four NMR spectra are 
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reported in fig. 56 at the end of the chapter, whereas fig. 48 shows the normalized chemical shift 
changes recorded after ISCU addition to frataxin.   
 
Figure 48. NMR chemical shift mapping of residues of Fe2+-bound FXN mutants affected by ISCU 
binding. Mutant FXN + Fe2+ + ISCU spectra were collected at a 1:4:1 FXN to iron to ISCU dimer 
stoichiometric ratio. The normalized chemical shift changes are reported for Fe2+-bound FXN mutants with 
and without ISCU. The red line represents the threshold value calculated as one standard deviation of the 
shifts. Residues indicated with an * were considered significantly perturbed not because of the shift but 
because of the strong decrease of signal intensity. 
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The NMR mapping results reported in fig. 48 indicate that the four mutations have a different effect 
on the direct interaction of FXN with ISCU. 
In the D122Y mutant, the residues affected by the interaction with ISCU mostly localize on 
iron-binding 1-1 acidic ridge, as the wild type protein, and in a smaller section of the -sheet 
surface where only residues 155, 156 and 158 belonging to the ȕ4 strand were found to be perturbed 
upon ISCU addition. Instead, residues 131-133 and 145-147 (of ȕ2 and ȕ3 respectively), which are 
significantly shifted in the wild type FXN protein, result unaffected in its D122Y variant, indicating 
a weaker interaction. This suggests that the effects of this point mutation in residue D122 of FXN 
could be due to a combination of an impaired iron-binding (see previous paragraph) with local 
structural rearrangements involving the region encompassing ȕ2 and ȕ3 strands. 
G130V mutant was expected to have a low aptitude to interact with ISCU due to its poor 
protein stability and to the tendency to form insoluble aggregates (fig. 44). Surprisingly, NMR 
analysis showed that the G130V ISCU-binding region is only slightly modified, keeping most of the 
chemical shifts changes observed with the wild type protein. In particular, the main differences, 
when compared to the wild type protein, are observed in residues belonging to the ȕ-sheet: with 
G130V, residues T133 of ȕ2, I145 of ȕ3, W155 of ȕ4 and Y166 of ȕ5 are perturbed as with the wild 
type protein, whereas shifts in peaks of residues L132 of ȕ2, N146 and K147 of ȕ3 and L156 of ȕ4 
are missing. On the other hand, additional shifts are observed in this region (i.e. residues V134, 
I154 and S158) (fig. 48). Taken together, these results indicate the iron-dependent interaction of 
G130V FXN variant with ISCU takes place, although in a slightly different manner when compared 
to the wild type protein. 
The most striking effects on the direct interaction with ISCU were observed with the N146K 
and W155R mutations, which map in the middle of the FXN ISCU-binding region (i.e. in ȕ3 and 
ȕ4, respectively). As reported above, the two mutations have a different impact on structural 
rearrangements, resulting more intense and diffused in variant W155R respect to N146K (fig. 45), 
while showing essentially the same iron-binding region (figs. 46); instead, ISCU-binding appears 
strongly affected, since in both cases chemical shift differences upon ISCU addition are observed 
only in the iron-binding region and significant effects on other portions of the ȕ-sheet were almost 
undetectable, suggesting a weaker interaction for both N146K and W155R FXN variants. In the 
case of N146K variant, the binding to ISCU could be impaired by the introduction of a residue with 
different steric hindrance and charge, while maintaining the same overall protein structure. In 
variant W155R, instead, the mutation introduces a residue with different chemical characteristics 
but also leads to a structural rearrangement in the protein, involving additional flanking residues. 
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For this reason, it cannot be excluded that the impaired interaction would be due not only to the lack 
of native tryptophan 155, but also to perturbations of other key residues. 
Fig. 49, in which the four mutations D122Y, G130V, N146K and W155R are mapped onto 
the human frataxin structure, summarizes the whole structural rearrangements introduced in FXN 
by the mutations themselves and by the binding of iron and ISCU, compared to the wild type 
protein.  
 
 
 
Figure 49. Mapping the effects of frataxin clinically relevant mutations on protein structure, iron-
binding and ISCU-binding. All mapped residues are identified on the apo-FXN structure (PDBID 1EKG). 
Mutated residues are represented in spheres, colored in red for D122Y, yellow for G130V, green for N146K 
and orange for W155R. In the first column, I underlined the frataxin regions mostly perturbed by the relative 
mutation, as assessed by comparing the NMR spectra of mutant proteins with that of the wild type protein 
(only residues with normalized chemical shift values greater than the threshold (0.05) were considered). 
Residues considered in this study are depicted as spheres with different colors. In the second column, I 
mapped in purple the frataxin mutants region perturbed by Fe2+ binding (only residues with normalized 
chemical shift values greater than the threshold (0.01) were considered). In the third column, I mapped in 
blue the frataxin mutants regions perturbed by ISCU binding (only residues with normalized chemical shift 
values greater than the threshold (0.01) were considered).  
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The four frataxin FRDA-associated variants considered in this work have distinct effects on 
protein stability, iron-binding properties and capability to interact with the ISCU scaffold protein. 
The latter is pivotal to drive the biogenesis of FeS clusters at the assembly machinery, whatever is 
the specific role of frataxin in this pathway. All these mutations are expected to have a functional 
impact on FeS cluster assembly. Thus, to further investigate the structure-function relationships in 
frataxin mutants we next evaluated their activity of the whole FeS cluster assembly complex. 
 
Effects of frataxin mutations on the activity of the FeS-cluster biogenesis complex 
 As reported in the introduction, mammalian frataxin was proposed to stimulate the rate of 
FeS clusters assembly by enhancing the sulfide production at the NFS1/ISD11/ISCU assembly 
machinery (Tsai C.L. et al., 2011, Bridwell-Rabb J. et al., 2011 and Colin F. et al., 2012). The 
cysteine desulfurase NFS1, which forms a functional complex with the chaperone ISD11, catalyzes 
the breakdown of cysteine to alanine and produces a transient persulfide species that can be 
detected in vitro by the enzymatic assay described in details in Materials and methods. By taking 
advantage of this assay, we monitored the amount of sulfide produced by NFS1/ISD11 conversion 
of cysteine to alanine in the presence of ISCU, with or without wild type or mutant frataxin 
proteins. The results of these analyses are reported in fig. 50 and table 8.  
 
 
 
 
 
 
 
              noFXN    wtFXN   N146K   W155R  D122Y   G130V 
Figure 50. Modulation of the NSF1 cysteine desulfurase activity at the FeS cluster assembly complex. 
Sulfide production was assessed in the presence of  1 equivalent of the NSF1/ISD11 complex, 3 equivalents 
of ISCU and 10 Fe2+ equivalents, either in the absence or in the presence of 3 equivalents of wild type FXN 
and of each FXN variant, as described in details in Materials and methods. The enzymatic activity is 
normalized to the desulfurase activity in presence of wild type frataxin. Data represent the mean of three 
replicates ± S.D. 
 
108 
 
FeS cluster 
assembly complex 
NSF1 activity 
(mol H2S/mol NFS1/min) 
no FXN 1.125 ± 0.10 
wt FXN 3.9  ± 0.15 
N146K 1.11 ± 0.03 
W155R 0.95 ± 0.06 
D122Y 3.12 ± 0.06 
G130V 1.875 ± 0.14 
 
 
Table 8. NFS1 sulfide production at the FeS cluster assembly complex. The activity was monitored in the 
absence of FXN or in the presence of wild-type or mutant FXN. Activity is reported as micromoles of sulfide 
produced by NFS1 per micromole of NFS1 per minute. 
 
 
It was previously shown that mutations N146K and W155R affect the capability of frataxin to 
stimulate the NSF1 desulfurase activity in vitro (Tsai C.L. et al., 2011 and Bridwell-Rabb J. et al., 
2011), whereas these data was lacking for both D122Y and G130V variants. Our results confirmed 
that i) wild type FXN increases the cysteine desulfurase activity of NFS1/ISD11 complex and ii) 
N146K and W155R FXN variants are almost unable to further activate NFS1. We next analyzed the 
effects of G130V and D122Y point mutations. Interestingly, we found that, when compared to wild 
type FXN, both variants retain a partial capability to enhance the desulfurase activity in vitro (fig. 
50).  
 Since it has been previously proposed that the FXN stimulatory effect on the desulfurase 
activity relies on the presence of the ISCU (Colin F. et al., 2012), these functional data would be in 
accordance with the structural NMR analysis reported above, which indicates that G130V and 
D122Y FXN variants are able to form a binary complex with the ISCU scaffold protein, although 
with slight modifications when compared to the wild type frataxin. 
 
 
 
 
 
109 
 
Conclusions 
Taken together, the experimental data described in this chapter allowed us to confirm the 
capability of human frataxin (FXN) to form a direct complex with the FeS clusters scaffold protein 
ISCU, as well as the iron-dependence of this binding event. By means of a bidimensional NMR 
analysis we described in detail this complex, which involves the FXN N-terminal acidic iron-
binding region as well as a portion of its surface ȕ-sheet, where highly conserved residues are 
located. Several of these key residues are mutated in heterozygous Friedereich‟s ataxia (FRDA) 
patients, and the impact of some of these mutations on frataxin structural and functional properties 
have been investigated in this part of my PhD work. Four FXN mutations have been selected for 
this study, ranging from the iron-binding region (D122Y) to the putative ISCU-binding region 
(G130V, N146K and W155R). Our in vitro study indicates that all these mutations have an impact 
on iron-dependent human FXN aptitude to form a complex with ISCU and capability to enhance the 
NFS1 desulfurase activity at the FeS clusters assembly machinery. 
The clinical outcome of the four FRDA-associated mutations investigated in my work 
ranges from patients with atypical, less severe (as in the case of D122Y or G130V) or mild (as for 
N146K) phenotypes to classical FRDA (as for W155R). Although we found in distinct mutant 
proteins a different impact on the frataxin structural and functional properties, which appear to 
correlate with the clinical phenotype, it is difficult to speculate on a direct link between the 
alterations that we observed in vitro, using purified recombinant proteins, and the pathological 
effects found in vivo in FRDA heterozygous patients. In fact, frataxin has been proposed to be a 
multifunctional protein based on its involvement in further cellular pathways, beside FeS clusters 
assembly, for example by interacting with ferrochelatase to facilitate heme synthesis through 
ferrochelatase-mediate iron insertion into protoporphyrin IX (Lesuisse E. et al., 2003), or by 
modulating aconitase activity (Bulteau A.L. et al., 2004). Thus, alterations induced by frataxin 
mutations could lead to a combination of multiple, different cellular dysfunctions. 
On the other hand, the knowledge of the biochemical properties of different FXN variants 
may help to explain the clinical outcomes for FRDA missense mutations. From a mechanistic 
perspective, for example, it would be difficult to understand how frataxin works as a 
modulator/activator of the FeS clusters biogenesis process without structural details of the assembly 
machinery. By describing the direct complex between frataxin and the ISCU scaffold protein, and 
the molecular consequences of FXN point mutations at this level, we provide here new clues that 
could help to reach a comprehensive understanding of frataxin functions in physiological 
conditions, and of its dysfunctions in FRDA patients.  
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 The results described in this chapter opened new working perspectives. For example, since 
mitochondrial iron accumulation, which likely contributes to the increased sensitivity to oxidative 
stress, is one of the distinctive features of FRDA patients cells, we will further investigate the 
frataxin iron-binding properties. In particular, we will characterize into details the frataxin Fe-
binding sites which, based on the results of our fluorescence analysis, would have different 
affinities in distinct FXN variants. By combining fluorescence spectroscopy with 2D NMR 
analysis, we will titrate wild type and mutant frataxin proteins with sub-stoichiometric iron 
concentrations, in order to disclose a possible stepwise binding, and to identify on FXN structure 
these two sites. Moreover, additional frataxin FRDA-associated variants will be investigated to 
increase the knowledge of the structure-function relationships of this protein. Future experiments 
will be also aimed at defining the role of FXN-interacting residues in the whole NFS1/ISD11/ISCU 
assembly machinery, which would be pivotal to fully understand the molecular details of sulfur 
transfer and FeS clusters biogenesis. 
 Finally, it is worth to mention that in the very last part of my PhD work, by taking advantage 
of the availability in my laboratory of fibroblasts and lymphoblasts of FRDA patients, both with the 
classical disorder (i.e. homozygous for the GAA expansion) and with the atypical disease (i.e. 
heterozygous with the point mutation p.G130V in one FXN allele and the GAA expansion in the 
other), I started to characterize the mitochodrial phenotype associated to frataxin alterations, in 
isolated mitochondria and in intact cells. These preliminary experiments will be, in the next future, 
the starting point of a new research project, aimed at gaining insights into the link between frataxin 
alterations and cellular dysfunctions, which is a definitive resource for investigating disease 
pathogenesis in Friedereich‟s ataxia. 
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SUPPLEMENTARY INFORMATION 
 
Secondary structure 
component 
ISCU FXN 
α-helix 27.6 % 28.5% 
Parallel ȕ 14.1 % 13.7% 
Antiparallel ȕ 9.6 % 9.3% 
ȕ-turn 18.2 % 18.1% 
Random coil 32.2 % 31.3% 
Total 101.8 % 100.9% 
 
Table 9. Percentages of secondary structure elements obtained from the fitting of the CD spectra of 
ISCU and FXN. Obtained data are compatible with completely folded species of both the proteins. The 
CDNN software was exploited to perform data deconvolution (Bohm G. et al., 1992). Uncertainty on the 
reported values is estimated to be of the order of few %. 
 
 
Figure 51. NMR spectrum of frataxin, with the peaks assignment 
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Figure 52. Superimposition of frataxin NMR spectra in the absence (red) and in the presence (blue) of 
Fe
2+
 (upper spectrum) and Fe
3+
 (lower spectrum). Spectra were collected at a 1:4 FXN to iron 
stoichiometric ratio 
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Figure 53. Superimposition of frataxin NMR spectra in the absence (red) and in the presence (blue) of 
ISCU, in the absence of Fe. Spectra were collected at a 1:1 FXN to ISCU dimer stoichiometric ratio. 
 
Figure 54. Superimposition of NMR spectra of iron-loaded frataxin (Fe
2+
) in the absence (red) and in 
the presence (blue) of ISCU. Spectra were collected at a 1:4:1 FXN to iron to ISCU dimer stoichiometric 
ratio 
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Figure 55. Superimposition of frataxin mutants NMR spectra in the absence (red) and in the presence 
(blue) of Fe
2+
. Spectra were collected at a 1:4 FXN to iron stoichiometric ratio 
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Figure 56. Superimposition of iron-loaded (Fe2+) frataxin mutants NMR spectra in the absence (red) 
and in the presence (blue) of ISCU. Spectra were collected at a 1:4:1 FXN to iron to ISCU dimer 
stoichiometric ratio 
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Figure 57. Peaks intensity of FXN NMR spectra in the absence (gray) and in the presence (black) of 
Fe
2+
 (upper graph) or Fe
3+
 (lower graph). Peaks height was normalized on that of unperturbed residue 184 
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General conclusions 
 
FeS clusters are probably the most ancient and important prosthetic groups, being widely 
diffused in almost all living beings in which they are involved in several fundamental metabolic 
pathways. In fact, they allow proteins to perform redox reactions, electron transfer, enzyme 
catalysis and many other functions. According to this assortment, many different FeS clusters exist, 
from the simple rhombic [2Fe2S] and cubic [4Fe4S] clusters to the highly complex 2Fe[4Fe4S] H-
cluster (as in [FeFe]-hydrogenases). In both prokaryotic and eukaryotic organisms, distinct 
biosynthetic pathways exist for the assembly of different FeS clusters, that are in general rather 
complex processes carried out by many proteins interacting with each other. Despite this variability, 
FeS clusters biogenesis systems are highly conserved in terms of strategy, which can be divided in 
two main steps: the assembly of the FeS cluster on a scaffold protein and the subsequent transfer of 
the de novo generated cofactor from the scaffold to the acceptor apoprotein, which is eventually 
converted into the mature active holoprotein. The presence of scaffold proteins is strictly required in 
both steps, underlining their key role. Scaffold proteins must be able to structurally and functionally 
interact with their biosynthetic partners as well as with a combination of several chaperones and co-
chaperones which participate into the final transfer of the prosthetic group to the recipient FeS 
protein. On the other hand, a clear structure-function relationship is still an open issue for many of 
them, and the complex multistep molecular pathways in which they are involved have to be further 
explored for a complete characterization.  
This PhD work has been part of a larger project aimed at filling these gaps, and has been 
focused on two different FeS clusters biosynthetic systems: 1) the [FeFe]-hydrogenases maturation 
system and 2) the human mitochondrial FeS clusters biosynthetic system. In both research projects, 
I took advantage of a combination of biochemical and spectroscopic approaches to assess structural 
features of 1) the GTPase domain of HydF, the scaffold protein of [FeFe]-hydrogenases maturation 
system and 2) frataxin (FXN), a small iron-binding protein involved in human mitochondrial FeS 
clusters biosynthetic, whose specific function is still under debate. In particular, to explore the 
HydF protein and its structural response to GTP binding I exploited an advanced spectroscopic 
approach, EPR (Electron Paramagnetic Resonance), that is the ultimate technique for the study of 
FeS proteins; to characterize into detail the direct interaction between FXN and the mitochondrial 
FeS cluster scaffold protein ISCU, I applied the two-dimensional NMR (Nuclear Magnetic 
Resonance) technique. 
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The work on HydF characterization, reported in Chapter 1, allowed me to obtain new data to 
state that the GTPase domain of HydF can be considered a K+ dependent GTPase, and that it could 
be a molecular switch undergoing significant structural modifications upon GTP binding, as other 
members of the same family. Moreover, we detected diffuse conformational changes due to GTP 
binding to HydF that may be pivotal for its dynamic structural and functional interactions with the 
other proteins involved in [FeFe]-hydrogenase maturation and activation. Future experiments will 
further address this issue, by exploring the structure and the kinetics of the complex composed by 
all proteins participating in the [FeFe]-hydrogenases FeS cluster assembly, as well as the potential 
effects of GTP-binding at the whole biosynthetic machinery. 
The study of the direct interaction between human ISCU and FXN, reported in Chaper 2, 
allowed me to identify in FXN the residues involved in the binding of Fe3+/2+ and in its interaction 
with ISCU. Since many FXN residues which we found to be involved in the binding to ISCU are 
mutated in patients with variants of FRDA, it was then evaluated if and how these mutations can 
interfere with ISCU-FXN direct interaction and with other FXN features, such as iron-binding and 
allosteric activation of FeS cluster assembly machinery. We found that FRDA-related mutations of 
residues located in the putative ISCU-binding region do not affect frataxin iron-binding capability, 
while impairing its interaction with ISCU as well as the ability to modulate the FeS cluster 
biosynthetic process. Other FRDA-related frataxin variants, instead, in which mutations are located 
in the iron-binding region or between the latter and ISCU-binding region, affect frataxin iron-
binding capability while not completely impairing the interaction with ISCU. In this case, the 
capability to activate assembly complex is also partially maintained. These data open new 
perspectives in the study of the mechanisms leading to FRDA variants, and give additional hints 
useful to clarify the physiological role of FXN as well its involvement in the pathogenesis of 
Friedreich‟s ataxia. 
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Abstract [FeFe]-hydrogenases catalyze the reversible interconversion of protons
to molecular hydrogen (H2) at an active site called H-cluster. The maturation
pathway of these enzymes is a complex process involving three proteins, HydE,
HydF and HydG. The maturase protein HydF has been suggested to interact with
HydE and HydG and to be the transferase that shuttles the complete H-cluster to the
hydrogenase; however, the exact molecular mechanism driving this translocation
remains unclear. HydF is constituted by three different domains: a N-terminal GTP-
binding domain, a dimerization domain and a C-terminal [4Fe4S] cluster-binding
domain. To investigate possible conformational changes induced by the GTP
binding in the N-terminal domain, we have expressed, in Escherichia coli, a re-
combinant HydF protein from Thermotoga neapolitana including the GTP-binding
domain only. Site-directed mutants were designed in which the native residues were
substituted by cysteines and subsequently spin labeled with the nitroxide MTSSL.
CW-EPR was used to study the local mobility of the nitroxides at each site, and
double spin-labeled mutants have been investigated by PELDOR spectroscopy. We
found that the binding of the nucleotide does not induce large conformational
effects within the isolated GTP domain, at least at the level of the elements in-
vestigated in this work. However, small changes in the distance between spin labels
were observed which might reflect diffuse structural rearrangements. We suggest
L. Maso  E. De Rosa  G. M. Giacometti  P. Costantini (&)
Department of Biology, University of Padova, Viale G. Colombo 3, 35131 Padua, Italy
e-mail: paola.costantini@unipd.it
L. Galazzo  M. Di Valentin  M. Albertini  D. Carbonera (&)
Department of Chemical Sciences, University of Padova, Via F. Marzolo 1, 35131 Padua, Italy
e-mail: donatella.carbonera@unipd.it
F. Vallese
Department of Biomedical Sciences, University of Padova, Viale G. G. Colombo 3, 35131 Padua,
Italy
123
Appl Magn Reson (2015) 46:465–479
DOI 10.1007/s00723-015-0641-z
Applied
Magnetic Resonance
that the variations following the GTP binding could affect the dimer form adopted
by the whole HydF protein in solution and, as a consequence, the interactions with
the other maturases.
1 Introduction
[FeFe]-hydrogenases are metalloenzymes, found both in bacteria and eukaryotes
[1], that catalyze the reversible interconversion of protons to molecular hydrogen
(H2) at a very complex active site, referred to as the H-cluster. The structure of this
6Fe-cluster has been determined by X-ray crystallographic analysis [2, 3] and
comprises a [4Fe4S] subcluster, produced by canonical FeS cluster biosynthesis
proteins, linked via a cysteine bridge to a 2Fe unit with two terminal CN- ligands,
two terminal CO ligands, and azadithiolate and CO bridges. Extensive research is
devoted to define the catalytic mechanism of the [FeFe]-hydrogenases (see [4] for a
recent review); however, it still remains unclear how the H-cluster is formed within
the cell and only a partial knowledge of the machinery driving its assembly in vivo
is available (see [4–6] for comprehensive reviews on this topic). This pathway
involves three proteins, i.e., HydE, HydF and HydG, which have been originally
discovered in the unicellular green alga Chlamydomonas reinhardtii [7] and then
found in all microorganisms containing a [FeFe]-hydrogenase. HydE and HydG are
both radical S-adenosylmethionine (SAM) enzymes [7, 8], and HydF is a GTPase
containing an FeS cluster-binding motif [7, 9]. Different models have been proposed
to describe the maturation pathway involving these proteins. Several in vitro and/or
cell-free experiments using purified recombinant proteins led to a two-step model
(reviewed in [5, 6]), in which (a) HydE and HydG drive the chemical modifications
of a H-cluster precursor working on HydF as a scaffold protein, (b) HydF transfers
this cluster to the hydrogenase (HydA), completing the maturation process [10–12].
This model has been further supported by independent in vitro experiments showing
that a H-cluster synthetic mimic can be loaded on a recombinant HydF protein and
then transferred to an apo-hydrogenase, confirming the key role of this scaffold
protein [13, 14]. On the other hand, Kuchenreuther and co-workers [15] have
recently proposed that the iron, carbon monoxide, and cyanide components of the
2Fe unit in the active H-cluster of HydA, originate all from the chemistry which
takes place in one of the two [4Fe4S] centers of the HydG protein, with a diiron
subsite forming from two HydG synthons. The transfer of these components to the
apo-hydrogenase HydA (which contains the [4Fe4S] cluster of the H-cluster but not
the [2Fe] subsite) would lead to the functional protein, as proved by 57Fe-labeling
experiments showing that Fe in the [2Fe] subcluster is in fact provided by HydG
[15]. However, how the two complex units would assemble together with a
dithiolate bridge to form the [2Fe] subcluster remains to be clarified. Moreover, a
recent study on cell-free conditions has shown that a synthetic diiron subsite [16]
can be captured from solution by apo-HydA to give an active [FeFe]-hydrogenase
without participation of HydE or HydF. Nevertheless, these two proteins have a role
in the maturation process both in vitro [17] and in vivo, since C. reinhardtii
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recombinant mutant strains lacking single or combinations of maturases are
completely unable to express an active [FeFe]-hydrogenase [7].
A key point, which must be addressed to complete the knowledge of the [FeFe]-
hydrogenases’ activation, is related to the molecular mechanism allowing an
accurate delivery of the H-cluster precursor to the apoprotein. As assessed above,
HydF has been suggested to be the transferase that shuttles the complete [2Fe]
subcluster to the hydrogenase, but the exact molecular mechanism driving this
translocation is still under investigation.
The X-ray structure of the apo-HydF from T. neapolitana has been solved (PDB
ID: 3QQ5) [18], showing the presence of three different domains: a N-terminal
GTP-binding domain (I), a dimerization domain (II) and a C-terminal metal cluster-
binding domain (III). In a previous work, we explored the [4Fe4S] cluster
coordination sphere of HydF from Clostridium acetobutylicum and T. neapolitana
by means of continuous-wave Electron Paramagnetic Resonance (CW-EPR) and
Hyperfine Sublevel Correlation (HYSCORE) spectroscopies [19]. Our results
showed that, despite the presence of the highly conserved FeS cluster CxHx46–53
HCxxC putative coordination motif, alternative metal ligation of the FeS cluster
exists in the HydF proteins from the two microorganisms, and that the non-cysteinyl
ligand is easily exchangeable. This led us to suggest a possible role for the unusually
coordinated Fe in the catalytic process of HydF. On the other side, the HydF
GTPase activity, which has been shown to be essential for the H-cluster biosynthesis
[7], has been fully characterized in vitro with recombinant proteins from different
microorganisms [9, 20, 21], but its exact contribution to the [FeFe]-hydrogenase
maturation and activation is still elusive, and the role of GTP binding/hydrolysis
remains uncertain. Since both HydE and HydG have been shown to increase by
50 % the rate of GTP hydrolysis of a recombinant HydF protein from C.
acetobutylicum [20], it has been proposed that GTP binding and hydrolysis are
associated with interactions of HydF with the other accessory proteins, rather than
with hydrogenase. Interestingly, we found that the binding of GTP (either as such or
as non-hydrolyzable analog) induces the dissociation of HydE and HydG from
HydF [21]. Furthermore, the 3D structure of the apo-HydF protein showed that the
GTPase domain includes a flexible loop region, which could in principle become
ordered upon GTP binding [18]. This could in turn facilitate structural rearrange-
ments driving the interactions of HydF scaffold with the two other maturation
proteins. It has also been reported that the presence of GTP significantly affects the
EPR spectral properties of the HydF [4Fe4S] cluster [20], suggesting a commu-
nication between the GTP- and the iron–sulfur cluster-binding domains, where the
H-cluster precursor is probably finally assembled. This latter possibility would be
analogous to the case of the GTPase MnmE [22] or to the case of the nitrogenase Fe
protein [23–25].
Prompted by these experimental evidences, to investigate possible intrinsic
conformational changes induced by the nucleotide binding at the interface of the
GTPase domain with either the [4Fe4S] cluster-binding or the dimerization
domains, we have expressed in E. coli a recombinant HydF protein from T.
neapolitana including only the GTP-binding domain. Five single site-directed
mutants have been designed in which the native amino acids were substituted by
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cysteine residues and subsequently spin labeled with the nitroxide MTSSL. CW-
EPR was used to study the local mobility of the nitroxides at each site, to determine
the spin-labeling efficiency and choose the suitable positions for labeling of double
mutants to be investigated by pulse electron–electron double resonance (PELDOR)
spectroscopy. This spectroscopic method is known to be very useful for monitoring
distances and distance distributions between couples of spin labels, in the
nanometric scale [26–30].
2 Experimental
All chemicals were of the highest purity commercially available.
2.1 Cloning of HydFT.n. GTPase Domain
The sequence coding for the GTPase N-terminal domain (domain I, residues 1–185)
of the HydF protein from T. neapolitana (HydFT.n.I) was PCR amplified using as
template a vector containing the hydFT.n. gene, previously obtained in our laboratory
[18], and the following primers:
HydFT.n.I for, 5
0-CATATGAGACTGCCGGACGCCGGT-30 and
HydFT.n.I rev, 5
0-CTCGAGTTAAATCTCTTCATC-30.
These primers were designed to contain unique restriction sites allowing the
directional subcloning of the amplified sequence in frame with a 6His-tag sequence
at the 50 terminus in a pET-28b vector (from Novagen) suitable for T7-driven
expression in E. coli. The sequence and reading frame were confirmed by DNA
sequencing (BMR Genomics, University of Padova). The pET-28b/hydFT.n.I plasmid
was used as template to introduce different mutations in the wild-type hydF coding
sequence (see below).
2.2 Heterologous Expression and Purification of HydFT.n. GTPase Domain
E. coli Rosetta (DE3) cells were transformed with the pET-28b/hydFT.n.I plasmid,
and positive clones were selected by antibiotic resistance. Transformed cells were
grown overnight in selective LB medium and then subcultured the following day in
fresh medium. The expression of the 6His-tagged HydFT.n.I proteins, either wild
type or mutant, was induced by adding 1 mM isopropyl-b-thiogalactopyranoside
(IPTG) in LB medium and incubating the cells at 30 C overnight. The proteins
were purified starting from 1 L cultures. In brief, cells were harvested by
centrifugation, resuspended in lysis buffer (25 mM Tris–HCl pH 8, 200 mM KCl,
and protease inhibitors 1 lg/ml pepstatin A, 1 lg/ml leupeptin, 1 lg/ml antipain,
1 mM PMSF) and lysed by French press. The supernatant fractions were isolated
from cell debris by centrifugation and the proteins purified to homogeneity by
combining a nickel affinity chromatography (HIS-Select Nickel Affinity Gel, from
Sigma-Aldrich) and a gel filtration chromatography using a Superose 12 10/300 GL
column (from GE Healthcare, Italy), equilibrated in lysis buffer. Each run was
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performed by injecting the appropriate sample volume at a flow rate of 0.75 ml/min
and monitoring the UV absorbance at 280 nm, by a fixed wavelength detector. To
estimate the molecular weight of the analyzed samples, the column was equilibrated
in the lysis buffer and calibrated with the standards such as thyroglobulin
(669,000 Da), ferritin (440,000 Da), catalase (232,000 Da), aldolase (158,000 Da),
bovine serum albumin (67,000 Da), ovalbumin (43,000 Da), and ribonuclease
(13,700 Da). For each purification, the eluted fractions were pooled together and
concentrated by centrifugal filters (Vivaspin Centrifugal Concentrators, 10,000
MWCO, from Sartorius Stedim Biotech) to a volume suitable for EPR charac-
terization (see below), giving rise to a final concentration ranging from 800 lM to
3 mM, as determined with a Micro BCA Protein Assay Kit (from Thermo Scientific
Pierce Protein Research). Purified proteins were analyzed by 12 % SDS-PAGE.
2.3 Site-Directed Mutagenesis of HydFT.n.I
Site-directed mutagenesis of the hydFT.n. gene was performed with the Quick-
Change II Site-Directed Mutagenesis Kit (from Stratagene), using as template
pET-28b/hydFT.n.I recombinant plasmid. Oligonucleotides, listed in Table 1, were
designed according to the manufacturer’s guidelines and the mutant constructs
analyzed by DNA sequencing.
2.4 GTP Hydrolysis Assay
The purified recombinant wild-type HydFT.n.I protein was assayed for the ability to
hydrolyze GTP using the protocol optimized by Shepard and co-workers [20], with
slight modifications. In brief, the affinity-purified protein was incubated at a
Table 1 List of primers used in this study (with the modified bases underlined)
Primer name Primer sequence
C91S_for 50-TCTACAGGGCAGATTCTGGAATTCTCGTGAC-30
C91S_rev 50-GTCACGAGAATTCCAGAATCTGCCCTGTAGA-30
M26C_for 50-GTTGGAAAATCCTCTTTCTGCAACGCCTTAGTTGGTCAG-30
M26C_rev 50-CTGACCAACTAAGGCGTTGCAGAAAGAGGATTTTCCAAC-30
R84C_for 50-TGAGGGTAGAGAAGGCAAGGTGCGTGTTCTACAGGGCAGATTG-30
R84C_rev 50-CAATCTGCCCTGTAGAACACGCACCTTGCCTTCTCTACCCTCA-30
R88C_for 50-GGCAAGGAGGGTGTTCTACTGCGCAGATTGTGGAATTCTCG-30
R88C_rev 50-CGAGAATTCCACAATCTGCGCAGTAGAACACCCTCCTTGCC-30
A15C_for 50-GAAGATACATCGTTGTTTGCGGAAGAAGGAACGTTGG-30
A15C_rev 50-CCAACGTTCCTTCTTCCGCAAACAACGATGTATCTTC-30
T164C_for 50-GATTCGACGATATCGGGAAGTGCATCTCCGAAATTCTTCCGGG-30
T164C_rev 50-CCCGGAAGAATTTCGGAGATGCACTTCCCGATATCGTCGAATC-30
R88C0_for 50-GGCAAGGTGCGTGTTCTACTGCGCAGATTGTGGAATTCTCG-30
R88C0_rev 50-CGAGAATTCCACAATCTGCGCAGTAGAACACGCACCTTGCC 30
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concentration of 10 lM for 10 min at 30 C in 20 mM Tris–HCl buffer, pH 8.0,
containing 200 mM KCl and 2 mM MgCl2 with different concentrations of GTP
(ranging from 125 lM to 2 mM). Aliquots with different concentrations of substrate
were collected and assayed for production of GDP. Assay aliquots were incubated at
95 C for 3 min, centrifuged at 14,000 rpm at 4 C in a benchtop microcentrifuge,
and the supernatants analyzed by reverse phase HPLC on a Synergi MAX-RP 80A
(150 9 4.6 mm, 4 lm, Phenomenex). The samples were eluted with an isocratic
mobile phase of 50 mM sodium phosphate buffer, pH 7.0, 10 mM tetrabutylam-
monium bromide, and 10 % CH3CN. The guanosine nucleotides were detected by
their absorbance at 254 nm. Under these conditions, GDP and GTP were eluted
after 8.1 and 18.6 min, respectively. Integration of peak areas (using software
Agilent Chemstation) of the samples taken at identical time points allowed the
quantification of the lmoles of GDP produced L-1 min-1, from which the ratio
between the kcat was finally determined.
2.5 CW-EPR Experiments
Samples for EPR (about 100 lM protein labeled with MTSSL spin label in lysis
buffer) were obtained by adding to the purified protein a fivefold molar excess of
MTSSL (dissolved in DMSO) and incubating the protein at 4 C overnight in the
dark. Excess of non-ligated spin label was removed from the protein by several
cycles of dilution with the lysis buffer and concentration by centrifugal filters.
Twenty microliters of each sample with a protein concentration of about 150 lM,
were loaded into quartz capillaries with 0.6 mm ID and 0.8 mm OD. Non-
hydrolyzable GTP analogous (GTPcS, 50 mM) and 10 mM MgCl2 were added to
the samples and incubated 30 min at 37 C before starting the EPR measurements.
EPR spectra were collected at room temperature (298 K) on an Elexsys E580
X-band spectrometer (Bruker) using a Super High Sensitivity cavity. The field
modulation frequency was set at 100 kHz, with a field modulation amplitude of
0.03 mT and a microwave power of 6.4 mW. Simulations of the CW-EPR spectra
were performed using the EasySpin function ‘‘chili’’ to obtain the correlation times
for the nitroxide in the different mutants [30]. Rotamers of the spin label in the
different mutated sites were evaluated, starting from the X-ray structure, using the
molecular modeling software MMM2013 [31].
2.6 PELDOR Experiments
Samples for PELDOR were concentrated and exchanged with deuterated buffer.
Deuterated glycerol (40 % w/v) was also added to the samples before freezing. The
final protein concentration was about 300 lM for all the samples. In the nucleotide-
binding experiments, 50 mM GTPcS and 10 mM MgCl2 were added to the samples
and incubated 30 min at 37 C before freezing. Samples were loaded into quartz
capillaries with 2.0 mm ID and 3.0 mm OD. Pulsed EPR was performed with the
same EPR spectrometer equipped with a Bruker ER4118X-MS3 split-ring resonator
(microwave frequency 9.55 GHz) and an Oxford CF935 cryostat. The measure-
ments were done at a temperature of 50 K. For PELDOR experiments, a standard
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four-pulse sequence was applied; the microwave power was adjusted to obtain an
observer sequence of 16/32/32 ns and a pump pulse of 16 ns. The difference
between the pump (nitroxide) and observer (nitroxide) frequency was set to
70 MHz. A two-step phase cycle was applied for baseline correction while
deuterium nuclear modulations were suppressed using an eight-step s cycle from a
180 ns starting value with 56 ns increment steps. Data on each sample were
collected for about 15 h. Distance distributions were extracted from PELDOR traces
using DeerAnalysis2013 [32].
3 Results
As assessed in the Introduction, an active HydF GTPase domain is essential to
produce a functional [FeFe]-hydrogenase, both in vivo and in vitro [7, 17].
However, the role of GTP binding and/or hydrolysis in the H-cluster assembly is
still unknown. To explore the dynamic behavior required for the HydF
scaffold/carrier role in the [FeFe]-hydrogenase maturation, we obtained a
recombinant HydFT.n. protein including only its GTPase domain (domain I,
residues 1–185), i.e., HydFT.n.I, and analyzed, by EPR spectroscopy, several spin-
labeled mutants, where cysteine residues were introduced at proper sites by site-
directed mutagenesis. The selected sequence includes the five consensus motifs
shared by all NTPases and essential to bind and hydrolyze GTP (i.e., P-loop:
GRRNVGKS, and G2 to G4 loops: TTT, DTPG and NKID, respectively, where
the conserved amino acids are underlined), and a short extra stretch of residues
belonging to the loop between domains I and II has also been conserved in the
construct.
3.1 Heterologous Expression, Purification and Preliminary Biochemical
Characterization of Wild-Type HydFT.n.I
The recombinant protein HydFT.n.I was expressed in E. coli Rosetta (DE3) cells in
frame with a 6His-tag at the N terminus, as described in Sect. 2, and purified by
combining a NiNTA affinity and a gel filtration chromatography. As shown in Fig.
1, the isolated domain I can be indeed purified to homogeneity (lane 2) and as a
single monomeric species, as assessed by the gel filtration chromatogram (not
shown). The same elution profile has been obtained in the presence of GTPcS (not
shown) at the same concentration used for the following spectroscopic analysis (i.e.,
50 mM).
The capability of this protein to bind and hydrolyze GTP has been then evaluated,
as described in Sect. 2, and compared with activity of the full-length protein,
previously characterized in our laboratory. As reported in Table 2, the isolated
domain, obtained in a soluble form, keeps the capability of GTP hydrolysis.
According to the measurements, in the isolated domain, the catalytic rate constant
(kcat) increases about ten times when compared to that of the whole protein, which is
comparable to that reported before for the HydF proteins from T. maritima and C.
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acetobutilycum [9, 20]. The higher enzymatic activity of the isolated domain is
likely due to a higher accessibility of the active site.
3.2 Site-Directed Spin Label of HydFT.n.I
A close look at the HydF GTPase domain suggested several useful positions for
cysteine residues to be introduced and derivatized using thiol-specific spin labels.
The wild-type domain contains a single cysteine (i.e, C91), depicted in red in the
X-ray structure of the whole HydFT.n. protein shown in Fig. 2. Five additional sites
were chosen to introduce the cysteine residues to evaluate the potential effect of
GTP binding on the protein conformation, i.e., residues A15 and M26, close to the
GTP-binding site; residues R84 and R88, located at the interface of domain I and
III; and residue T164, which belongs to the terminal part of an a-helix connecting
domain I and II via a long loop. The positions of the five residues selected to
introduce new cysteines are highlighted in blue in Fig. 2, which also reports the
97.0
66.0
45.0
30.0
20.1
(kDa)
1 2Fig. 1 HydFT.n.I expression
and purification. Lane 1 affinity-
purified protein (20 ll); lane 2
protein purified by a
combination of affinity and size-
exclusion chromatography
(20 ll). 12 % SDS-PAGE,
Coomassie Brilliant Blue
staining
Table 2 Rate constant of GTP hydrolysis by HydF proteins from T. neapolitana
Protein [GTP] kcat (min
-1)
HydFT.n. (full-length protein) 62 lM–2 mM 1.13 ± 0.08
HydFT.n.I (GTPase domain) 125 lM–1.5 mM 11.2 ± 0.6
[KCl] = 200 mM, [MgCl2] = 10 mM, T = 298 K
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cutting site in the long loop connecting domain I with domain II. To obtain single-
labeled species and evaluate the spin-labeling efficiency at each site, the native
cysteine C91 was first substituted by serine (C91S) in all the mutants.
The new recombinant mutant proteins were assayed for expression and solubility,
and were purified by the double chromatography approach described above (data
not shown).
Fig. 2 Structure of HydF protein (PDB code 3QQ5) showing the mutated residues in the single cysteine
mutants of the GTP domain (I). Green sticks correspond to residues involved in GTP binding
Table 3 Spin-labeling yield, as percentage of labeled protein, of the wild-type and mutant HydFT.n.I
proteins
Mutant Labeling yield (%)
WT (C91) 23
C15 40
C26 50
C84 40
C88 65
C164 46
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3.3 Spin Labeling of HydFT.n.I Wild-Type and Mutant Proteins and EPR
Analysis
The wild-type (containing C91) and the five mutant (A15C-C91S, M26C-C91S,
R84C-C91S, R88C-C91S, T164C-C91S) proteins were labeled using the spin label
MTSSL, as described in detail in Sect. 2. The labeling yield, calculated by spin
quantification of the EPR spectrum double integrals and comparison with those of
standard solutions of the free spin label MTSSL, is reported in Table 3.
In Fig. 3 the CW-EPR spectra of the single mutants, with the simulations and the
characteristic correlation times at each site, are reported. The mobility of the
nitroxides derived from simulations is in good qualitative agreement with
the distributions of rotamers calculated with the software MMM [31], starting
Fig. 3 Room temperature experimental X-band CW-EPR spectra (black) and simulations (red) of single-
labeled samples. Positions of the labels in the protein sequence are indicated together with the correlation
times derived from simulations. In the simulation of R88C-C91S and T164C-C91S, two components are
present in relative amounts of 0.75:1 and 0.37:1, respectively. Small amount of free spin label is present
in the C15 and C91 spectra (narrow peaks). Rotamers, calculated using the software MMM [31], are
shown as red/blue balls and sticks
cFig. 4 Left background-corrected PELDOR data for the M26C-R88C-C91S (a) and R88C-T164C- C91S
(b) spin-labeled samples in the absence (black, upper trace) and after the addition of 50 mM GTPcS
(black, bottom trace). Right Tikhonov-derived distance distributions for samples in the absence (blue) and
in the presence (red) of the nucleotide analogous. Double-labeling positions are indicated in the protein
structure
474 L. Maso et al.
123
2 3 4 5 6 7
d (nm)
0,0 0,2 0,4 0,6 0,8 1,0 1,2 1,4 1,6
0,6
0,7
0,8
0,9
1,0
N
o
rm
a
li
z
e
d
 E
c
h
o
 I
n
te
n
s
it
y
 (
u
.a
.)
0,0 0,2 0,4 0,6 0,8 1,0 1,2 1,4 1,6
0,6
0,7
0,8
0,9
1,0
N
o
rm
a
li
z
e
d
 E
c
h
o
 I
n
te
n
s
it
y
 (
u
.a
.)
0,0 0,2 0,4 0,6 0,8 1,0 1,2 1,4 1,6
0,6
0,7
0,8
0,9
1,0
N
o
rm
a
liz
e
d
 E
c
h
o
 I
n
te
n
s
it
y
 (
u
.a
.)
2 3 4 5 6 7
d (nm)
0,0 0,2 0,4 0,6 0,8 1,0 1,2 1,4 1,6
0,5
0,6
0,7
0,8
0,9
1,0
N
o
rm
a
li
z
e
d
 E
c
h
o
 I
n
te
n
s
it
y
 
t (µs)
t (µs)
t (µs)
t (µs)
a
b
A conformational study of the GTPase domain 475
123
from the crystallographic data, and displayed in Fig. 3. In fact, as expected,
nitroxides at positions R88, T164 and R84 possess high mobility, although an extra
contribution of a slower component is required to simulate the spectra of T164 and
R84, while those in the sites C91 and A15 are more buried and characterized by
slow motion. Unexpectedly, the most immobilized nitroxide, among the six selected
positions, is found at position 26, the correlation time derived from the simulation of
the EPR spectrum being very close to the estimated tumbling time of the protein in
solution (11 ns). On the basis of the rotamers calculated with the software MMM at
position 26, starting from the X-ray structure of the apoprotein, the nitroxide was
expected to show high mobility at this site. However, the residue 26 is located close
to a protein portion (residues 32–44) which was not resolved in the X-ray structure
and therefore was not included in the MMM calculations. This missing region in the
diffraction map was suggested to correspond to a flexible loop [18]. Therefore, it is
likely that in solution this loop is largely responsible for the immobilization of the
spin label at position 26.
Taken together, the EPR data indicate that the isolation of the GTPase domain,
from the rest of the HydF protein, does not alter the structure significantly.
In all themutant andwild-type samples, the addition of50 mMGTPcSdid not change
the line shapes of the CW-EPR spectra (data not shown), indicating that the nitroxide
mobility of the spin labels does not undergo dramatic changes upon GTP binding.
On the basis of the labeling yield of single mutants, the more suitable positions
for a double labeling, necessary for PELDOR experiments, were chosen. The
Fig. 5 Cartoon representation of the HydF dimer. The two monomers are related by a twofold axis,
approximately parallel to the plane of the paper in the vertical direction. Cysteine side chain residues,
which are the putative ligand of the [4Fe4S] cluster of domain III, are in yellow; T164 side chain in
magenta, R88 side chain in blue and M26 side chain in red. The long loop connecting domain I and II is
colored in green
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proteins containing the cysteine at positions either C91 or C84 were discharged
because of the low labeling yield (C91) and tendency to dimerization (C84) (not
shown). Triple mutants (R88C-C91S-M26C and R88C-C91S-T164C) were pro-
duced, using as template for the mutagenesis the plasmid pET-28b/hydFT.n.I_C91S-
R88C, purified as described above, and, after reaction with the spin label MTSSL,
double spin-labeled samples were finally obtained.
The PELDOR traces of M26C-R88C-C91S and R88C-C91S-T164C mutants are
shown in Fig. 4. Tikhonov-derived distance distributions provide main values which
correspond, roughly, to those expected on the basis of the X-ray structure of the apo-
HydF protein (i.e., 1.9 and 2.1 nm, measured at the a-carbon atoms for M26-R88
and R88-T164 couples, respectively) [18]. When the GTP analogous was added to
the M26C-R88C-C91S sample (Fig. 4a), only very little differences at distances
larger than 3.3 nm were detected. On the other hand, the distance distribution
detected for R88C-C91S-T164C undergoes a higher effect upon GTPcS binding. In
fact a contribution centered at 4 nm appears, which was not present in the absence
of the nucleotide and, at the same time, the two main distance distributions (at about
2.0 and 3.0 nm) shift toward longer distances (2.5 and 3.2 nm).
4 Discussion
The N-terminal GTPase domain of HydF is essential to its role in [FeFe]-
hydrogenase maturation, since mutations in the Walker P-loop prevent the
formation of an active HydA in vitro [17]. It has been demonstrated that HydE
and HydG increase the rate of GTP hydrolysis by 50 % [20], suggesting a direct
interaction of HydF with the other accessory proteins, and a possible effect of the
binding of GTP in the dissociation of HydE and HydG from HydF [21]. Thus, the
GTP binding and/or hydrolysis might be responsible for structural changes in HydF
itself leading to a change in the interactions with HydG and/or HydE. With this
working hypothesis, we have started a structural study in solution to monitor the
intrinsic conformational changes of the isolated GTP-binding domain of HydF, by
EPR techniques. Indeed, as assessed above, the X-ray crystal structure of the apo-
HydFT.n. suffers the lack of the GTP nucleotide, thus hindering a clarification of its
binding effect on the protein structure.
The measurements of the GTPase activity and the analysis of the CW-EPR
spectra of five single-labeled mutants as well as of the wild-type domain carrying
the native cysteine C91 show that the isolated domain maintains the functional
characteristics and the general structure of the whole protein. Some diagnostic
positions for couples of spin labels have been designed to monitor, by PELDOR
spectroscopy, the conformational changes at the interface regions of domain I with
the other two domains of the whole HydF protein. The PELDOR results show that
the distance between residues 26 and 88, belonging to the protein region close to the
GTP-binding site and to the interface with domain III, respectively, remains
substantially unaffected upon binding of the nucleotide. Instead an effect is found
for the couple of spin labels at the 88 and 164 sites. In this case, the binding of the
nucleotide induces an average increase of the distance, although the main
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component centered at 3.0 nm is only slightly affected. Since the labeled position 88
is common to both double mutants under investigation, it is likely that the protein
rearrangement takes place mainly in the region close to T164, rather than to R88.
Interestingly, T164 belongs to an a-helix element connecting a loop close to the
GTP-binding site with a long protein loop (highlighted in green in Fig. 5) which
connects domain I with the dimerization domain (II).
As suggested by the crystal structure, the dimeric form of HydF (Fig. 5), which is
the prevalent state in solution, represents an open form of the protein with both the
[4Fe4S] cluster and the GTP-binding site fully accessible. It is plausible that the
open dimer interacts with the maturase partners in the extended conformation
revealed by the X-ray structure. As the PELDOR experiments suggest, the binding
of the nucleotide does not induce dramatic effects in the conformation within the
GTP domain, at the level of the diagnostic positions investigated in this work.
However, subtle changes are observed which may reflect large-scale effects in the
dimer conformation, as suggested by the involvement of residue T164 which is
close to the long loop connecting the GTPase with the dimerization domain.
5 Conclusions
The specific role of GTPase domain of HydF in the maturation process of HydA is
likely related to conformational changes of the protein upon ligation/hydrolysis of
the nucleotide. Using a non-hydrolyzable analogous of GTP, we have investigated
the effect due to the binding of the nucleotide in the truncated protein domain.
We found that the binding of the nucleotide does not induce large effects within
the GTP domain, at least at the level of the elements investigated in this work.
However, subtle changes are observed which may produce diffuse effects in the
supramolecular dimeric assembly of the whole HydF protein. It is worth noting that,
not only the binding but also the hydrolysis of GTP could facilitate structural
rearrangements and promote interactions also with HydA facilitating the transfer of
the 2Fe subcluster.
To obtain more significant data, further investigation will be carried out by
designing new site-directed mutants of residues belonging to the above mentioned
long loop and to the unstructured region reported in the X-ray structure (residues
32–44). Spin labeling of the GTPase domain in the whole protein will be also
performed.
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Abstract The catalytic site of [FeFe]-hydrogenase, the
‘‘H-cluster’’, composed by a [4Fe–4S] unit connected by a
cysteinyl residue to a [2Fe] center coordinated by three
CO, two CN- and a bridging dithiolate, is assembled in a
complex maturation pathway, at present not fully charac-
terized, involving three conserved proteins, HydG, HydE
and HydF. In this contribution we review our studies on
HydF, a protein which acts as scaffold and carrier for the
[2Fe] unit of the H-cluster. HydF is a complex enzyme
which contains one [4Fe–4S] cluster binding site, with
three conserved cysteine residues and a non-Cys ligand.
We have exploited EPR, HYSCORE and PELDOR spec-
troscopies to get insight into the structure and chemical role
of HydF. On the basis of the results we discuss the possi-
bility that the non-Cys ligated Fe atom of the [4Fe–4S]
cluster, is the site where the [2Fe] subcluster precursor is
anchored and finally processed to be delivered to the
hydrogenase (HydA). Our PELDOR experiments on the
isolated GTPase domain of HydF, have also suggested that
interactions with HydG and HydE proteins may be regu-
lated by the binding of the nucleotide.
Keywords HydF  Hydrogenase  EPR  HYSCORE 
PELDOR  [4Fe–4S] cluster
1 Introduction
[FeFe]-hydrogenases are enzymes occurring in several
bacteria and eukaryotes [1], which are able to catalyze the
reversible interconversion of protons to molecular hydro-
gen (H2), at an active site called H-cluster. The H-cluster,
composed by a [4Fe–4S] unit, connected by a cysteinyl
residue to a 2Fe center coordinated by three CO, two CN-
and a bridging dithiolate, is assembled in a complex mat-
uration pathway, at present not fully characterized,
involving three conserved proteins called HydG, HydE and
HydF [2].
HydE and HydG are enzymes belonging to the radical
SAM (S-adenosyl methionine) family [3, 4]. Both contain a
[4Fe–4S] cluster (at the N-terminus of the protein) with an
open binding site which can bind the SAM cofactor. HydE
and HydG chemically modify a H-cluster precursor, while
HydF is a GTPase with a suggested double role of scaffold,
on which the H-cluster precursor is synthesized and/or
modified, and carrier, to transfer this precursor to the
hydrogenase (HydA). Formation of the H-cluster within the
cell remains still unclear and only a partial knowledge of
the machinery driving its assembly in vivo is available.
Different mechanisms have been proposed on the basis of a
wide number of experiments. In vitro and/or cell-free
experiments using purified recombinant proteins led to a
two-step model (reviewed in [5, 6]), in which HydE and
HydG drive the chemical modifications of a H-cluster
precursor working on HydF as a scaffold protein and, in a
second step, HydF transfers this cluster to HydA, com-
pleting the maturation process [7–9]. This model has been
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further supported by independent experiments showing that
a H-cluster synthetic mimic can be loaded on a recombi-
nant HydF protein and then transferred to an apo-hydro-
genase, confirming the key role of this scaffold protein [10,
11]. However, a different model has been recently pro-
posed by Kuchenreuther et al. [12] who showed, in a
combined Fourier-transform infrared and electron-nuclear
double resonance spectroscopic work involving isotopic
labelling, that the iron, carbon monoxide, and cyanide
components of the H-cluster subsite in the active hydro-
genase HydA, all originate from a chemistry that occurs at
a [4Fe–4S] cubane center of HydG. A Fe(CO)2(CN) syn-
thon is formed as an integral part of the modified [4Fe–4S]
framework of HydG, as a Fe3S4Fe(CO)2(CN) cluster. The
authors suggest that two of these complex synthons may
assemble together with a dithiolate bridge to form the [2Fe]
subcluster. The mechanism allowing the final assembly and
the transfer of these moieties to apo-HydA (which contains
the [4Fe–4S] component of the H-cluster but not the [2Fe]
subsite) remains to be explained. Moreover, the specific
role of HydE and HydF is not clear in this frame, although
these proteins are known to have a function in the matu-
ration process both in vitro and in vivo, since Chlamy-
domonas reinhardtii recombinant mutant strains, lacking
single or combinations of maturases, are completely unable
to express an active [FeFe]-hydrogenase [2, 13].
HydF has been suggested to be the transferase that
shuttles the complete [2Fe] subcluster to the hydrogenase,
but the exact molecular mechanism driving this translo-
cation is still under investigation. HydF contains one [4Fe–
4S] cluster binding site, with three conserved cysteine
residues near the C-terminus, as well as a N-terminal
GTPase domain, whose specific function is unknown [14].
Both these domains turn out to be essential for a correct
HydA maturation [13]. Electron paramagnetic resonance
(EPR) spectroscopy has been widely employed to get
insights into structure and function of the maturation pro-
teins [3, 9, 13, 15–19]. In this paper we review the results
obtained in our group with this technique on the study of
HydF from Thermotoga neapolitana and Clostridium ace-
tobutilicum. The X-ray structure of HydF from T.
neapolitana, determined at 3 A˚ resolution, is the only
structure of an HydF protein available, although obtained
in the apo-form (PDB ID: 3QQ5) [20]. The protein
monomer present in the asymmetric unit of the crystal
comprises three domains: a GTP-binding domain, a
dimerization domain, and a metal cluster-binding domain,
all characterized by similar folding motifs. Two monomers
dimerize, giving rise to a stable dimer, held together
mainly by the formation of a continuous b-sheet compris-
ing eight b-strands from two monomers. Based on the
structural information available, we have designed several
mutants of the whole HydF protein as well as of its isolated
GTPase domain in order to get insight into the cluster
structure and protein function. In this short review we will
focus on the information derived from our EPR investi-
gation and discuss the spectroscopic data on the light of the
most recently proposed mechanisms of the [FeFe]-hydro-
genase maturation pathway.
2 Experimental
2.1 Heterologous Expression and Purification
of HydF Proteins
2.1.1 Full Length HydF and GTPase HydF Domain
from T. neapolitana (HydFT.n.)
The hydF gene (hydFT.n.) was isolated from purified
genomic DNA by PCR amplification and subcloned in
frame with a 6His-tag sequence at the N-terminus in a pET-
15b vector (from Novagen) [17, 18]. Site-directed muta-
genesis of the hydF gene at selected sites was performed
with the QuickChange II Site-Directed Mutagenesis Kit
(from Stratagene), using as template pET-15b/hydFT.n.
recombinant plasmid. Escherichia coli Rosetta (DE3) cells
were transformed with the obtained pET-15b/hydFT.n.
plasmids and positive clones were selected by antibiotic
resistance. The wild type and mutant 6His-tagged HydFT.n.
proteins were expressed in anaerobic conditions, using 1–2
L cultures, purified by affinity chromatography and gel
filtration, under anaerobic conditions. Briefly, cells were
harvested by centrifugation, resuspended in lysis buffer
(25 mM Tris–HCl pH 8, 200 mM KCl, and protease inhi-
bitors 1 lg/ml pepstatin A, 1 lg/ml leupeptin, 1 lg/ml
antipain, 1 mM PMSF) and lysed by French press. The
supernatant fractions were isolated from cell debris by
centrifugation and the proteins purified to homogeneity by
combining a nickel affinity chromatography (HIS-Select
Nickel Affinity Gel, from Sigma-Aldrich) and a gel filtra-
tion chromatography using a Superose 12 10/300 GL col-
umn (from GE Healthcare, Italy), equilibrated in lysis
buffer. The proteins were finally concentrated to a final
concentration ranging from 100 to 300 lM. All purification
steps were performed under anaerobic conditions in a glove
box with O2-free solutions [20].
GTPase domain The sequence coding for the GTPase
N-terminal domain (domain I, residues 1 to 185) was PCR
amplified using as template the vector containing the
hydFT.n. gene and primers were designed to contain unique
restriction sites allowing the directional subcloning of the
amplified sequence in frame with a 6His-tag sequence at
the 50-terminus in a pET-28b vector (from Novagen)
suitable for T7 driven expression in E. coli [21]. Site-di-
rected mutagenesis of the hydFT.n. gene at specific protein
Top Catal (2015) 58:708–718 709
123
sites was performed using as template the pET-28b/
hydFT.n.I recombinant plasmid. E. coli Rosetta (DE3) cells
were transformed with the pET-28b/hydFT.n.I plasmid, and
positive clones were selected by antibiotic resistance. The
over-expressed proteins were purified in aerobiosis starting
from 1 L cultures, as described above. Samples were
concentrated giving rise to a final concentration ranging
from 800 lM to 3 mM.
2.1.2 HydF Proteins from Clostridium acetobutylicum
(HydFC.a.)
The pCDFDuet-1/hydFC.a. plasmid, carrying the HydF
coding sequence from C. acetobutylicum in frame with a
StrepII-tag at the 30 terminus, was kindly provided by M.
C. Posewitz (from the Department of Chemistry and Geo-
chemistry, Colorado School of Mine, Golden, Colorado).
The pCDFDuet-1/hydFC.a. recombinant plasmid was used
as template to introduce different mutations in the wild type
hydF coding sequence. E. coli Rosetta BL21(DE3) cells
were transformed with pCDFDuet-1/hydFC.a. recombinant
plasmid, and positive clones were selected by antibiotic
resistance [17]. Site-directed mutagenesis of the hydF genes
from C. acetobutilycum was performed with the
QuickChange II Site-Directed Mutagenesis Kit (from
Stratagene), using as template the pCDFDuet-1/hydFC.a.
plasmid. The StrepII-tagged HydFC.a. proteins, either wild
type or mutant, were expressed in anaerobic conditions and
purified by a StrepTactin affinity chromatography (IBA,
Go¨ttingen, Germany), starting from 2 L cultures. For each
purification, the eluted fractions were pooled together and
concentrated by centrifugal filters (Vivaspin Centrifugal
Concentrators, 10,000 MWCO, from Sartorius Stedim
Biotech) to a volume suitable for EPR giving rise to a final
concentration ranging from 50 to 250 lM. All purification
steps were performed under anaerobic conditions in a glove
box (MBRAUN MB 200B) with O2-free solutions. Purified
proteins were analyzed by 12 % SDS-PAGE and elec-
troblotted onto a poly(vinyldifluoridene) membrane. For
immunoblotting analysis, the membrane was probed with
an anti-StrepII-tag monoclonal antibody (from IBA,
Go¨ttingen, Germany) and with a horseradish peroxidase-
conjugated goat anti-mouse IgG (from Kirkegaard & Perry
Laboratories). Labeled proteins were then visualized with
an ECL Western blotting detection kit (from Thermo Sci-
entific Pierce Protein Research).
2.2 EPR Spectroscopy
2.2.1 Full Length HydF Proteins
EPR tubes of as-isolated wild type and mutant of HydFT.n.
and HydFC.a. proteins were prepared in the anaerobic box
and frozen in liquid nitrogen. Reduced wild type and
mutant HydF samples were made by adding 20 mM
sodium dithionite. Low temperature continuous-wave EPR
(CW-EPR) spectra were recorded using a Bruker Elexsys
E580-X-band spectrometer equipped with a ER4102ST
cavity and a helium flow cryostat (ESR 900 Oxford Instru-
ments). Acquisition parameters were the following: tem-
perature = 10–50 K; microwave frequency = 9.38 GHz;
modulation = 1.0 mT, microwave power = 2.0 mW; time
constant = 163.84 ms; conversion time = 81.92 ms; num-
ber of data points = 4096 (scan range = 700 mT) or 1024
(scan range = 100 mT). Simulations of the CW-EPR
spectra, aimed to obtain the g-tensor principal components,
were performed using Easyspin routine in Matlab [22];
g values were estimated by calibration with a strong-pitch
sample.
Hyperfine sublevel correlation spectroscopy (HYSCORE)
experiments were carried out at a temperature of 10 K, using
the same spectrometer equipped with a dielectric ring res-
onator (ER4118X-MD5) and a helium flow cryostat (Oxford
CF935). A conventional two-dimensional (2D) four-pulse
sequence (p/2-s-p/2-t1-p-t2-p/2-s-echo) was applied with a s
delay varied around 256 ns and a 8 ns detector gate, cen-
tered at the maximum of the echo signal. The nominal
duration of both the p/2 and p pulses was 16 ns. The echo
intensity was measured as a function of t1 and t2, incre-
mented in steps of 8 ns from the initial value of 20 ns.
HYSCORE data were collected as a 256 9 256 matrix at a
repetition rate of 1200 Hz. A 4-step phase cycling procedure
was used to remove unwanted echoes. Spectral processing
was performed using a home-written Matlab routine. The
2D time domain data were corrected by a third-order poly-
nomial background in both dimensions. Traces were apo-
dized using a Hamming window function, zero-filled to
1024 points and Fourier transformed in both dimensions.
Frequency map was symmetrized before plotting as contour
plot in logarithmic scale of intensity.
2.2.2 GTPase Domain
Labelled samples were obtained by adding to the purified
HydFT.n. GTPase domain a fivefold molar excess of S-(1-
oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl
methanesulfonothioate) (MTSSL), dissolved in DMSO, and
incubating the protein at 4 C overnight in the dark. Samples
for pulsed electron–electron double resonance (PELDOR)
experiments were concentrated (300 lM) and exchanged
with deuterated buffer. Deuterated glycerol (40 % w/v) was
also added to the samples before freezing. In the nucleotide
binding experiments, 50 mM GTPcS and 10 mM MgCl2
were added to the samples and incubated for 30 min at
37 C before freezing. Samples were loaded into quartz
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capillaries with 2.0 mm ID and 3.0 mm OD. PELDOR was
performed on the same spectrometer described above
equipped with a ER4118X-MS3 split-ring resonator (mi-
crowave frequency = 9.55 GHz) and helium flow cryostat
(Oxford CF935). Measurements were carried out at 50 K. A
standard four pulse sequence was applied; the microwave
power was adjusted to obtain an observer sequence of 16/32/
32 ns and a pump pulse of 16 ns. The difference between
the pump and observer frequency was set to 70 MHz. A
two-step phase cycle was applied for base-line correction
while deuterium nuclear modulations were suppressed using
an 8 step s cycle, from a 180 ns starting value with 56 ns
increment steps. Data on each sample were collected for
about 15 h. Distance distributions were extracted from
PELDOR traces by using DeerAnalysis2013 [23].
3 Results and Discussion
3.1 The [4Fe–4S] Cluster
The presence of a [4Fe–4S] cluster in HydF proteins, ini-
tially suggested by the presence of three conserved cysteine
residues as putative ligands of an iron–sulfur cluster in
different organisms, was confirmed by the observation of
almost axial EPR signals (S = , g|| = 2.05 and
g\ = 1.90) following chemical reduction [9, 14–16].
These signals have microwave power and temperature
saturation properties characteristic of reduced [4Fe–4S]
centers. The role of this cluster was suggested to be
accessory to the assembly of a [2Fe] subcluster, since
HydF, isolated following heterologous co-expression with
HydE and HydG, revealed Fe–CO and Fe–CN vibrational
modes indicative of the ability of this protein to coordinate
an iron center which resembles the [2Fe] subcluster of
HydA [16]. When expressing HydF from C. aceto-
butylicum in the absence of HydE and HydG, Broderick
et al. identified two paramagnetic S = 1/2 species associ-
ated with photo-reduction of HydF [16]. One was assigned
to the [4Fe–4S]? cluster, and the second was assigned to a
[2Fe–2S]? cluster, suggested to be the [FeS] framework
onto which HydE and HydG synthesize the H-cluster
precursor. However, this assignment is still under discus-
sion since Fontecave et al. found that HydF from T. mar-
itima, when reduced with dithionite (DTH), coordinates
only a [4Fe–4S]? cluster while the [2Fe–2S]? cluster is not
present [14]. Moreover, Kuchenreuther et al. have shown,
in a cell free system, that as-isolated HydF, heterologously
expressed in a genetic background devoid of the HydE and
HydG proteins, already exhibits an EPR spectrum which in
the lineshape resembles the signal that Broderick et al.
characterized as the [2Fe–2S]? cluster [15]. The signal
disappears upon reduction with DTH, which indicates that
it cannot be due to a [2Fe–2S]? center. The conclusion
drawn was that HydF neither coordinates a [2Fe–2S]
cluster when anaerobically produced in the absence of
HydE and HydG, nor does supply an [FeS] cluster frame-
work onto which the H-cluster non protein ligands are
assembled. Kuchenreuther et al. suggest that the as-isolated
HydF paramagnetic species observed, which appears to be
the same signal assigned by Broderick et al. to a [2Fe–2S]?
cluster [16], represents instead either a protein-associated
radical or a [3Fe–4S]? cluster.
Afterwards, Kuchenreuther et al. [12] found that a
Fe(CO)2(CN) synthon is formed as an integral part of a
modified [4Fe–4S] framework (i.e. Fe3S4Fe(CO)2(CN)) of
HydG. This strongly indicates that the first step in the
assembly of the [2Fe]-subsite occurs on one of the two
[4Fe–4S] clusters of HydG. On the other hand, FTIR, EPR,
and EXAFS experiments on HydF from C. acetobutylicum,
which has been expressed in its native background with
HydE and HydG, demonstrate that a binuclear iron species
similar to the H-cluster is present also in fully ‘‘assembled’’
HydF [9, 26]. Thus it may be possible that a pre-synthe-
sized binuclear model of the [2Fe] cofactor is introduced
into HydF. According to this hypothesis, the [4Fe–4S]
cluster of HydF would coordinate the 2[Fe]H-precursor
before the transfer to HydA. Therefore, a detailed spec-
troscopic characterization of the [4Fe–4S] cluster of HydF
is important to get insight into the chemistry taking place at
that site.
All HydF proteins identified to date share an iron-sulfur
cluster-binding motif (CxHx46-53HCxxC) in the C-terminal
end [14], with three highly conserved cysteine residues
which are supposed to bind the FeS cluster. Indeed, site-
specific mutagenesis experiments on the HydF protein from
C. acetobutylicum confirmed that two of these conserved
cysteines, i.e. Cys 353 and Cys 356, are essential to drive
the assembly of a functional H-cluster [13]. On the basis of
the three-dimensional crystal structure of HydF from T.
neapolitana (PDB ID code 3QQ5) we described the
domain containing the three conserved cysteine residues
(i.e. Cys 302, Cys 353, Cys 356), which likely bind the FeS
cluster [20]. Close to these residues, we have identified the
position of the two conserved histidines (i.e. His 304 and
His 352) which may be part of the cluster coordination
sphere but their role is still controversial. In a work on the
HydF from T. maritima, HYSCORE experiments excluded
the presence of nitrogen atoms in the cluster coordination
sphere, ruling out the role of histidine residues as ligands
[14]. On the other hand, the same kind of experiments
performed on the HydF protein from C. acetobutylicum
showed the presence of nitrogen in the coordination of the
[4Fe–4S] cluster [24], leading Czech et al. to interpret the
HYSCORE data as due to a histidine ligation to the [4Fe–
4S] unit.
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In this panorama, we have used CW-EPR and
HYSCORE, combined with a site-specific mutagenesis
approach to investigate the role of cysteine and histidine
residues, from the CxHx46-53HCxxC consensus sequence,
as putative ligands of the [4Fe–4S] cluster of HydF pro-
teins from T. neapolitana and C. acetobutylicum, and their
influence on the characteristics of the cluster itself [17]. As
shown in Fig. 1, we found that the mutants HydFT.n.C302S,
HydFT.n.C353S and HydFT.n.C356S do not show the pres-
ence of an assembled [4Fe–4S] cluster, suggesting that
none of the three conserved cysteines can be replaced by an
isosteric serine residue. Instead, in both HydFT.n.H304A
and HydFT.n.H352A proteins an EPR signal has been
detected, although in the case of HydFT.n.H352A the signal
exhibited a shift of the principal g-values (1.840, 1.875,
2.055). These results indicate that while the three cysteines
of the cluster binding consensus sequence of HydF from T.
neapolitana are all essential for the assembly of a func-
tional [4Fe–4S] center, the two conserved histidines are not
decisive for metal coordination. Further investigation by
HYSCORE was performed to evaluate the potential his-
tidine ligation of the [4Fe–4S] cluster of HydFT.n [17]. The
spectra reported in Fig. 2a, collected in correspondence of
the gy = 1.90 field position, clearly show the presence of a
nitrogen ligand coupled to the spin system, in the (? -)
and (? ?) quadrants, in the low frequency region around
the Larmor frequency of the 14N nucleus. However, this
signal is likely due to the presence of imidazole used in the
column elution buffer since, if the sample is subjected to
gel filtration, to remove the excess of imidazole, the
spectral signatures of the nitrogen ligand disappear and
only the peaks around 15 MHz, due to the weak interac-
tions with surrounding protons, are clearly visible in the
(? ?) quadrant. Thus, the HYSCORE results show that a
His coordination is not present in the wild type HydFT.n.
protein and that the native fourth ligand can be easily
exchanged with imidazole, as previously found for the
HydF protein from T. maritima [14]. Different results were
obtained for HydF protein from C. acetobutylicum. In fact,
the HYSCORE experiments performed to evaluate the
ligation of the [4Fe–4S] cluster of HydFC.a.. reveal the
presence of a nitrogen atom coupled to the spin system in
the wild type protein as well as in the mutant HydFC.a.
H306A (Fig. 2b). The parameters of hyperfine and
a b
Fig. 1 a Cartoon tube representation of monomeric HydFT.n. (PDB
entry code: 3QQ5). The three recognized domains are highlighted in
different colours: GTPase domain in orange, dimerization domain in
olive green and [4Fe–4S] cluster binding domain in brown. Residues
of the iron-sulfur cluster-binding motif (CxHx46-53HCxxC) are
shown as sticks. b X-band EPR spectra of as-isolated HydFT.n. and
anaerobically reduced (20 mM sodium dithionite) wild type and
mutant HydFT.n. and HydFC.a. proteins. The inset shows the EPR
signal of the as-isolated sample of HydFT.n. in the g = 4 region where
nonspecifically bound Fe3? contributes. Colour code: as-isolated
HydFT.n. in orange, reduced HydFT.n. in black, reduced HydFC.a. in
brown. Experimental conditions are reported in the Sect. 2. The figure
has been created starting from the EPR spectra reported in [17]
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quadrupolar interactions (double-quantum frequencies,
dq = [±2.6; ±6.6 MHz]; hyperfine coupling constant,
a = 4.2 ± 0.2 MHz; quadrupolar term, K2(3 ? g2) =
0.71 MHz2), derived according to the formula reported in
Ref. [25], are in the range of those reported before for
histidine ligands of iron-sulfur clusters [26–28]. The
HydFC.a.H352A HYSCORE spectrum lacks all the cross
peaks due to strong N-coupling (Fig. 2b), clearly suggest-
ing that His 352 is the fourth ligand of the [4Fe–4S] cluster
in HydFC.a., differently from what observed in the HydFT.n.
protein. Interestingly, a [4Fe–4S] cluster can be assembled
also in the HydFC.a.H352A mutant protein, as supported by
the presence of the EPR signal of the reduced protein.
This evidence suggests that also in C. acetobutylicum the
His 352 residue, which coordinates the iron atom of the
[4Fe–4S] cluster in the native protein, can be at least par-
tially substituted, upon deletion, by another undefined
ligand. Moreover, very recently, Berggren et al. [19] have
shown that His-tag may be responsible for unnatural
coordination to the cluster in T. maritima. These authors
suggest that also preparation containing a Strep-tag II (an
eight amino acid oligopeptide featuring a histidine residue)
could give an adventitious histidinyl ligation. Thus, at
present it cannot be excluded that also the [4Fe–4S] cluster
of the wild type HydF from C. acetobutylicum presents, in
its native form, a non histidinyl fourth ligand.
Although the two histidines in the [4Fe–4S] binding
pocket are not necessary for binding the cubane cluster, at
least in T. neapolitana and T. maritima, we have proven
that they are essential for a correct maturation of HydA
a
b
Fig. 2 a X-Band HYSCORE spectra (14N region) of reduced wild-
type HydFT.n. before (left) and after (right) imidazole removal. b X-
Band HYSCORE spectra (14N region) of reduced wild-type and
mutant HydFC.a. proteins. Experimental conditions are described in
Sect. 2. Spectra are recorded at 10 K and at the field position
corresponding to the gy value (1.90). The figure has been created
starting from the spectra reported in [17]
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[17]. Indeed, all the introduced mutations, including those
not affecting the HydFC.a. EPR and HYSCORE spectra,
resulted in a severe impairment of the HydAC.a. activation
under anaerobic inducing conditions, as assessed by
hydrogen gas evolution activities measured in whole-cell
extracts. Thus, the two histidines are likely to play an
active role in the stabilization of the [2Fe] precursor in
HydF (e.g., through hydrogen bonding) [19].
In conclusion, taken all together, the reported results on
the HydF proteins from different microorganisms indicate
that only the three cysteines are strictly required for the
binding of the [4Fe–4S] cluster, whereas the fourth ligand
of the coordination sphere can vary depending on the
molecular environment created by local residues and/or
experimental conditions. In the experiments carried out in
both T. neapolitana and T. maritima, a [4Fe–4S] cluster-
imidazole complex is detectable in the presence of an
excess of imidazole, suggesting that the fourth metal
coordination site is easily accessible and readily
exchangeable. This may have important implications for
the synthesis of a complete H-cluster precursor. Non-cys-
teinyl ligation to a cubane-type FeS cluster is known to
occur in several enzymes and in each case the anomalous
cluster coordination has a functional significance [29]. An
accessible iron coordination site could be relevant in sub-
strate binding and transfer. According to this evidence, as
remarked before [19], HydF is able to bind a diiron syn-
thetic complex, mimicking the active site of HydA, via a
bridging cyanide ligand, and to eventually use it to activate
apo-HydA [10].
The [4Fe–4S] cluster coordination in HydF proteins is
evocative of the members of radical SAM superfamily
including HydG and HydE, in which three cysteine resi-
dues coordinate three of the four irons of the [4Fe–4S]
cluster at the active site of the enzyme, while the remaining
ligand to the fourth iron, in the absence of SAM, is likely a
small-molecule from the buffer and not a protein ligand
[30]. The coordination of this fourth iron makes it labile,
explaining why in many cases these proteins are found to
contain [3Fe–4S]? clusters in their as-isolated or air-ex-
posed states, as also observed for HydF (see Fig. 1, orange
trace). Upon reduction with a reducing agent, such as DTH
or photoreduced 5-deazariboflavin, the [3Fe–4S]? clusters
can usually be reconverted to the [4Fe–4S]? clusters, by
scavenging of adventitious iron or by cannibalization of a
fraction of the clusters [31]. Protein-bound [3Fe–4S]
clusters are generally derived from [Fe4S4(S-Cys)3L] cen-
ters with L = H2O/OH
-, a side chain carboxylate, or some
other non-cysteinate ligand [32]. It has been suggested that,
under oxidizing conditions, the reaction [Fe4S4]
3?
?
[Fe3S4]
?
? Fe2? may occur, the removal of ferrous ion
being assisted by complexation with an exogenous ligand
[33].
To further investigate this crucial problem of the cluster
ligation characteristics, we focused on the iron-sulfur
cluster environment of HydF from T. neapolitana, by
analyzing the low temperature CW-EPR spectra of a series
of significant site-directed mutants (D310A, D337A,
E300A and Y380A), corresponding to residues which are
in close proximity to the [4Fe–4S] cluster binding site,
according to the crystal structure of apo-HydFT.n. [18].
These residues represent putative Fe cluster ligands.
HYSCORE spectra of the mutants were also detected and
compared to those of the wild type protein [18]. The results
are reported in Fig. 3. Comparison of the g principal values
of the mutants with those of the wild type shows that the
[4Fe–4S] cluster is only slightly affected by the substitu-
tion of Glu300, Asp310, Asp337 and Tyr380 with alanine,
meaning that the assembly of the cluster is not compro-
mised or altered by the removal of these residues. Thus, it
seems likely that either the residues are not directly
involved in the ligation of the [4Fe–4S] cluster or they can
be easily substituted by other residues. This is also con-
firmed by the analysis of the HYSCORE spectra in the
proton coupling frequency region. Three different protons
contributions have been recognized in the spectra of the
WT: (1) weakly coupled protons (hyperfine couplings
between 2.5 and 3.5 MHz) assigned to distant nuclei, likely
belonging to protein residues or backbone, located at long
distance from the cluster; (2) protons characterized by a
strong coupling (hyperfine couplings between 14 and
16 MHz) (ridges III) tentatively assigned to the b-cysteinyl
protons; (3) protons corresponding to ridges II, showing
isotropic hyperfine couplings with intermediate values
(7–9 MHz), which reflect a close distance to the spin car-
rying cluster. Since no significant changes of the hyperfine
interactions are found in the mutants compared to the wild
type, an involvement of the selected residues in either
direct bonding or specific interactions, such as H-bonding
of coordinated water, in close proximity of the FeS cluster,
can be excluded. Therefore, the most likely non-Cys ligand
of the cluster is an exogenous molecule such as a hydroxyl
or water. This is also in agreement with the observed easy
exchangeability of the fourth ligand. Further HYSCORE
experiments based on 2H2O exchange, to determine the
exchangeable protons, and H2
17O exchange, to eventually
measure the direct oxygen coordination to the iron, are in
progress in our laboratory to support this hypothesis.
3.2 The GTPase Domain
As suggested by Lubitz et al. [33], since in the living cell
the concentration of free cofactors is small, transferases are
needed to move a pre-assembled 2Fe-subcluster precursor
to HydA. The role of HydF is likely to be crucial at this
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stage. However, both the mechanisms of ligand transfer to
HydF and delivery of the 2Fe-subcluster precursor from
HydF to HydA are still unknown. At present, it is not clear
whether the CO and CN ligands are delivered as free to a
FeS cluster bound to HydF, or mononuclear Fe species
with bound ligands are delivered to HydF, or the whole 2Fe
subcluster is synthesized on HydG before being transferred
to HydF.
The GTPase activity of HydF is likely involved in the
interaction with HydE and HydG rather than with HydA. In
fact, Vallese et al. have shown that GTP addition to either
the HydF–HydE or HydF–HydG complexes results in an
increase in the rates of dissociation, suggesting that the
dissociation of HydE and HydG from HydF may be driven
by the GTPase activity of HydF [34]. It has also been
reported that the presence of GTP significantly affects the
a
c
b
Fig. 3 a Cartoon tube representation of the FeS cluster binding
domain of HydFT.n. (PDB entry code: 3QQ5). Putative residues
involved in the cluster binding are shown as sticks (colour code:
carbon in black, nitrogen in blue, oxygen in red, sulfur in yellow).
b Low temperature X-band EPR spectra of anaerobically reduced
(20 mM sodium dithionite) wild type and mutants of HydFT.n..
c HYSCORE spectra of reduced HydFT.n. proteins. A comparison
between wild type and mutant proteins is reported. Spectra are
recorded at 10 K, at the field position corresponding to the gy value
(1.90). Experimental conditions are described in Sect. 2. The figure is
based on the data reported in [18]
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EPR spectral properties of the HydF cluster, showing that a
communication between the GTP and the iron-sulfur
cluster binding domains of the protein may be present [16].
In order to investigate possible conformational changes
induced by the GTP binding in the N-terminal domain of
HydF, we have expressed in E. coli, a recombinant HydF
protein from T. neapolitana including only the GTP-bind-
ing domain [21]. The isolated domain I can be indeed
purified to homogeneity as a single monomeric species,
keeping its capability of GTP hydrolysis. Site-directed
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Fig. 4 Structure of HydFT.n. (PDB entry code: 3QQ5) showing the
mutated residues in the GTPase domain (a). Background-corrected
PELDOR traces for the M26C-R88C-C91S (b, c, d) and R88C-
T164C-C91S (e, f, g). Samples in the absence (black, b, e) and after
the addition (black, c, d) of 50 mM GTPcS. Tikhonov-derived
distance distributions (d, g) for samples in the absence (black) and in
the presence (red) of the nucleotide analogous. The figure has been
modified starting from [21]
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mutants have been designed for PELDOR measurements, in
which the native residues have been substituted by cysteines
and subsequently spin-labeled with the methanethiosulfonate
nitroxide. The wild type domain contains a single cysteine
(i.e. C91), buried in the protein core, which, as proven by
preliminary experiments, gives a low labeling yield. For this
reason, it was substituted by serine (C91S) while three other
sites were selected to introduce the cysteine residues in the
construction of double labeled species for PELDOR experi-
ments. They are the following: residue M26, close to the
GTP-binding site; residue R88, located at the interface of
domain I and III; residue T164, which belongs to the terminal
part of an a-helix connecting domain I and II via a long loop
(see Fig. 4). Triple mutants (R88C–C91S–M26C and R88C–
C91S–T164C) were produced and, after reaction with the spin
label MTSSL, double spin labeled samples were obtained.
The corresponding PELDOR spectra are shown in Fig. 4.
Tikhonov-derived distance distributions analysis of the
PELDOR traces for the M26C–R88C–C91S and R88C–
C91S–T164C mutants give main values which correspond,
roughly, to those expected on the basis of the a-carbon dis-
tances derived from the X-ray structure of the apo-HydF
protein (19 and 20 A˚, respectively).
The PELDOR results show that the distance between
residues 26 and 88, belonging to the protein region close to
the GTP binding site and to the interface with the domain
III, remains substantially unaffected upon binding of the
nucleotide. An effect is found for the spin labels at the 88
and 164 sites. In this case, the binding of the nucleotide
induces an average, although small, increase of the distance
with a change also in the distance distribution. Interest-
ingly, T164 belongs to an a-helix element connecting a
loop close to the GTP binding site with a long protein loop
which connects domain I with the dimerization domain (II).
Although the nucleotide binding does not induce dramatic
effects on the conformation within the GTP domain, at the
level of the diagnostic positions investigated in our work,
the observed changes may reflect a diffuse effect in the
dimer conformation of HydF, which is the main form of the
whole protein in solution. This hypothesis needs to be
tested by performing spin-labeling experiments on the
GTPase domain of the full-length protein.
Our preliminary experiments show that the PELDOR
might be a powerful technique to investigate the mecha-
nism of the maturation process, at the level of the
nucleotide binding and/or hydrolysis. Design of new site-
directed mutants of residues belonging to the above men-
tioned long loop and to an unstructured region reported in
the X-ray structure (residues 32-44), together with spin-
labeling of the GTPase domain in the full-length protein,
will be performed to get a detailed map of the conforma-
tional changes.
4 Conclusions
HydF is a complex enzyme which contains one [4Fe–4S]
cluster binding site with three conserved cysteine residues
near the C-terminus and a N-terminal GTPase domain,
whose specific function is unknown. It has been increas-
ingly observed that, in many enzymes, the ligands of [4Fe–
4S] clusters can be other than Cys and that the presence of
the non-Cys ligands can strongly influence the physical
properties of the clusters in terms of reduction potential,
stability, and reactivity [35]. Therefore, it is likely that also
in HydF the non-Cys ligated Fe atom of the cluster, whose
ligand is easily exchangeable and variable depending on
the organism, as we have shown, carries out the relevant
chemistry.
HydF has been suggested to be the transferase that
shuttles the complete [2Fe] subcluster to the hydrogenase,
but the exact molecular mechanism driving this translo-
cation is still under investigation. It seems likely that the
[4Fe–4S] cluster of HydF is the site where the [2Fe] sub-
cluster precursor is anchored and finally processed to be
delivered to HydA. The dimeric form of HydF in solution
probably allows the interactions with HydG and HydE
proteins for the transfer of the synthons. These interactions
may be regulated by the GTPase domain of HydF, as
revealed by our preliminary PELDOR experiments. In
order to obtain more significant data in this regard, further
investigation is needed.
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Identifying conformational changes 
with site-directed spin labeling 
reveals that the Gtpase domain of 
HydF is a molecular switch
Laura Galazzo2, Lorenzo Maso1, edith De Rosa1, Marco Bortolus2, Davide Doni2, Laura 
Acquasaliente3, Vincenzo De Filippis3, paola Costantini1 & Donatella Carbonera2
[FeFe]-hydrogenases catalyse the reduction of protons to hydrogen at a complex 2Fe[4Fe4S] center 
called H-cluster. the assembly of this active site is a multistep process involving three proteins, Hyde, 
HydF and HydG. According to the current models, HydF has the key double role of scaffold, upon which 
the final H-cluster precursor is assembled, and carrier to transfer it to the target hydrogenase. The 
X-ray structure of HydF indicates that the protein is a homodimer with both monomers carrying two 
functional domains: a C-terminal FeS cluster-binding domain, where the precursor is assembled, and a 
N-terminal Gtpase domain, whose exact contribution to cluster biogenesis and hydrogenase activation 
is still elusive. We previously obtained several hints suggesting that the binding of Gtp to HydF could be 
involved in the interactions of this scaffold protein with the other maturases and with the hydrogenase 
itself. In this work, by means of site directed spin labeling coupled to epR/peLDoR spectroscopy, we 
explored the conformational changes induced in a recombinant HydF protein by Gtp binding, and 
provide the first clue that the HydF GTPase domain could be involved in the H-cluster assembly working 
as a molecular switch similarly to other known small Gtpases.
Biohydrogen production, one of the most promising frontiers in the field of renewable energies, is achieved in 
nature by several prokaryotic and eukaryotic microorganisms through a general class of evolutionarily unrelated 
metalloenzymes called hydrogenases. Among them, [FeFe]- and [NiFe]-hydrogenases are the most widespread1. 
These proteins have different distribution, catalytic properties and molecular architectures, but they are both able 
to reversibly reduce protons to H2 by means of metal clusters with some key similarities, including the coordi-
nation to the polypeptide chain through four conserved cysteine residues and the presence of iron-bound CO 
and CN− ligands2. In the case of [FeFe]-hydrogenases, the active site (referred to as the H-cluster) is particularly 
complex since it is composed of a [4Fe4S] cubane linked via a cysteine bridge to a 2Fe subcluster comprising 
the CO and CN- molecules and an additional dithiomethylamine ligand3–5. This 2Fe subcluster needs a specific 
set of maturation proteins to be first assembled in the active form and then inserted into the target functional 
[FeFe]-hydrogenase. Three conserved proteins are involved in its biosynthesis and delivery, i.e. HydE, HydF and 
HydG, discovered in the unicellular green alga Chlamydomonas reinhardtii and then found in all microorgan-
isms containing a [FeFe]-hydrogenase6. Both HydE and HydG are radical S-adenosylmethionine (SAM) proteins 
whereas HydF is a GTPase carrying a [4Fe4S] cluster binding motif6. The 3D crystal structures of all these matu-
rases have been solved7–10, and several in vitro and cell-free experiments using purified recombinant proteins have 
been performed to understand their functions, allowing to propose a two-steps model that describes a H-cluster 
biosynthetic pathway in which a 2Fe precursor is assembled and chemically modified on a scaffold protein prior 
to the transfer to the apo-hydrogenase (as reviewed in refs 11 and 12). Several independent experiments indicated 
that HydE and HydG would be responsible for the dithiomethylamine and CO/CN- biosynthesis respectively9–17, 
and that the double key role of scaffold and carrier of the H-cluster precursor is played by HydF18–21. Although 
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many unresolved questions remain, the most supported model consists in the building of the synthon Fe(CO)2CN 
by HydG, with two synthons needed to synthesize a [2Fe]H subcluster16. From the other side, a synthetic [2Fe] 
precursor was loaded into HydF to finally yield the active hydrogenase (HydA)22, suggesting a key role of HydF in 
the last steps of the H-cluster maturation and delivery. As a scaffold protein, HydF must efficiently interact with 
the two maturation partners (i.e. HydE and HydG), and with the target apo-hydrogenase itself, keeping them in 
close proximity in order to get a functional unit able to follow the ordered biosynthetic pathway described in the 
proposed two-step model. Several functional insights have been gained from the 3D structure of the apo-HydF 
(i.e. devoid of both GTP and FeS cluster), as well as from several spectroscopic analyses of the FeS cluster carrying 
protein in solution. HydF is a dimer in which each monomer is composed of three distinct domains, two with the 
consensus sequences for the binding of GTP (domain I) and of a [4Fe4S] cluster (domain III)8; the third domain 
(domain II) allows two monomers to associate through a large surface, giving rise to a stable, left-handed helical 
shaped dimer with an open and accessible surface enabling it to interact with potential partners8. The [4Fe4S] 
cluster coordination sphere of HydF has been thoroughly investigated by spectroscopic analysis of the protein in 
solution19, 23–29, which provided several clues on how the H-cluster precursor is kept in-site by the scaffold during 
biosynthesis and chemical modifications by HydE and HydG; however, the exact mechanism by which the mature 
precursor is transferred from the scaffold to the hydrogenase has not been clarified. A further unresolved issue 
is the specific role of the HydF GTPase moiety, which is essential for the [FeFe]-hydrogenase maturation and 
activation30. We found that the binding of GTP to HydF induces the dissociation of HydE and HydG from the 
scaffold31, suggesting that the GTPase domain could be involved in a dynamic network of interactions with the 
other maturases. Interestingly, the crystal structure of the apo-HydF protein showed the existence of flexible loops 
in this domain, which could undergo structural rearrangements upon GTP binding8. This could in turn have an 
impact on the capability of the holo-protein to interact with HydE and HydG in the maturation machinery, and 
to drive the proper delivery of the H-cluster precursor to the target hydrogenase.
In a previous work, we investigated the intrinsic conformational changes triggered in HydF upon GTP bind-
ing using a recombinant form comprising only the HydF domain I. Nitroxide spin labeled cysteine residues 
were introduced at diagnostic positions in different elements of the protein secondary structure, with the aim 
of monitoring large rearrangement of the structure32. Combining CW-EPR (electron paramagnetic resonance) 
and PELDOR (pulse electron-electron double resonance) spectroscopic analysis, either in the absence or in the 
presence of GTP, we monitored the local mobility of the spin label at the selected sites and the distance between 
couples of labels, respectively. We found that the binding of the nucleotide to the isolated HydF GTPase domain 
does not induce large conformational effects, at least at the level of the positions investigated. Instead, small 
changes in the distance between spin labels were observed, suggesting diffuse rearrangements upon GTP binding 
at the level of these structural elements32.
Since the presence of the other two domains may be important in producing structural constrains in HydF, 
by directing and/or amplifying the conformational changes induced at the GTP binding site, in the present work 
we used CW-EPR and PELDOR analysis by mapping the GTP-induced conformational changes along the entire 
HydF protein. We provide the first hint that the HydF GTPase domain functions as a molecular switch, simi-
larly to other small GTPases33, 34 containing the GTP-sensitive switch regions 1 (sw1) and 2 (sw2). Strikingly, we 
recognized sw1 and sw2 regions in the HydF GTPase domain and showed that, upon GTP binding, the protein 
undergoes conformational changes which are likely instrumental in promoting HydF activity in the maturation 
process of hydrogenases35, 36.
Results
Design of recombinant mutants of HydF Gtpase domain by in silico analysis. An active HydF 
GTPase domain is essential to produce a functional [FeFe]-hydrogenase, both in vivo and in vitro6, 30. Sequence 
analysis indicated that the HydF GTPase domain contains the consensus motifs shared by all NTPases and essen-
tial to bind and hydrolyze GTP, i.e. the P-loop: (GRRNVGKS) and G2 to G4 loops (TTT, DTPG and NKID)6, 30. 
However, the role of GTP binding and/or hydrolysis in the H-cluster assembly is still elusive. By structural analy-
sis, we found a similarity of the HydF folding with that of small GTPases, which are well-established regulators of 
several cellular functions, such as FeoB, MnmE, RbgA and TrmE. These GTPases alternate between GDP-bound 
and GTP-bound forms, differing by the conformations of the so-called switch 1 (sw1) and switch 2 (sw2) regions, 
and of other, more protein dependent, structural elements33, 34, 37 (see Fig. 1, panel A, where FeoB is taken as an 
example of the two different forms). In the HydF GTPase domain, we recognized the regions corresponding to 
putative sw1 and sw2, together with the GTPases consensus motifs (Fig. 1 panels A and B). Moreover, according 
to previous experimental evidences indicating that the HydF GTPase activity is increased in the presence of 
K+19, the region of HydF nucleotide-binding G1 motif (…GRRNVGKSSFMNALV…) contains two asparagine 
residues, namely Asn19 and Asn27, which are highly conserved in the K+ activated G-proteins37, as indicated 
by a detail of the multiple sequence alignment reported in panel C of Fig. 1 (see Supplementary Fig. S1 for the 
complete alignment). In all reported structures of the K+ activated GTPases, the first conserved asparagine is a 
ligand to the potassium ion, which is also coordinated by three oxygen atoms from the GTP nucleotide and two 
backbone carbonyl groups from the sw1 region.
In order to coordinate K+, sw1 must adopt a particular structure in which its ‘K-loop’ lies directly over the 
nucleotide binding site. The GTP-bound sw1 conformation is a unique feature of the cation dependent GTPases. 
Moreover, in K+-activated GTPases the second conserved asparagine residue forms hydrogen-bonds with the 
backbone of sw1, and contributes in positioning it in the proper conformation. Interestingly, the putative sw1 
of the HydF GTPase domain was not resolved in the X-ray structure of the apo-protein8, likely due to the high 
flexibility of this loop, which in the mentioned homologous proteins undergoes large conformational rearrange-
ment upon GTP binding. Since the structure of HydF in the presence of either GTP or GDP is not yet available, 
the hypothesis of a structural analogy of its sw1 in the GTP-bound state with those of other K+-activated GTPase 
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guided our experimental design aimed to detect possible rearrangements upon nucleotide binding. Panel A of 
Fig. 1 reports the details of the mentioned structural elements of the HydF GTPase, together with the apo- and 
[K+/Mg2+/GDPAlX4]-structures of the GTPase domain of FeoB, a membrane protein that imports Fe2+ 38, taken 
as reference structure of a K+-activated GTPase. Note that the putative sw1 region of HydF (residues 31–46) 
is mostly missing, since it was unresolved in the X-ray structure8, while the two conserved asparagines are 
highlighted.
As reported above, sw2 is another common protein region of the GTPases, which usually undergoes structural 
modification upon nucleotide binding/hydrolysis. This part is well resolved in the HydF X-ray structure and 
Figure 1. Structural features of the GTPase domain of HydF (Panel a, left. PDB ID: 3QQ5) and of the 
G-domain of Streptococcus thermophilus FeoB in the apo form (Panel a, middle. PDB ID: 3LX5) and in the holo-
form binding GDP_AlF4 (Panel a, right. PDB ID: 3LX8). The magnesium atom that binds at the active site is 
shown as a green sphere, and the potassium atom as a violet sphere. The GDP_AlF4 ligand is not shown. GTP 
binding residues (orange), sw1 (yellow) sw2 (green), conserved Asn (cyan) are highlighted. The colour code is 
adopted from ref. 37 and maintained in the displayed structure. Note that in the structure of the GTPase domain 
of HydF sw1 is almost completely unresolved and consequently not displayed. Panel b: aminoacid sequence of 
HydF GTPase domain, with positions of G1–G4 (orange), sw1 (yellow) and sw2 (green) indicated. G5 (orange) 
corresponds to the less conserved G domain motif, that usually participates in recognition of the guanine base. 
Asparagine residues highly conserved in K+ activated small GTPases are marked in cyan. Secondary structure 
elements are also indicated. Panel c: Detail of the multiple sequence alignment (MSA) of HydF, FeoB, RbgA, 
MnmE and TrmE GTPase domains, generated by Clustal Omega algoritm. An *indicates positions which 
have a single, fully conserved residue, a: indicates conservation between groups of strongly similar properties 
and a. indicates conservation between groups of weakly similar properties. The complete MSA is reported in 
Supplementary Fig. S1. G1 motif and conserved asparagine residues are highlighted with black and cyan bold 
characters, respectively.
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corresponds to a long loop ending with an α-helix (Fig. 1, panel A). A similar sw2 motif was found in FeoB, as 
clearly seen in the structural comparison. In K+-activated GTPases, the structure of sw2 and its rearrangement 
vary in a much more protein-dependent way with respect to sw137. Thus, it is difficult to foresee the conforma-
tional change of this protein region upon GTP binding/hydrolysis. The same consideration holds for other protein 
segments, which may be involved in the specific interactions with other proteins or domains in relation to the 
protein function.
We obtained a first hint of a structural change induced by GTP in HydF from the circular dichroism spectra 
of a recombinant HydF protein expressed in Escherichia coli (see below), as shown in Fig. 2. The GTP binding 
induces a change of the secondary structure of the protein corresponding to a few percent decrease of ellipticity. 
The deconvolution of the CD spectra suggested a possible change of an α-helix element into β-strand and random 
coil traits (Supplementary Table S1).
Heterologous expression, purification and site-directed spin-labeling (SDSL) of HydF pro-
teins. To get insight into the specific regions undergoing the conformational changes suggested by the CD 
results, we made use of SDSL combined with EPR spectroscopy. This technique requires the introduction of a 
unique spin label that reports on localized regions of a protein39. All native cysteines must be eliminated in order 
to obtain a protein carrying a single cysteine introduced in the position of interest. This cysteine is then chemi-
cally modified with a sulfhydryl-specific EPR probe. To this end, a recombinant HydF protein was expressed in 
E. coli in frame with a 6His-tag at the N-terminus, as described in details in the Methods section, and purified 
by combining a NiNTA affinity and a gel filtration chromatography. Due to the presence of cysteine residues in 
wild type HydF at site 91 (GTPase domain I) and sites 302, 353 and 356 (FeS cluster binding domain III), we 
first substituted these native cysteines with serines by means of site-specific mutagenesis, in order to obtain a 
cysteine-less pseudo-wild type mutant protein. Only in one case C356 was maintained and spin labeled itself (see 
below). It should be noted that the removal of the cysteines in the domain III, where a [4Fe4S] cluster is bound 
to the holo-protein, precludes the cluster assembly; however, since the GTPase domain is not directly affected by 
the absence of the FeS cluster, the analysis of the cysteine-less mutants are meaningful. Moreover, the effect of 
the GTP binding in the CD spectrum of the cysteine-less mutant was the same as that of the recombinant wild 
type protein giving a comparable analysis in terms of secondary structure composition change upon nucleotide 
binding (see Supplementary Fig. S2 and Table S1).
The spin labeling positions were selected based on the in silico analysis described above, to explore possible 
rearrangements of: 1) the switch regions (sw1: S35C, S38C, T44C; sw2: V71C); 2) the interface region between 
the GTPase domain and the catalytic domain (R88C, A89C, D340C, L341C); 3) the catalytic domain (C356); 4) 
the helix connecting the GTPase domain with the long loop leading to the dimerization domain (T164C); 5) the 
long loop itself (I175C); 6) the dimerization domain (V261C). Figure 3 reports the HydF structure with all these 
residues highlighted except for residues S35, S38 and T44, which belong to the unresolved loop in the X-ray struc-
ture. All single mutants were labeled using the spin label MTSSL. In some cases, 3-maleimido-proxyl (5-MSL), 
having a higher steric hindrance, was also used. The labeling yields, calculated by spin quantification of the EPR 
spectrum double integrals and comparison with those of standard solutions of the free spin labels are reported in 
Supplementary Table S2.
All the spin labeled mutants showed changes of the CD spectrum upon GTP binding, indicating that the 
introduction of the spin label was not altering the capability of the protein to adopt the nucleotide-induced struc-
tural changes.
CW-epR spectroscopy. The combination of site-directed spin labeling (SDSL) and electron paramagnetic 
resonance (EPR) is a well-established method to determine protein dynamics and conformations39, 40. Following 
protein site-directed cysteine mutagenesis, a nitroxide spin label binds to the mutated Cys residue and reports on 
local dynamics, conformational dynamics of protein domains, and possibly, global protein motion. The lineshape 
of the EPR spectrum of a spin label reflects its mobility and is therefore sensitive to conformational changes. 
Highly mobile spin labels, as those on the surface of a protein, have a characteristic narrow spectrum with three 
Figure 2. Far-UV CD spectrum of HydF taken before (blue) and immediately after (red) addition of GTP.
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sharp peaks, whereas the reduction in mobility, due to intramolecular constrains, leads to the broadening of the 
spectrum and/or the appearance of an additional peak in the low field region41. We recorded the EPR spectra 
of purified HydF proteins individually spin-labeled with MTSSL at the 12 different positions mentioned above, 
and looked for mobility changes upon GTP addition (Fig. 4). In the majority of the explored sites, the spin probe 
exhibited multiple motional states, indicating that either the side chains of the probes may have different motional 
states and/or the protein backbone may assume different conformations. Notable effects upon GTP binding were 
detected at position 38, belonging to sw1, 71, belonging the sw2, 88, corresponding to the terminal part of sw2 
and to the interface region of GTPase doman with the catalytic domain. In some cases, conformational changes 
were better evidenced by using 3-maleimido-proxyl (5-MSL) (Fig. 5). While 5-MSL is rigidly attached to the pro-
tein, providing information on the rotation of whole structural elements of the labeled protein, MTSSL is bound 
by a more flexible linkage and describes better the local environment of the target residue in the protein structure. 
It can be seen that two dynamic components are present in the EPR spectrum of 5-MSL labeled protein at posi-
tion 38, while in the corresponding MTSSL labeled protein three components are contributing to the spectrum. 
The differences are even more pronounced if glycerol is added to the buffer solution (50% v/v) to increase the vis-
cosity of the medium and thus lengthen the correlation time of the motions. The changes induced by GTP binding 
lead to a redistribution of the different components. Also in the case of position 71, 5-MSL is more affected by the 
nucleotide binding compared to MTSSL.
Minor, but still detectable, mobility changes were observed at positions 35 and 44 (sw1), 340 (catalytic domain, 
region facing residue 88), 164 (α-helix of GTPase domain close to the loop connecting the dimerization domain), 
and 175 (belonging to the long loop connecting the dimerization domain) (Fig. 5). For these positions, the effects 
were strongly dependent on different conditions such as spin label structure and/or addition of glycerol. In the 
case of S35 and T44 changes on the EPR lineshapes are observed in particular when 5-MSL is used as spin label 
in the presence of glycerol, that is when the mobility is reduced. In these conditions changes are detected which, 
although small, are reproducible.
Finally, very little or no effects were detected at position 341 (catalytic domain, region facing residue 88), 356 
(catalytic domain, position corresponding to [4Fe4S] cluster binding in the functional protein), and 261 (dimer-
ization domain).
To better characterize the role played by the nucleotides in determining the conformation of HydF, the effects 
of GDP, GDP-AlF4 (a transition-state analogue) and GTPγS (a non-hydrolysable GTP analogue) were also 
explored. The results are shown in Fig. 6 for the MTSSL spin labeled R88C mutant, which was the one showing 
the clearest mobility change upon GTP binding. No spectral changes were observed upon addition of GDP and 
GDP-AlF4, while GTPγS induced the same effect as GTP (note that in the presence of GTPγS the spectrum 
showed a high fraction of free spin label, due to the release of MTSSL by reaction of the spin labeled protein with 
GTPγS itself).
As expected, the conformational changes were reversible once the GTP was hydrolysed and left the protein 
binding site. Interestingly, the relaxation to the initial state was very slow compared to the kinetics of hydrolysis. 
Indeed, while the hydrolysis of the nucleotide occurs in minutes19, 31, detection of the EPR spectrum at different 
delay times after the GTP addition showed that only after several hours the spectrum returned to the lineshape 
preceding the nucleotide addition (see Fig. 7).
A reported above, the HydF GTPase domain contains the conserved residues of K+-activated GTPase. 
Accordingly, it was previously reported that potassium largely increases the hydrolysis rate19. Thus, we performed 
the EPR experiment on R88C also in a buffer solution without K+. The analysis of these spectra indicates that the 
Figure 3. Cartoon representation of HydF monomer structure (PDB ID: 3QQ5). The GTP-binding domain 
is coloured in light blue violet, the dimerization domain in blue and the cluster-binding domain in teal. The 
P-loop is highlighted in orange, the terminal parts of sw 1 in yellow and sw 2 in green. The residues that have 
been mutated and labeled are indicated in the structure and coloured according to the effect on change mobility 
undergone upon GTP binding and detected by EPR (red, blue and grey, going from high to low effect). Positions 
S35, S38 and T44 are not highlighted, as they were not resolved in the crystallographic structure.
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absence of K+ does not preclude the conformational change induced by GTP addition, however the extent of the 
change is reduced (Supplementary Fig. S3).
peLDoR. Since HydF adopts a dimeric structure8, with the aim to map possible large conformational changes 
induced by the GTP binding at the level of this dimeric structure, we also performed Pulse Electron DOuble 
Resonance (PELDOR, also known as DEER) experiments42. It is well known that this pulse EPR technique, based 
on the measure of dipole-dipole interaction between unpaired electron spins, has become the most widely used 
method for measuring distances between electron spins in (bio)macromolecules. The V261C HydF mutant was 
chosen to perform intra-dimer distance measurements because, based on the X-ray structure, the expected dis-
tance between spin labels belonging to the two moieties composing the dimer is 3.5 nm, which is in the suitable 
range of reliable distances measured by PELDOR. Moreover, according to the X-ray structure, residue 261 is 
Figure 4. CW-EPR spectra of the 12 investigated mutants of HydF labeled with MTSSL, taken before (blue) 
and immediately after (red) addition of GTP. For each mutant, an enlargement of the low-field region is shown. 
Spectra are taken at room temperature.
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Figure 5. CW-EPR spectra of some HydF mutants labeled with either MTSSL (50% v/v glycerol) or 5-MTS (in 
the presence or in the absence of 50% v/v glycerol) taken before (blue) and immediately after (red) addition of 
GTP. For each mutant, an enlargement of the low-field region is shown. Spectra are taken at room temperature.
Figure 6. Effects of different nucleotides binding on the CW-EPR spectrum of labeled R88C: absence of 
nucleotides (blue), in the presence of non-hydrolysable GTP analogue (brown), GTP (red), GDP (magenta) and 
GDP-AlFx (violet).
www.nature.com/scientificreports/
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located in a portion of the dimerization domain, that does not interfere with the folding of the β-sheet forming 
the dimeric structure of HydF, thus representing a good choice to detect conformational changes induced by GTP 
at the level of the dimer structure.
The spectra of samples frozen in the absence of GTP and immediately after its addition are reported in Fig. 8, 
together with the data analysis. The very good signal to noise ratio allowed us to obtain a reliable measure of 
the effects. Tikhonov-derived distance distributions provided main values, that correspond, roughly, to those 
expected on the basis of the X-ray structure of the apo-HydF protein (3.5 nm), confirming the dimer struc-
ture of the protein in solution. When GTP was added, some differences were detected. The distance distribution 
showed that about 25% of the shortest distance (2.8 nm) is converted into the longer (3.0 nm) in the presence of 
GTP. This is a clear indication of a rearrangement occurring in a protein region far from the nucleotide binding 
site. It does not correspond to a dramatic reassembly of the dimer, however the protein region around V216 
clearly “feels” the switch triggered by the GTPase domain. We also performed the PELDOR experiments in a 
double spin labeled mutant (V261C-T164C) having an expected intra-monomer distance of 4.5 nm and estimated 
inter-monomer distances (261–164 and 164–164) 6.2 and 7.0 nm, respectively. The spectra, reported in Fig. 8, 
show also in this case emerging differences when GTP was added. Although quantitative analysis of multispin 
systems (four spins in this double labeled mutant) is quite complicated43, it seems clear that such differences are 
present not only in the region corresponding to the 261-261 distance, as for the single labeled mutant V261C, but 
also at the level of the other inter- and intra- monomer distances. Validation of the distance analysis performed 
with DeerAnalysis2015 is reported in Supplementary Fig. S4.
Discussion
The sequence homology of the HydF GTPase domain with those of proteins belonging to the K+ activated 
GTPase family is a strong indication of its possible role as a molecular switch. The suggested double function of 
HydF as scaffold and carrier of the 2Fe unit of the [FeFe]-hydrogenase (HydA) H-cluster precursor may be facil-
itated by conformational changes of the protein during the cycle of interaction with HydG, HydE and/or HydA. 
Shepard and coworkers previously showed that the HydF-dependent GTP hydrolysis in vitro increases in the 
presence of HydE or HydG19, suggesting the existence of a HydF GTPase domain function/structure relationship 
driving the interactions of this scaffold with the other two maturases. More recently, Vallese et al. showed, based 
on Surface Plasmon Resonance experiments performed by injecting the nucleotide during the step of HydE and 
HydG dissociation from HydF, that the binding of GTP increases the dissociation rate31. This could be related to 
the maturation mechanism by which the displacement of an interaction partner from the scaffold occurs, allow-
ing subsequent association of a different protein. Thus, it seems likely that a conformational switch due to the 
GTP binding to HydF is responsible for a fast release of the other two maturases.
With the aim to prove the occurrence of conformational changes of HydF upon GTP binding, we first used 
CD spectroscopy. The addition of GTP induced a clear change of the secondary structure, reflected in the CD 
spectrum. However, the technique is not very sensitive to the rearrangement of unstructured regions, such as 
loops or random portions of the protein. Therefore, to get further insight into the protein regions undergoing 
structural rearrangement, we used SDSL EPR spectroscopy, which, with the introduction of a unique spin label 
at specific sites, reports on localized regions of a protein. If the nucleotide binding induces some changes in the 
protein structure, the lineshape of the EPR spectrum of a spin label is expected to change, when the probe is 
located at a site involved in/close to the rearrangement. A highly mobile spin label on the surface of a protein has 
Figure 7. Curves of the relaxation to the initial state following addition of GTP (t = 0 h), detected as change of 
the EPR signal of spin label at site 88, at the field positions indicated by arrows in the inset. The dots represent 
respectively the percentage of recovery of the broader spectral component (grey dots) and of decay of the 
narrower spectral component (black). In the inset, the zoom of the EPR spectra (red t = 0 h; blue t = 5.5 h) with 
the positions used to obtain the kinetics shown by arrows.
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Figure 8. PELDOR of spin labeled V261C and V26C-T164C with HydF dimer structure representation. (Panel 
a) Cartoon representation of HydF dimer structure with the indication of the distance between the residues 
V261 (left) and between residues V261 (blue) and T164 (black) (right). (Panel b) PELDOR data of mutant 
V261C (left) and V26C-T164C (right), in the absence (blue) and in the presence (red) of GTP before (upper 
panels) and after (middle panels) background correction, Tikhonov-derived distance distributions in the 
absence (blue) and in the presence (red) of the nucleotide, are shown in the bottom panels.
www.nature.com/scientificreports/
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a characteristic narrow spectrum with sharp peaks, whereas the reduction in its mobility due to intramolecular 
constrains or “trapping” in a protein-protein interaction interface is reflected in the broadening of the spectrum.
To provide adequate coverage of the protein structure analysis by EPR, we expressed and purified 12 cysteine 
single mutants, modified them with spin labels and compared their EPR spectra taken before and after GTP addi-
tion. In this way, we were able to obtain information concerning different protein regions. Most of the changes 
detected in the EPR spectra of HydF are not as dramatic as one would expect for a large protein reassembly and 
reshaping. The 12 positions probed by our experiments, however, are indicative of structural changes taking place 
at different extent depending on the protein region.
Significant effects are found at the level of putative sw1 and sw2, in particular at positions 38 and 71. Looking 
at the structural analogies common to all the known K+ dependent GTPases at the level of sw1, it seems likely 
that in HydF, after GTP addition, residue 38 could become very close to the K+ binding region, starting from an 
extended loop far from this site. This would be consistent with the observed reduced mobility of the backbone, as 
revealed by the 5-MSL spin label. The MTSSL spin probe at the same positions has a more complicated behaviour, 
described by three components. The most immobilized component undergoes a reduction in intensity as well as 
the most mobile, while the intermediate regime component gains intensity. This suggests that MTSSL, having 
higher flexibility compared to the 5-MSL, may adopt different local conformations. Since both spin probes reveal 
a redistribution of the components of the EPR spectrum upon GTP binding, a significant structural change lead-
ing to many local effects is clearly taking place. Residues 35 and 44, which are very close to 38, undergo similar 
changes in terms of redistribution of components, although less pronounced. Changes of EPR lineshapes are 
observed for these two residues when 5-MSL is used as spin label and in the presence of glycerol, when their 
mobility is reduced. Looking at the spectra of the two proteins labelled with MTSSL it appears that residues 35 
and 44 are both characterized by relatively high intrinsic mobility either in the presence or in the absence of GTP. 
For residue 44 this was expected on the basis of a possible structural analogy of HydF with FeoB (Fig. 1) in the 
apo form. In that protein, when sw1 undergoes the large conformational change this residue moves from a loop 
position towards another, although different, loop position. Thus, its intrinsic mobility is expected to undergo 
only little changes. On the contrary, position 35 was expected to behave differently starting from the equivalent 
position in apoFeoB structure, that is a β-strand which rearranges into a loop interacting with the K+ binding 
site upon GTP binding. However, it is worth noting that an unresolved sw1 region was found in the X-ray struc-
ture of apo MnmE [PDB:3gee], and a long loop was characterizing the sw1 in the X-ray structure of apoTrmE 
[PDB;1xzp]. Both these proteins are members of the K+ GTPase family and show the conserved structure of sw1 
which characterize the family in the GTP-bound state. Thus, it is likely that also in HydF sw1 is characterized by 
a loop in the apo form which rearranges upon binding of the nucleotide into another loop, close to the K+ site.
A clear structural rearrangement is detected at position 71, in the putative sw2 region, which, according to the 
X-ray structure, adopts a loop conformation in the apo-form of the protein. The EPR results indicate an immo-
bilization of this residue upon GTP binding. Taken together, all the effects relative to residues 35, 44, 38 and 71 
strongly corroborate the hypothesis of a molecular switch role for the GTPase domain of HydF.
As observed for other GTPases, the conformational changes may extend to additional portions of the molec-
ular structure, more protein dependent, which could be relevant for specific protein-protein interactions and/
or protein-ligand assembly [ref. 37 and refs therein]. Since HydF interacts with HydE/HydG and is believed to 
act as a scaffold for the assembly and delivery of the 2Fe unit of the H-cluster, it is well possible that the GTP 
binding either produces some effects in regions of the protein involved in the interaction with the other matu-
ration proteins or induces modification in the catalytic domain of HydF, where the cluster precursor is bound 
and processed. In this respect, the extended change on spin mobility measured by EPR at the position 88 is very 
interesting, since this residue is located at the interface between the GTPase domain and the catalytic domain. 
The increase of mobility detected at this site after GTP addition may be related to a larger separation of the two 
domains induced by the nucleotide binding. A confirmation of this interfacial change is also proven by the effect 
experienced by the spin probe at site 340 belonging to the catalytic domain and facing residue 88. The effect at site 
88 was not observed in our previous work on isolated GTPase domain32, because the spin probe was completely 
exposed to the solvent due to the absence of domain III.
The structure and length of the sw2 region are more heterogeneous in the GTPases compared to those of 
sw1. The conformational change in sw2 upon nucleotide binding differs among distinct GTPases, ranging 
from small rearrangements, such as in Ras44, to a major reorientation of helix a2, as in EF-Tu45. Interestingly, in 
NFeoBLp, sw2 includes a long loop region (10–14 residues) and a helix (a2). The unique location of a2 between 
the nucleotide-binding site and the GDI domain of NFeoBLp suggested for this helix a function of relay ele-
ment transmitting the signal induced by nucleotide binding to the GDI and transmembrane domains46. In this 
way, nucleotide binding to the G domain in FeoB regulates ferrous iron uptake across the membrane. The 3D 
structure of HydF indicates that sw2 contains a long loop constituted by 14 residues followed also by a helix 
(a2). R88 is located at the base of a2, facing domain III. Thus, an effect similar to that observed in FeoB proteins 
could take place in HydF with the conformational change of sw2 upon nucleotide binding transmitted to the 
catalytic domain via a2, as suggested by the change in mobility experienced by the spin probe at site 340. In this 
respect, it is worth noting that the EPR spectrum of HydF [4Fe4S] cluster was found to be sensitive to GTP19. 
We did not observe changes in the spin label mobility at position 356 where a Cys ligand of the [4Fe4S] cluster is 
present in the wild type protein, however the lack of the cluster in the recombinant mutant protein may alter the 
response of the spin label at this site due to the absence of structural constrains imposed by the cluster itself in 
the holo-protein.
HydF is characterized by a dimerization domain, which is directly connected to the GTPase domain through a 
long loop (see Fig. 2). Similar long loops connecting different domains and undergoing structural rearrangements 
upon nucleotide binding are found, for instance, in the K+-dependent GTPases MnmE and TrmE47, 48. To explore 
the response of the loop to the GTP binding in HydF, we considered the spin label at position 175. Interestingly, 
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we found that the spin label bound at this site, although far away from the GTP binding site, undergoes a detect-
able change in the mobility upon nucleotide binding. We also monitored the possible effects in the dimerization 
domain by SDSL at site 261 and measuring the 261-261 inter-monomer distance by PELDOR. Clear effects were 
found on the order of few Å displacement upon GTP binding, showing that the changes occurring in the GTPase 
domain are felt by distant residues belonging to the dimerization domain as well. The effects induced on the dimer 
structure were further confirmed by the PELDOR analysis of the double mutant T164-V261.
Proteins acting as GTPase switches show conformational changes, induced by a cycle of GTP hydrolysis, with 
different mechanisms. Changes in protein forms can be promoted either by GDP binding or by GTP binding/
hydrolysis34. Thus, it was of primary importance to investigate the effects of the different nucleotides. The addi-
tion of GDP and GDP-AlF4 to the protein did not produce any observable effect in the EPR spectra, while GTPγS 
induced the same effect as GTP, strengthening the hypothesis that the trigger of the conformational change is 
given by the binding of the nucleotide rather than by its hydrolysis. Thus, as common for many other GTPases, 
the conformation of HydF in the presence of GDP is the same as that of the apo-protein. From the time evolution 
of the EPR spectra after the addition of GTP, we found that the return to the apo-conformation is very slow com-
pared to the kinetic of hydrolysis of GTP. This inertia could be due to the absence of some cellular effector in our 
in vitro experiments compared to the in vivo conditions, as observed for a number of GTPases needing effectors to 
perform the GTP/GDP cycle34, but could even be functional to generate a rest time for the switch, allowing other 
steps of the maturation process to take place. This would fit with the previously proposed stepwise model of the 
H-cluster assembly on the HydF scaffold11, 12.
Functional and sequence analysis clearly indicate that HydF is a K+ activated GTPase19. Our EPR experiments 
show that the absence of K+ does not preclude the conformational change induced by GTP binding, however its 
presence favours the switch of the structure. According to the known structures of the K+ activated GTPases, 
the cation contributes to the coordination of the sw1 upon nucleotide binding, thus the observed effect in HydF 
is in agreement with the rearrangement of sw1 and with the contribution to the stabilization of the switched 
conformation.
Most of the sites investigated by SDSL EPR reveal the presence of more than one conformation, both in the 
apo- and in the GTP-bound state. We never observed a complete conversion of the EPR spectrum from one 
form to another, even in large excess of either GTP or GTPγS. For instance, in the case of R88C the change in the 
lineshape of the EPR spectrum induced by GTP can be assigned to a 30% population shift between the two com-
ponents needed for the simulation of the spectra (Supplementary Fig. S5 and Table S3). This is in agreement with 
the results we obtained from Isothermal Titration Calorimetry (ITC) experiments (reported in Supplementary 
Fig. S6 and Table S4), showing that only 60% of the wild type recombinant HydF is able to bind GTP. There are 
different possible explanations for this experimental evidence: a) a percentage of protein is in a misfolded con-
formation, therefore only a certain amount of protein is sensitive to the nucleotide binding; b) HydF is always 
present in an equilibrium of different conformations and the GTP binding just shifts the equilibrium among 
different forms. The presence of some unknown effectors in vivo, might restrict the conformational space of 
the protein generating a limited number of conformations compared to the in vitro conditions adopted in this 
work. In this respect, it is interesting to note that in cell-free experiments an addition of cellular extract is always 
necessary to allow the [FeFe]-hydrogenase maturation process to take place49. Although it is difficult at this stage 
to discriminate between the a) and b) possibilities, the main result remains, showing that the GTPase domain of 
HydF may undergo conformational changes upon GTP binding. The presence of a correct cluster assembly and/
or the interaction with other unknown effectors/maturases may well enhance the differences between energies 
of the conformations that we have detected shifting the equilibrium between different forms, which are however 
intrinsically determined by the nucleotide binding. EPR experiments will be performed in the near future by 
using unnatural aminoacids carrying a spin label to avoid the substitution of native cysteine residues and allow 
refolding of the protein in the presence of the [4F-4S] cluster in the catalytic domain, with the aim of studying the 
influence of the cluster presence on the conformational equilibrium shift induced by GTP.
Conclusions
In the present work, we recognized for the first time the analogies of HydF with the K+ dependent GTPases, in 
terms of sw1 and sw2 regions and conserved Asn residues, and established that the GTPase domain is a switch 
undergoing significant structural modifications upon GTP binding, as in other members of the same family. 
Starting from this discovery, it will be possible to model the sw1 in the GTP bound state of HydF, an important 
structural information which was missing also in the X-ray structure of the apo-protein.
Although the predicted cation-dependent GTPases from various superfamilies (TEES, Obg-HflX, and 
YqeH-like) are all involved in ribosome biogenesis, exceptions are reported. For instance, FeoB is a membrane 
protein that imports Fe2+ 38 and MnmE modifies tRNA50. Thus, HydF may represent an additional K+-activated 
GTPase with a novel function, showing that the K+ GTPases may have a larger spread of functions than supposed 
before.
We have provided evidence that EPR is a suitable technique to follow the changes induced by GTP binding 
and hydrolysis in HydF and monitor the states of nucleotide cycle. The effects monitored at different protein sites, 
by using SDSL-EPR techniques, showed that the structural changes upon GTP binding in HydF are diffuse, and 
indicate that not only the GTPase domain but the whole protein undergoes conformational rearrangements. 
This is in agreement with previous data suggesting that GTP alters the EPR signal of the reduced [4Fe4S] cluster 
of HydF, and facilitates the dissociation of HydE and HydG from HydF. The interaction areas between the two 
maturation proteins and HydF are not known, however they likely involve extended protein regions not only sw1 
and 2. Thus, the diffuse conformational changes detected in HydF upon GTP binding may well be functional to 
a variation of interaction with the other maturases. Experiments to measure these effects in the HydF-HydG and 
HydF-HydE spin labeled complexes will help to confirm this hypothesis.
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As a final remark, it is worth noting that a GTP-dependent step in the maturation process is found also in 
[NiFe]-hydrogenases. The maturase HypB is a metal-binding GTPase involved in this step51, which is essential 
for hydrogenase maturation/activation. Size exclusion chromatography and cross-linking studies demonstrated 
that the binding of GTP triggers the dimerization of HypB. The HypB GTP-dependent dimerization facili-
tates nickel delivery to hydrogenase by loading nickel to the metal-binding site at the dimeric interface. Thus, 
a GTPase-dependent molecular switch may be a common strategy adopted by the different hydrogenases in the 
assembly of their complex metal active sites.
Methods
Heterologous expression and purification of HydF proteins. The Thermotoga neapolitana hydF 
gene was isolated from purified genomic DNA by PCR amplification and subcloned in frame with a 6His-tag 
sequence at the N-terminus in a pET-15b vector (from Novagen®), as described in ref. 8. Site-directed mutagen-
esis of the hydF at selected sites was performed with the QuickChange® II Site-Directed Mutagenesis Kit (from 
Agilent Technologies), using as template pET-15b/hydF recombinant plasmid and the couples of primers listed 
in Supplementary (Table S5). The sequence of each mutant hydF gene was confirmed by DNA sequencing (at 
GATC Biotech, Germany). E. coli Rosetta (DE3) cells were transformed with the obtained plasmids and positive 
clones selected by antibiotic resistance. The expression of the wild type and mutant 6His-tagged HydF proteins 
was induced by adding 1 mM isopropyl-β-thiogalactopyranoside (IPTG) in LB medium and incubating the cells 
at 30 °C overnight. Proteins were purified starting from 0, 5 to 1 L cultures and combining affinity chromatog-
raphy and gel filtration. Briefly, cells were harvested by centrifugation, resuspended in lysis buffer (25 mM Tris-
HCl pH 8.0, 200 mM KCl supplemented with protease inhibitors 1 µg/ml pepstatin A, 1 µg/ml leupeptin, 1 µg/
ml antipain, 1 mM PMSF) and lysed by French press. The supernatant fractions were isolated from cell debris 
by centrifugation and the proteins purified to homogeneity by a nickel affinity chromatography (HIS-Select® 
Nickel Affinity Gel, from Sigma-Aldrich) and a gel filtration chromatography using a Superdex 200 GL 10 300 
column (from GE Healthcare), equilibrated in a buffer containing 25 mM Tris-HCl pH 8.0, 200 mM KCl, and 
1 mM MgCl2 (final buffer). To estimate the molecular weight of the analyzed samples, the column was equili-
brated in the same buffer and calibrated with the standards thyroglobulin (669 KDa), ferritin (440 KDa), β-amyl-
ase (200 KDa), bovine serum albumin (67 KDa), carbonic anhydrase (29 KDa) and cytochrome c (12 KDa). The 
eluted fractions containing the HydF dimer were finally pooled together and concentrated by centrifugal filters 
(Amicon Ultra Centrifugal Filter, 10000 NMWL, from Merck Millipore) to a volume suitable for spectroscopic 
analysis (see below), giving rise to a final concentration up to 600 µM, as determined spectroscopically using 
ε280nm = 26360 M−1cm−1. Purified proteins were analyzed by 12% SDS-PAGE.
Isothermal Titration Calorimetry (ITC). ITC measurements were carried out at 25 °C on a MicroCal 
OMEGA ultrasensitive titration calorimeter. The titrant and sample solutions were made from the same stock 
buffer solution (25 mM Tris-HCl pH 8.0, 200 mM KCl, and 1 mM MgCl2), and both solutions were thoroughly 
degassed before each titration. The solution (75 µM wild type HydF protein) in the cell was stirred at 200 rpm to 
ensure rapid mixing. Typically, 7 µL of titrant (500 mM either GTP or GTPγS) were delivered every 10 s with an 
adequate interval (4 min) between injections to allow complete equilibration. Titrations continued until no fur-
ther complex formation following addition of excess titrant was detected. A background titration, consisting of 
identical titrant solution and buffer solution in the sample cell, was subtracted to account for heat of dilution. The 
data were collected automatically and then analyzed by the Windows-based Origin software package supplied by 
MicroCal. A one-site binding model was used.
Circular Dichroism (CD). CD measurements were performed with a Jasco J-810 spectropolarimeter. Far-UV 
CD spectra were collected using cells of 0.1 cm path-length. Data were acquired at a scan speed of 20 nm/min 
and at least three scans were averaged. Proteins were used at a concentration of 5 µM (0.2 mg/ml), in a 0.5 mM 
Tris-HCl buffer, pH 8.0, containing 4 mM KCl and 20 µM MgCl2. Measurements in the presence of GTP were per-
formed in the same samples analyzed in the absence of the nucleotide, adding 1 µL of GTP to a final concentration 
of 250 µM in 400 µL of total volume. Experiments were performed at 25 °C using a thermostated Jasco PTC-423 
Peltier Cell Holder connected to a Jasco PTC-423S Peltier Controller. The secondary structure content of HydF 
was calculated using the CD spectrum deconvolution software CDNN51. This software calculates the secondary 
structure by comparison with a CD database of known protein structures.
CW-epR. Samples for EPR labeled with either MTSSL or 5-MSL were obtained by adding to the purified pro-
tein (at a concentration of about 150 µM) a fivefold molar excess of spin label, either MTSSL or 5-MSL, dissolved 
in DMSO and ethanol respectively, and incubating the protein at 4 °C overnight in the dark. Excess of non-ligated 
spin label was removed from the protein by several cycles of dilution with final buffer (25 mM Tris-HCl, pH 8.0, 
200 mM KCl and 1 mM MgCl2), and concentration by centrifugal filters. Twenty microliters of each sample, with 
a protein concentration of about 600 µM (in 25 mM Tris-HCl, pH 8.0, 200 mM KCl, and 1 mM MgCl2) were 
loaded into quartz capillaries with 0.6 mm ID and 0.84 mm OD. In GTP binding experiments, GTP (up to 10 mM) 
was added to the samples and EPR measurements were performed immediately after the addition. EPR spectra 
were collected at room temperature (298 K) on an Elexsys E580-X-band spectrometer (Bruker) using a Super 
High Sensitivity Probehead cavity. The field modulation frequency was set at 100 kHz, with a field-modulation 
amplitude of 0.5 G and the microwave power was 6.4 mW. Time constant was set at 40.96 ns and conversion time 
at 81.92 ms; data collection was carried out acquiring 1024 points. The center of the field was set to 351 mT and 
the sweep width to 10 mT. Simulations of the CW-EPR spectra were performed using a program based on the 
stochastic Liouville equation and adopting the MOMD model as standard for spin-labeled proteins52. The overall 
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rotational correlation time of the HydF dimer was estimated using the program by Zerbetto et al.53. Details are 
reported in Supplementary information.
Pulse ELectron DOuble resonance (PELDOR). Samples were exchanged with deuterated buffer. 
Deuterated glycerol (33% v/v) was also added to the samples before freezing. The final protein concentration 
was about 150 µM for all the samples. In the nucleotide binding experiments, GTP was added to a 10 mM final 
concentration. All the samples, loaded into quartz capillaries with 1.1 mm ID and 1.6 mm OD, were quickly 
frozen. Q-band pulse EPR experiments were performed with the same EPR spectrometer used for CW-EPR 
(Elexsys E580) equipped with a Bruker EN 5107D2 resonator (microwave frequency = 33.86 GHz) and an Oxford 
CF935 cryostat. The measurements were performed at a temperature of 50 K. A standard four pulse sequence was 
applied; the microwave power was adjusted to obtain an observer sequence of 28/56/56 ns and a pump pulse of 
56 ns. The difference between the pump and observer frequency was set to 80 MHz. A two-step phase cycle was 
applied for base-line correction, while deuterium nuclear modulations were suppressed using an 8 step τ cycle 
from a 180 ns starting value with 56 ns increment steps. Data on each sample were collected for about 15 hours. 
Distance distributions were extracted from PELDOR traces by using DeerAnalysis201554.
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Multiple sequence alignment (MSA) of HydF, FeoB, RbgA, MnmE and TrmE GTPase 
domain
FeoB ----------MTHALLIGNPNCGKTTLFNALTNANQR-VGNWPGVTVEKKTGEFLLGE-H
RbgA ------MQPRPVRAVVIGFPNVGKSALINRLLNRRVVDSARRPGVTRQLRWVRIS----D
HydF --MRLPDAGFRRYIVVAGRRNVGKSSFMNALVGQNVSIVSDYAGTTTDPVYKSMELHPIG
MnmE --------GM--KVVIAGRPNAGKSSLLNALAGREAAIVTDIAGTTRDVLREHIHIDGM-
TrmE SSGRLLREGI--RTVIVGKPNAGKSSLLNALLGEERAIVTEIEGTTRDTLEEELSLKDL-
:: *  * **::::* * . .        *.* :     : 
FeoB LIEITDLPGVYSLVANAEGISQDEQIAAQSVIDLEYDCIINVIDACHL------------
RbgA QLELLDAPGVLPSR-----LTD-----------QQAATKLAICDDIGEAAYNTQNMAAAL
HydF PVTLVDTPGLDDV-GELGRLRVEKAR----RVFYRADCGILVTDSA-PTPYE--------
MnmE PLHIIDTAGLREASDEVERIGIERAW----QEIEQADRVLFMVDGT-TDAV--------
TrmE NLRVIDTAGIRETEDPVERIGVERAR----RAAEEADLIIYVVDAS-RPLDS--------
: : *  *:         :              .    : : * 
FeoB ---ERHLYLTSQ-------LFELGKPVVVALNMMDIAEHRGISIDTEKLESLLGCSVIPI
RbgA VDLLQHLEVKNQILPGLLPKNPLHHRYQVSIDPNQLP-----------------------
HydF -------DDVVNL------FKEMEIPFVVVVNKIDVLGEKAEE-LKGLYESRYEAKVLLV
MnmE --------DPAEIWPEFIARLPAKLPITVVRNKADIT--GETL---GM-SEVNGHALIRL
TrmE --------SDEEI----LRFLPGKKALLL-LNKSDLRTIISEE---EM-KKRSGCPVLSI
:                :  :  :: 
FeoB QAHKNIGIPAL---------------------QQSLLHCSQKIKPLKLSLSVAAQQILND
RbgA -ILT--GEDYLLKLAAERYQGDAERA---------------------------ARQLLND
HydF SALQKKGFDDIGKTISEILPGDEEI-----------------------------------
MnmE SARTGEGVDVLRNHLKQSMGFDTNMEGGFLARRRHL--------QAL----EQAAEHLQQ
TrmE SARTEEGISMLSEKIREMF-F-----GGELRWNQELIICSERQRKLL----QNAGQALRE
*   : 
FeoB LENQLISKGYKNSFAYYFSRRLAEGDTLIGEKAFTESLLIKLQETEQNLDVLLADARYQK
RbgA FRKGLLG-----AIALELPPEVSPLTDSQSDSVTQSDLMTQPEQSDQD----QSDPA---
HydF ------------------------------------------------------------
MnmE GKAQLLG-----AWAGELL---------------AEELRLAQQNLSEITGEFTSDDLLGR
TrmE LCRSIEN-----GMPEDFY---------------TIDIMRAYEELGQILGERVSEDLIDE
FeoB IHEIVTLVQKK
RbgA -----------
HydF -----------
MnmE IFSSFCIGK—
TrmE IFSKFCMGK--
Figure S1. Multiple sequence alignment (MSA) of HydF, FeoB, RbgA, MnmE and TrmE GTPase 
domain, generated by Clustal Omega algoritm (v1.2.3). An * indicates positions which have a 
single, fully conserved residue, a : indicates conservation between groups of strongly similar 
properties and a . indicates conservation between groups of weakly similar properties; dashes (-) 
indicates deletions. According to Clustal Omega, color code is: red, small, hydrophobic and 
aromatic residues (except for Y); blue, acidic residues; magenta, basic residues (except for H); 
green, residues with hydroxyl, sulfhydryl and amine groups, and G.
 
 
 3 
CD spectra analysis of HydF WT and cysteine-less mutant 
Comparison  of the CD spectra of HydF WT (spectra reported in the main text)  and cysteine-less 
mutant  (Figure S2) show that the addition of GTP induce similar conformational transition in the 
two samples.  The secondary structure content was calculated using the CD spectrum deconvolution 
software CDNN [51]. This software calculates the secondary structure by comparison with a CD 
database of known protein structures. The results of the spectra analysis are reported in table S1. 
 
Figure S2. CD spectra of cysteine-less HydF mutant, before (blue) and after (red) GTP addition. 
Table S1. CD spectra analysis of HydF WT and cysteine-less mutant 
Table: percentages of secondary structure elements obtained from the fitting of the CD spectra by CDNN  
software. Uncertainty on the reported values are estimated  to be of the order of few %. 
 WT cysteine-less 
  +GTP  +GTP 
helix 32.9 30.0 33.0 30.4 
parallel 8.7 11.8 7.8 9.8 
antiparallel 8.7 9.1 8.9 9.6 
turn 17.0 17.6 16.7 17.2 
random 32.8 33.8 34.5 36.5 
Total 100.1 102.3 100.9 103.5 
 Structural Changes 
WT 
Structural Changes 
cysteine-less 
helix -2.9 -2.6 
parallel +3.1 +2.0 
antiparallel +0.4 +0.7 
turn +0.6 +0.5 
random +1.0 +2.0 
Total +2.2 +2.6 
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Labeling yields of HydF mutants 
Labeling yield for the different mutants at the cysteine positions were evaluated by spin 
quantification of the EPR spectrum double integrals and comparison with those of standard 
solutions of the free spin labels, and are reported in table S1. 
Table S2. Labeling yields of HydF mutants 
Mutant Yield (%) with MTSSL Yield (%) with 5-MSL 
S35C 85 60 
S38C 85 60 
T44C 80 65 
V71C 55 35 
R88C 80 20 
A89C 15  
T164C 75 60 
I175C 90 70 
V261C 70  
D340C 45  
L341C 45  
C356 55 35 
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Effects of K+ on the change of the CW-EPR spectrum of spin labelled R88C upon GTP 
addition 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S3: Top: CW-EPR spectra at room temperature of the mutant R88C in the absence (blue) 
and in the presence (red) of GTP, when potassium is not added to the buffer. Bottom: comparison 
between CW-EPR spectra of R88C in the absence of potassium (blue) and when 50 mM potassium 
is added to the buffer before (brown) or after (orange) the addition of GTP.  
 
 
 
 
 HydF R88C no KCl
 HydF R88C no KCl GTP
 HydF R88C no KCl
 HydF R88C +50 mM KCl / +GTP
 HydF R88C +GTP / +50 mM KCl
 
 
 
 
 
1 mT 
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Validation of the distance distributions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S4: Validations of the distance distributions performed with DeerAnalysis2015 for the 
investigated mutants in the absence (top) and in the presence (bottom) of GTP. The black lines 
represent the distribution with the best r.m.s.d. after the validation procedure, while grey bars 
indicate the full variation of the probability for each distance over all trials. The other lines 
represent the mean value of the probability minus (blue) or plus (red) two times the standard 
deviation. 
V261C T164C-V261C 
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Simulation of CW-EPR spectra for spin labeled R88C mutant 
The simulation of EPR spectra can provide information on the protein backbone dynamics at the 
different sites, and also a multicomponent analysis can determine the relative amounts of the 
different components in a spectrum. We performed an analysis of the EPR spectra of the MTSSL 
label at position 88 since it proved to be the most sensitive to GTP addition.  
First we analysed the different components of the R88C-MTSSL spectrum to determine the extent 
of the changes induced by GTP. Since the experimental spectra clearly showed that only two 
components were present and that the addition of GTP likely shifted only the relative abundance, 
but not the lineshape, we were able to separate them by a properly weighed subtraction of the 
spectra with and without GTP: in Fig. S5, in the center we report the simulations of the individual 
components, the parameters of the simulation are reported in table S3. The two spectral shapes were 
simulated using a program based on the stochastic Liouville equation and adopting the MOMD 
model as standard for spin labeled proteins. The starting values for the principal components of the 
g and 14N hyperfine (A) tensors of the TOAC label were obtained from fitting of the frozen solution 
spectra. The values of the magnetic (g and A) and diffusion (D) tensors, their relative orientation 
(ΩD), and the order parameter (S), were then refined by simplex fitting. The two simulated 
lineshapes were then normalized to the same number of spins and used to obtain the simulation of 
the original experimental spectra as shown in Fig.S5 in the bottom part. The spectrum of the apo-
protein is simulated by equal amounts of the two components (55% broad; 45% narrow), while the 
spectrum in the presence of GTP has a predominance of the narrow component (30% broad / 70% 
narrow). Given that the simulations are not perfect, an uncertainty of ±5% in the relative amounts of 
the two components can be estimated. Overall, the simulations suggest that the addition of GTP 
affects roughly a fourth of the protein at position 88. 
As regards the analysis of the backbone dynamics, the diffusion tensors of the two components are 
both isotropic, the narrow component has a slightly faster diffusion (lower rotational correlation 
time) than the broad one, and the marked change in spectral width can be ascribed to the tumbling 
around different axes. The diffusion parameters suggest that no marked change in the backbone 
dynamics takes place upon GTP addition. We also estimated the overall rotational correlation time 
of the HydF dimer; the diffusion tensor is axial with slightly faster rotation around the “helical” axis 
of the dimer: D|| = 3.65 MHz and D = 2.05 MHz, this corresponds to a τHydF = 1/6(D||D)1/2 = 61 ns. 
This value is higher than those obtained from the simulations, indicating that the overall tumbling 
of the protein should not strongly affect the lineshape of the EPR spectra.  
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Figure S5. Top: spectrum and simulation of R88C-MTSSL; bottom: spectrum and simulation of 
R88C-MTSSL with GTP; center: simulate individual components. The dashed lines help highlight 
the main features of the two components. 
 
Table S3. Parameters obtained from the fitting of the individual components of R88C. 
 gxx gyy gzz Axx Ayy Azz D  D S 
Broad 2.0088 2.0070 2.0030 7.9 G 5.4 G 36.2 G 11 MHz 15 ns 0°/0°/0° 0.60 
Narrow 2.0088 2.0070 2.0030 8.0 G 5.4 G 35.0 G 31 MHz 5 ns 0°/37°/0° 0.60 
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ITC measurements 
ITC measurements of GTPγS binding to wild type HydF were carried out at 25 °C on a MicroCal 
OMEGA ultrasensitive titration calorimeter. The samples, in 25 mM Tris-HCl pH 8.0, 200 mM 
KCl, and 1 mM MgCl2 buffer solution, were degassed before measurements. A 500 mM stock of 
GTPγS was titrated into a protein solution of 75 μM. Data were collected automatically and then 
analyzed with a Windows-based Origin software package supplied by MicroCal. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S6. ITC measurements of GTPγS binding to wild type HydF 25 °C. Experimental data 
(circles) are interpolated by the curve (red) calculated with the parameters reported in the table S3 
reported below. 
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Table S4.  GTPγS binding to wild typeHydF monitored by Isothermal Titration Calorimetry 
(ITC) 
 
Sample 
 
titrant 
 
n 
ΔH 
(cal mol-1) 
ΔS 
(cal mol-1 deg-1) 
KD 
(μM) 
HydF GTPγS 0,594 -2873 ± 28,36 17,9 0,96  ± 0,09 
 
Table S5. List of primers used in this study 
Primer name Primer sequence 
C91S_for        5′-TCTACAGGGCAGATTCTGGAATTCTCGTGAC-3′ 
C91S_rev        5′-GTCACGAGAATTCCAGAATCTGCCCTGTAGA-3′ 
C302S_for        5’-GTCATCATGGAAGGCAGCACCCACAGACCTC-3’ 
C302S_rev        5’-GAGGTCTGTGGGTGCTGCCTTCCATGATGAC-3’ 
C353S_for        5’-CTTATCATCCACAGCGGTGGATGTATTCTG-3’ 
C353S_rev        5’-CAGAATACATCCACCGCTGTGGATGATAAG-3’ 
C353S_C356S_for        5’-CCACAGCGGTGGAAGTATTCTGAACCGTTC-3’ 
C353S_C356S_rev 
S35C_for  
S35C_rev 
S38C_for  
S38C_rev                      
       5’-GAACGGTTCAGAATACTTCCACCGCTGTGG-3’ 
       5'-GTTGGTCAGAACGTGTGCATCGTGAGCGATTAT-3' 
       5'-ATAATCGCTCACGATGCACACGTTCTGACCAAC-3' 
      5'-TGTCCATCGTGTGCGATTATGCGGGAA-3' 
      5'-TTCCCGCATAATCGCACACGATGGACA-3' 
T44C_for       5’-AGCGATTATGCGGGAACATGCACCGATCCCGTCTACAA-3’ 
T44C_rev       5'-TTGTAGACGGGATCGGTGCATGTTCCCGCATAATCGCT-3' 
V71C_for                       5'-CCTGGACTCGACGACTGTGGAGAACTTGGAAGA-3' 
V71C_rev                       5'-TCTTCCAAGTTCTCCACAGTCGTCGAGTCCAGG-3' 
R88C-C91S_for             5′-GGCAAGGTGCGTGTTCTACTGCGCAGATTGTGGAATTCTCG-3′ 
R88C-C91S_rev       5′-CGAGAATTCCACAATCTGCGCAGTAGAACACGCACCTTGCC-3′ 
A89C-C91S_for            5'-GGAGGGTGTTCTACAGGTGCGATTCTGGAATTCTC-3' 
A89C-C91S_rev            5'-GAGAATTCCAGAATCGCACCTGTAGAACACCCTCC-3' 
T164C_for                      5’-GATTCGACGATATCGGGAAGTGCATCTCCGAAATTCTTCCGGG-3’ 
T164C_rev                     5’-CCCGGAAGAATTTCGGAGATGCACTTCCCGATATCGTCGAATC-3’ 
I175C_for                  5’-CCGGGTGATGAAGAGTGTCCTTACCTCGGTGATC-3’ 
I175C_rev                      5’-GATCACCGAGGTAAGGACACTCTTCATCACCCGG-3’ 
 11 
V261C_for                     5'-TGATGTCCCGGAAGACTGCGAACTCACCACCTTTT-3' 
 
 
 
 
 
 
 
 
 
Primer name Primer sequence 
V261C_rev        5'-AAAAGGTGGTGAGTTCGCAGTCTTCCGGGACATCA-3' 
D340C_for        5'-CCGGAAAAGATTTTCCTTGTCTTGAGGAAATAGAAAACGC-3' 
D340C_rev        5'-GCGTTTTCTATTTCCTCAAGACAAGGAAAATCTTTTCCGG-3' 
L341C_for        5'-CCGGAAAAGATTTTCCTGATTGTGAGGAAATAGAAAACGC-3' 
L341C_rev        5'-GCGTTTTCTATTTCCTCACAATCAGGAAAATCTTTTCCGG-3' 
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trans-activator of transcription from HIV-1. 
 
Abstract 
Friedreich͛s Ataxia is a disease caused by a decrease in the levels of expression or 
loss of functionality of the mitochondrial protein frataxin (FXN). The development of an 
active and stable recombinant variant of FXN is important for protein replacement therapy. 
Although valuable data about the mature form FXN81-210 has been collected, not enough 
information is available about the conformation of frataxin precursor (FXN1-210). We 
investigated the conformation, stability and function of a recombinant precursor variant 
(His6-TAT-FXN1-210), which includes a TAT peptide in the N-terminal region to assist with 
transport across cell membranes. His6-TAT-FXN1-210 was expressed in E. coli and conditions 
were found for purifying folded protein free of aggregation, oxidation or degradation, even 
after freezing and thawing. The protein was found to be stable and monomeric, with the N-
terminal stretch (residues 1-89) mostly unstructured and the C-terminal domain properly 
folded. The experimental data suggest a complex picture for the folding process of full-
length frataxin in vitro: the presence of the N-terminal region increased the tendency of FXN 
to aggregate at high temperatures but this could be avoided by the addition of low 
concentrations of GdmCl. The purified precursor was translocated through cell membranes. 
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In addition, immune response against His6-TAT-FXN1-210 was measured, suggesting that 
the C-terminal fragment was not immunogenic at the assayed protein concentrations. 
Finally, the recognition of recombinant FXN by cellular proteins was studied to evaluate its 
functionality. In this regard, cysteine desulfurase NFS1/ISD11/ISCU was activated in vitro by 
His6-TAT-FXN1-210. Moreover, the results showed that His6-TAT-FXN1-210 can be 
ubiquitinated in vitro by the recently identified frataxin E3 ligase RNF126, in a similar way as 
the FXN1-210, suggesting that the His6-TAT extension does not interfere with the 
ubiquitination machinery. 
 
Introduction  
Friedreich͛s Ataxia (FRDA) is a disease caused in 95% of the cases by a decrease in 
the levels of expression of frataxin (FXN) because of a GAA-repeat expansion present within 
the first intron of both fxn alleles [1]. In the remaining 5% of the FRDA patients, the loss of 
FXN functionality is caused by a combination of the typical expansion present in only one 
allele and a mutation in the other [2]. The outcome of the lack of FXN functionality is an 
inefficient iron-sulfur cluster assembly, with widespread enzymatic deficit and oxidative 
damage catalysed by an excess of labile iron [3, 4]. 
In humans, FXN is translated in the cytoplasm as a precursor of 210 residues (FXN1-
210). Then, this protein is imported into the mitochondrial matrix and processed in a two-
step process [5, 6]. The first step yields the intermediate form (FXN42-210), whereby the 
signal peptide for mitochondria import is excised. The second step of proteolysis results in 
the mature form (FXN81-210). This form is functional as an activator of the 
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NFS1/ISD11/ISCU desulfurase protein complex, which is involved in the mitochondrial iron-
sulfur cluster assembly [7], whereas several FXN mutants exhibited compromised activation 
[7-9]. In addition, FXN was first described as an iron chaperone given its iron binding activity 
and it is related to redox balance inside the organelle [10, 11]. 
Significant efforts are being done by the scientific community to increase the 
concentration of active FXN inside mitochondria. One outstanding strategy involves the 
production of recombinant variants of FXN that have the capability of crossing the cell 
membrane and being imported into the mitochondrial matrix, thus yielding an active and 
stable form of the protein. Recently, to achieve this objective, a TAT-derived peptide (TAT 
stands for trans-activator of transcription from HIV-1) was fused with FXN precursor [12-15]. 
TAT was one of the first cell-penetrating proteins (CPPs) to be discovered. [16]. Like other 
CPPs, HIV-TAT (herein, just TAT) behaves as a transduction motif allowing cell penetration 
by crossing the cytoplasmic membrane. The amino acid sequence of TAT peptide is 
RKKRRQRRR. This peptide carries eight positive charges that are important for an efficient 
translocation. TAT peptide promotes the cellular uptake of coupled peptides and proteins, 
as well as oligonucleotides, siRNAs, nanoparticles and cell-impermeable drug molecules 
[17]. 
Even though the precise mechanism of the TAT-mediated translocation is unknown, 
some aspects of the process have been characterised over the last years. The TAT sequence 
is very rich in arginine and lysine residues, giving a non-amphipathic short moiety with a 
high positive charge, which favourably interacts with the phosphate groups on both sides of 
the cell membrane [18]. Most likely, the mechanism of TAT translocation involves lipid 
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perturbation and local membrane thinning with a pore formation [19]. However, there are 
still some controversies about the TAT internalisation pathway. 
For an eventual TAT-FXN-based therapy, protein conformation is one of the most 
important issues; but in the case of FXN, there is not enough information about the 
conformation of the precursor FXN1-210. Nonetheless, there have been some reports 
concerning this issue, where it was described that the intermediate form (FXN42-210) and 
variant FXN56-210 exhibit a tendency to form soluble oligomers, or even, to aggregate in an 
irreversible fashion, yielding insoluble protein [20, 21]. Furthermore, it has been observed 
that the N-terminal stretch of these variants is most likely unfolded or at least disordered 
[22, 23]. Moreover, the N-terminal of FXN56-210 is directly involved in the oligomerisation 
process [24]. Thus, it is not obvious that the precursor will be well-folded under in vitro 
conditions. 
In this paper, we investigated the conformation and stability of a recombinant 
precursor variant (His6-TAT-FXN1-210) that included a TAT peptide in the N-terminal region. 
This allowed protein translocation across the cytoplasmic membrane. In addition, a histidine 
tag was incorporated for easy purification. Given that the protein exhibited a certain 
tendency to aggregate during freeze and thaw, we optimised buffer conditions to preserve 
the protein in a monomeric and active folded state. 
Results 
FXN Precursor Purification, Optimisation of Buffer Conditions and Conformational Analysis 
The His6-TAT-FXN1-210 variant was produced in E. coli and expression conditions 
were optimised to purify the precursor variant from the soluble fraction. Even though the 
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protein was produced using codon plus ROSETTA2pLysDE3 BL21(DE3) cells, the level of 
protein expression was substantially lower than the level observed for the mature form 
FXN90-210 (data not shown). In addition, a significant fraction of protein was found in the 
insoluble fraction. Degradation of the full-length FXN into a shorter species was observed 
consistently when cells were disrupted by sonication. By contrast, when bacteria were 
disrupted by French Press, the species of lower molecular weight was not observed. The 
latter strategy, therefore, was usually adopted, while purification was performed 
immediately after cell lysis.     
Aggregation of the purified protein was observed during freeze and thaw, or even 
when the protein was maintained at 4 C for two days. After testing various buffer 
conditions, we found buffer 20 mM Tris-HCl pH 7.5, 300 mM NaCl, 1mM EDTA, 1mM DTT, 
15% glycerol to be appropriate as this amount of glycerol was enough to preserve the 
protein in a soluble, non-aggregated form at 4° C and even after freezing and thawing. 
It is worthy of note that the presence of EDTA and DTT was critical for inhibiting the 
oxidation and degradation of the protein in the early stages of the purification process. The 
FXN precursor has two cysteine residues in the N-terminal stretch (Cys 37 and Cys 50, 
GenBank: AAH48097.1) that might confer propensity to oxidation by forming intra and inter 
disulfide bonds. In fact, after long incubation times in the absence of DTT, no thiols were 
detected (data not shown); this result suggests oxidation. On the other hand, it is well 
known that FXN binds iron and that the precursor may undergo autoproteolysis mediated 
by the metal ion, yielding the shorter form FXN78-210, as detected by SDS-PAGE and ESI-MS 
[25].  
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His6-TAT-FXN1-210 was mainly monomeric, as inferred from MALS-SEC-FPLC 
experiments (Figure 1), and the molecular weight matched with the theoretical one (dashed 
line), even though species of higher molecular weight were also observed in the SEC profile 
(at an elution volume of 13-13.5 mL). In addition, mass spectrometry (the experimental and 
theoretical masses were 25773.6 and 25768.2 Da, respectively) and SDS-PAGE analysis 
(inset, Figure 1) indicated that the primary sequence corresponded to the one expected for 
His6-TAT-FXN1-210. Therefore, no proteolytic cuts occurred during purification or during 
the experiment. 
To determine the conformational properties of the recombinant precursor, we 
studied this protein by circular dichroism (CD) and fluorescence spectroscopy (Figure 2). Far-
UV CD spectra were acquired (Figure 2A). Results showed that His6-TAT-FXN1-210 has a 
secondary structure content compatible with an / protein. When molar ellipticity was 
calculated assuming it to be full length, the CD signal was substantially lower than the one 
observed for the mature form of FXN; however, when ellipticity was calculated considering 
only the number of residues of the C-terminal domain (90-210), spectra of both proteins 
superimposed very well, indicating that the N-terminal region does not significantly 
contribute to the spectrum of the former and that the N-terminal residues 1-89 are more 
likely unstructured. Analyses of near-UV CD spectra of the precursor form (Figure 2B) 
suggest that some changes in the local environment of aromatic residues may occur; yet the 
addition of 1.0 M GdmCl did not produce significant changes in spectra features (Figure S1), 
being the latter evidence of the integrity of the C-terminal domain of the protein in this 
condition. More important, results suggest the absence of chiral environments for the 
aromatic side-chains of the 1-89 stretch. In the same fashion, results suggest that some of 
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the tryptophan residues that contribute to the fluorescence spectra of variant His6-TAT-
FXN1-210 are considerably exposed to solvent (Figure 2C). This was inferred from the 
observed shift to the red in the value of MAX (335 nm and 340 nm for FXN90-210 and His6-
TAT-FXN1-210, respectively), and by comparison to tryptophan fluorescence spectra (352 
nm) and spectra corresponding to GdmCl-induced unfolded proteins (3 hours of incubation 
in 3.7 M GdmCl, 351-352 nm). These results are compatible with a substantial solvation of 
tryptophan residues located in the N-terminal region (Trp 2 and/or Trp 66) and a preserved 
C-terminal domain. 
On the other hand, the absence of ANS binding (Figure 2D) indicates that N-terminal 
residues 1 to 89 of His6-TAT-FXN1-210 do not present hydrophobic pockets accessible to 
this dye as is commonly observed in molten globules or partially folded conformations. 
 
Conformational Stability of FXN Precursor and its Aggregation Tendency 
Thermodynamic stability of the His6-TAT-FXN1-210 variant was researched by 
carrying out a GdmCl-induced equilibrium unfolding experiment followed by tryptophan 
fluorescence (Figure 3A). Although FXN90-210 exhibited a folding intermediate state (it can 
be inferred from folding/unfolding kinetic experiments), a two-state unfolding model can 
properly describe the equilibrium unfolding [26]. Results showed that the precursor was as 
stable as FXN90-210 and unfolding was cooperative (Table 1). The comparison between mNU 
values obtained for the studied variants suggests that the transition observed corresponds 
to the unfolding of the C-terminal domain of the precursor. This indicates that the N-
terminal domain is more likely unstructured at low denaturant concentrations. The fact that 
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the GdmCl-induced unfolding process was reversible (Figure S2) suggests that low 
denaturant concentrations can solubilise the N-terminal region, resulting in less strong intra- 
and inter-molecule interactions. The aggregation tendency of the precursor form was also 
investigated. The protein was incubated at different temperatures and the aggregation 
profile was compared with that of FXN90-210. Even though the former showed a higher 
tendency towards aggregation at higher temperatures than the latter, both proteins 
exhibited marked thermostability (Figure 3B) in these buffer conditions. 
It is worth mentioning that temperature-induced unfolding/aggregation followed by 
CD spectroscopy showed an apparent Tm= 60 C (Figure 3C), a value that is significantly 
lower than the one observed for FXN90-210 (Tm= 69.4 C). In addition, unfolding of the 
recombinant precursor was not reversible (after heating, only 20% of the CD signal at 222 
nm was recovered when the sample returned to 4 C, Figures 4 and S3), thus hampering 
thermodynamic characterisation of this protein and indicating that the N-terminal region 
affects foldability of the C-terminal domain at high temperatures, regarding the mature 
form of FXN that unfolds in a reversible fashion. Remarkably, the apparent Tm value for His6-
TAT-FXN1-210 was more likely affected by an increased propensity for aggregation (Figure 
3C). In fact, the absence of the CD signal in the last part of the His6-TAT-FXN1-210 
denaturation profile (80-90 C, Figure 3C) indicated that most of the protein aggregated 
during the heating of the sample. 
In agreement with the chemical unfolding experiment results, the addition of low 
concentrations of GdmCl (1.0 M) to the protein samples resulted in a completely reversible 
temperature-induced unfolding process of His6-TAT-FXN1-210 (Figures 4 and S3) showing 
that the effects of the N-terminal were minimised in these conditions. Moreover, the Tm 
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value that characterises the unfolding transition of the precursor was practically the same as 
the one observed for FXN 90-210 and the temperature-unfolding profiles of both variants 
perfectly superimposed. On the other hand, lower GdmCl concentrations (in the range 0.25-
0.50 M, Figures 4 and S3) only resulted in a partial recovery of the CD signal at 222nm after 
sample cooling, thus indicating that the N-terminal domain established intra- or inter-
molecular interactions favouring FXN aggregation at high temperatures. It is worthy of note 
that in these experiments the percentage of recovery depended on both the kinetic and 
thermodynamic aspects of aggregation and refolding, making it hard to interpret.  
 
To gain information on the structural dynamics of the variant, we studied the 
sensitivity to proteolysis of His6-TAT-FXN1-210 (Figure 5). After a short incubation with 
chymotrypsin (or trypsin, data not shown), the recombinant precursor was digested to a 
shorter form of ∼14.3 kDa, suggesting that the C-terminal domain (residues 81-210) was 
resistant, whereas the N-terminal was highly sensitive as in the case of FXN56-210 [24]. On 
the other hand, as previously shown, the control variant FXN 90-210 was completely 
resistant. 
 
The N-terminal region of FXN is predicted as a disordered stretch. 
 Given that experimental evidence firmly suggested that the N-terminal region is 
unstructured, we evaluated whether the complete N-terminal polypeptide segment 
(residues 1-89) was predicted as disordered by bioinformatics tools [27, 28]. As can be seen 
in Figure 6, where the sequence of His6-TAT-FXN1-210 was analysed, different predictors 
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[29-36] coincided in the fact that the N-terminal region may indeed be unstructured and 
similar results were obtained for the precursor FXN1-210 (without the His6-TAT N-terminal 
stretch, Figure S4). In addition, secondary structure predictions using JPred4 [37] suggested 
that only very short helical segments may be immersed in the N-terminal coil region of the 
human FXN. Our results are in good agreement with previous studies. On the one hand, the 
short N-terminal segment of the mature form of FXN comprising residues 81 and 89 
(recombinant variant FXN90-210 lacks this segment) was completely unstructured, as 
judged by secondary chemical shifts [23]; the recombinant protein FXN45-210 (similar to the 
intermediate form FXN41-210) was devoid of a periodic structure in the segment 41-81 [22]. 
In agreement with the latter, the N-terminal region of the form FXN41-210 (in this case, FXN 
was in the context of a multimeric protein assembly that included NFS) exhibited a non-
periodic structure, as judged by electron microscopy results [38]. In this case, only some 
short segments showed a helical conformation (residues 52-57 and 68-69, PDB ID: 
5KZ5). Remarkably, the unfolded nature of the N-terminal segment was previously related 
to its functionality as a substrate during proteolytic processing [22], in the transit to the 
mitochondrial matrix.  
 
Activation of NFS1/ISD11/ISCU Protein Complex in Vitro, Interaction with Cells and with 
the Immune System 
The activation of the NFS1/ISD11/ISCU protein complex by FXN is indeed one of the 
most relevant functions of FXN described to date. It can easily be followed by activation of 
desulfurase activity of the protein complex. Activation directly depends on the interaction of 
FXN with the protein complex and it is enhanced by the presence of Fe+2 [7, 39]. Therefore, 
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activation is an attractive probe for His6-TAT-FXN1-210 structural dynamics. His6-TAT-FXN1-
210 produces desulfurase activation in a similar fashion as variant FXN90-210. This fact 
suggests that, at least in the experimental conditions herein assayed, the N-terminal 
extension was not detrimental from a functional view point (Figure 7).  
We studied the translocation of the recombinant purified protein across the 
cytoplasmic membrane using mouse neuroblastoma cell line as a model. To achieve this, 
neuroblastoma B104 cells were cultured in the presence of FITC-labeled His6-TAT-FXN1-210 
for 4 to 5 hours at 37º C, a period of time considered to be enough for protein 
internalisation. Nuclei were stained with Hoescht dye and outer membrane fluorescence 
was quenched using trypan blue. Fluorescence microscopy results showed a significant 
intracellular fluorescence pattern suggesting that the precursor protein not only exhibited a 
correctly folded C-terminal domain, but also, that it was able to translocate across cell 
membranes (Figures 8 A-C). On the other hand, FITC-labeled FXN90-210 was not able to 
interact in an efficient fashion with the cell culture (Figure 8D).  
To gain more information on the localisation of the FITC-labeled recombinant variant 
inside the cell, we carried out confocal fluorescence microscopy (CFM) that allowed for an 
increase in resolution by blocking out-of-focus light in image construction. To infer whether 
the recombinant protein was guided to the mitochondria, cells were incubated with a 
MitoRed indicator reagent (Abcam), a cell-membrane-permeable rhodamine-based 
fluorophore whose interaction with the organelle depends on the membrane potential and, 
once inside the mitochondria, is covalently trapped.  
Results showed that FITC fluorescence was distributed in regions that superimposed 
with those regions revealed by MitoRed fluorescence, suggesting that the FITC-labeled 
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recombinant FXN variant reached mitochondria (Figures 8E-I). Remarkably, cell fixing 
slightly altered the distribution of the recombinant protein by comparison with the unfixed 
cells, which showed clear-cut results indicating an overlapping between FICT and MitoRed 
fluorescence (Figures 8J-N).  
As His6-TAT-FXN1-210 has been proposed as an exogenous construct to be used as a 
substitute for the physiological FXN (which is absent or decreased in FRDA patients), 
another important issue was whether His6-TAT-FXN1-210 was immunogenic, given that 
replacement therapies are applied for life, and considering that the TAT sequence is a viral-
derived peptide. To test this, we evaluated the specific antibody response after a single 
injection of the precursor, in two doses. Serum was extracted and titrated against FXN90-
210, FXN56-210 or His6-TAT-FXN1-210 (Figure 9) by ELISA. Only a mild antibody-mediated 
immune response was detected, and this response was mainly directed against the N-
terminal stretch, as suggested by the absence of reactivity detection when FXN90-210 was 
used in the test. On the other hand, similar responses were observed for FXN56-210 or His6-
TAT-FXN1-210. At this moment, we cannot rule out a specific, but weak, response against 
the TAT peptide or His tag, and more experiments should be conducted. However, results 
support the notion that the C-terminal fragment of the construction (residues 90-210) is not 
immunogenic. Regarding the immune response observed against the N-terminal of FXN56-
210, it is important to consider that this region of the protein concentrates most of the 
differences existing between mouse and human FXN sequences and this might be one of the 
reasons for its immunogenicity. It is worthy of mention that one of the main features of the 
N-terminal stretch 1-89 is the low conservation of this segment by comparison to the highly 
conserved FXN domain 90-210 (Figure S5 and S6). 
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Ubiquitination of His6-TAT-FXN1-210  
A significant portion of the FXN precursor undergoes ubiquitination, mediated by the 
recently identified E3 ligase RNF126, before reaching the mitochondria. This event leads to 
proteasomal degradation of the precursor, negatively affecting the amount of mature FXN 
generated [40]. To determine whether His6-TAT-FXN1-210 was susceptible to ubiquitination 
and degradation as the endogenous precursor, we tested the ability of the E3 ligase RNF126 
to ubiquitinate this FXN variant in vitro, using an established FXN ubiquitination assay [40]. 
As shown in Figure 10, when His6-TAT-FXN1-210 was incubated with the E1, the E2 and 
RNF126 as the E3 ligase, the anti-frataxin antibody detected slower migrating bands by 
Western blot, indicating that His6-TAT-FXN1-210 can be ubiqutinated as observed for FXN1-
210. Moreover, ubiquitination of His6-TAT-FXN1-210 was prevented by the addition of the 
Zn2+ chelating agent 1,10-phenanthroline, as described for FXN1-210 [40], suggesting that 
His6-TAT-FXN1-210 ubiquitination is dependent on RNF126 catalytic activity. These 
experimental data suggest that structural features, which are necessary for FXN recognition 
by RNF126, are preserved in the His6-TAT-FXN1-210 variant and, more important, the His6-
TAT extension does not interfere with the ubiquitination machinery. 
Discussion  
His6-TAT-FXN1-210 was expressed in E. coli and purified under native conditions. The 
protein principally behaved as a monomer with its C-terminal domain compact and 
structured. However, its N-terminal domain showed an extremely low conservation score 
compared to the C-terminal domain (Figure S4) and it was disordered and extremely 
sensitive to proteolysis. Even though His6-TAT-FXN1-210 had an increased propensity to 
aggregate by comparison with the mature form, conditions were set in which the protein 
A
cc
ep
te
d 
A
rt
ic
le
FEBS Open Bio (2018) © 2018 The Authors. Published by FEBS Press and John Wiley & 
Sons Ltd 
was stable at 4 C and the precursor remained soluble after freeze and thaw, and auto-
proteolysis was minimised. In addition, the incubation of the FXN precursor with low GdmCl 
concentration hampered N-terminal-mediated aggregation and promoted in vitro the 
reversible unfolding of the C-terminal domain. Although we inferred that the 
thermodynamic stability of the C-terminal domain of the precursor variant His6-TAT-FXN1-
210 was similar to that of the mature form, at this time we cannot rule out that the N-
terminal stretch has a role in folding kinetics. 
One of the most noticeable features of the FXN structure is the large anionic surface 
formed by the Glu and Asp residues located in the acidic ridge motif (helix 1, loop-1 and 
strand 1). Given that the N-terminal region formed by residues 1 to 89 exhibited a 
substantial number of positively charged residues, one simple explanation for the 
aggregation propensity was that electrostatic intra and intermolecular interactions between 
both regions were the driving force. The presence of disorder segments may make this 
interaction process more efficient by adding a certain conformational freedom, allowing for 
the exploration of a larger conformational space. Furthermore, as the cell-penetrating 
peptide TAT stretch was highly positive, we suggest that electrostatic interactions may 
become stronger in His6-TAT-FXN1-210 than in the wild-type FXN precursor. In this context, 
it was reasonable to conclude that the addition of 1.0 M GdmCl completely prevented these 
interactions, making the subsequent temperature unfolding process reversible, whereas 2.0 
M urea or 1.0 M NaCl were less efficient and aggregation occurred. Remarkably, the 
simultaneous addition of both urea and NaCl at these concentrations allowed for 100% of 
reversibility (Figure 4); on the one hand, this was indicative of the key role of electrostatics 
in the establishment of interactions that resulted in aggregation and, on the other hand, it 
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suggested the contribution of apolar contacts to protein-protein interaction. In this context, 
it will very important to carry out aggregation and refolding measurements varying pH to 
test the involvement of ionisable groups in the aggregation process of His6-TAT-FXN1-210. 
Evidence of intermolecular interaction in human FXN was provided by the FXN56-210 
variant, which exhibited a high aggregation propensity. In fact, it formed large soluble and 
stable oligomers at room temperature [24] and the unstructured N-terminal region 
mediated this interaction. When the N-terminal was removed by proteolysis the oligomer 
disassembled.  
FXN oligomers have been proposed as playing a role in vivo, and a low resolution 
(14.3 Å) cryoelectron microscopy structure of a high molecular weight multimolecular 
complex involving human NFS1/ISD11, ISCU and FXN (PDB ID: 5KZ5, the proteins responsible 
for the iron-sulfur cluster assembly) was recently published [38]. Trimers formed by FXN42-
210 subunits interacted through their N-terminal stretches. Short -helical regions (residues 
52-58) and a high content of non-periodic structure established several intermolecular 
contacts. It is worth noting that interaction was also mediated by contacts established by 
numerous residues located in the C-terminal domain, thus forming a large contact surface, 
which suggests a cooperative assembly. Interesting information concerning desulfurase 
activity of the NFS1/ISD11/ISCU/FXN42-210 protein complex was obtained showing that 
FXN42-210 was active [38]. 
The fact that His6-TAT-FXN1-210 was also functional as the activator of the 
desulfurase complex NFS1/ISD11/ISCU suggests that conformational features were 
preserved in this variant and that the N-terminal part of the protein did not produce steric 
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clashes (in the context of the multiprotein complex) that might have resulted in a significant 
loss of FXN functionality.  
It is also worth noting that His6-TAT-FXN1-210 was recognized and ubiquitinated by 
the recently identified frataxin E3 ligase, RNF126. These experimental data indicated that 
structural requirements for interaction between frataxin and E3 ligase were maintained in 
the His6-TAT-FXN1-210 variant. However, since it is known that ubiquitination leads to 
proteasomal degradation of FXN precursor and, in turn, results in a reduced amount of the 
mature FXN generated, a FXN variant that loses the ability to interact with RNF126 is 
expected to yield a more mature and functional FXN. With the aim of obtaining an efficient 
tool for protein delivery therapeutics, it may be possible to envision the generation of such 
aŶ ͚ubiquitin-resistant͛ FXN variant. 
Important studies of other groups have shown that TAT constructs have a key effect 
on the mitochondrial metabolism, suggesting that FXN locates inside the organelle and can 
restore mitochondrial function. In this way, Vyas et al. used TAT-FXN fusion protein to 
deliver human FXN to mitochondria both in cultured patient cells and in a severe mouse 
model of FRDA, increasing lifespan and cardiac function in the latter [13]. In addition, Britti 
et al. studied the effect of the TAT- FXN variants on the progression of neurodegeneration 
markers on frataxin-depleted neurons. Also, they investigated the ability of TAT-FXN to 
reach muscle mitochondria by restoring the enzymatic activity levels of the succinate 
dehydrogenase [41]. Furthermore, Kim et al. showed the capability of TAT-FXN to cross the 
blood-brain barrier that protects neurons against oxidative stress in mouse models [14]. 
Moreover, Marcus et al. studied several heterologous mitochondrial targeting sequences 
(MTS) for delivering FXN. They showed that the level of functional FXN in the mitochondria 
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is higher than the one observed when native MTS sequences are used, and the result was 
supported by the rescue of FRDA cells from oxidative stress and the observation of the 
increase in aconitase enzymatic activity and ATP levels, compatible with a restoration of 
mitochondrial function [42]. 
In this context, we hope that our results, which show that the purified His6-TAT-
FXN1-210 variant was thermodynamically stable and exhibited a well-folded C-terminal 
domain that was functional as a desulurase NFS1/ISD11 activator, will help to delineate the 
strategy for FXN precursor production and its conformational evaluation, an important 
aspect in protein replacement therapy. In this regard, the propensity for aggregation that is 
observed for the recombinant variant at high temperatures should be taken into account in 
future works.  
Materials and Methods 
Expression and Purification of the FXN Variants 
 Variants FXN90-210 and His6-TAT-FXN1-210 were expressed in Escherichia coli codon 
plus ROSETTA2pLysDE3 BL21(DE3) cells, and purified from the soluble fractions under native 
condition. Variant FXN90-210 was prepared as previously [26, 43]. On the other hand, 
variant His6-TAT-FXN1-210 ǁas purified to ≥ ϵϱ% ;ĐheĐked ďǇ SDS-PAGE). Briefly, His6-TAT-
FXN1-210 expression was induced with 1% lactose for 3 h, at 250 rpm and 37° C. Cells were 
harvested by centrifugation (at 6000 rpm for 15 min at 4° CͿ aŶd stored at −ϮϬ° C until use. 
Typically, 3 g of cells were disrupted by French Press in 20 mMTris–HCl buffer, 300 mM 
NaCl, 0.02% (V/V) Tween20 and 20 mM imidazole, at pH 7.5. Soluble and insoluble fractions 
were analysed by SDS-PAGE. His6-TAT-FXN1-210 was purified from the supernatant by Ni2+-
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NTA-agarose chromatography using steps of 20, 50, 100, 200 and 500 mM imidazole for the 
elution. Most of the recombinant protein typically elutes with 500 mM imidazole. After that, 
His6-TAT-FXN1-210 was extensively dialysed against 20 mM Tris-HCl, 300 mM NaCl, 1 mM 
EDTA,1 mM DTT, at pH 7.5 to remove imidazole. Before freezing, 15% glycerol was added to 
the protein. To confirm the expected masses of the proteins, ESI-MS (Thermo Finnigan) was 
performed. In addition, when DTT was removed using a PD10 column, two thiols per protein 
molecule were detected by reaction with 5,5'-dithiobis-(2-nitrobenzoic acid), indicating the 
absence of intra or intermolecular disulfide bonds interactions.  
 
Size Exclusion Chromatography and Light-Scattering Measurements 
 Mass determination were performed by multiple-angle laser light-scattering (MALLS) 
using miniDawn (Wyatt Technology) coupled to a size-exclusion Superose-12 column (GE 
Healthcare). Protein concentration was 10 μM and the elution buffer was 20 mM Tris-HCl, 
600 mM NaCl, 1 mM EDTA, 15% glycerol, at pH 7.5. It is worthy of mention that a 
concentration of 600 mM NaCl prevented the interaction of the protein with the 
chromatographic media. The experiments were carried out at room temperature (~25° C) at 
a 0.2-04 mL/min flow rate. Data analysis was performed using the Astra 6.0 software (Wyatt 
Technology). 
 
Spectroscopic Characterisation of the FXN Variants 
Circular dichroism (CD) measurements were carried out with a Jasco J-810 
spectropolarimeter. Near-UV and far-UV CD spectra were collected using cells of 1.0 and 0.1 
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cm path-length, respectively. Data were acquired at a scan speed of 20 nm min-1 and at least 
ten scans were averaged. For near-UV CD spectroscopy, protein concentration was 10 M. 
Steady-state intrinsic fluorescence measurements were performed in a Jasco FP-6500 
spectrofluorometer operating in the ratio mode. A 1.0 cm path-length cell was used. 
Intrinsic fluorescence of proteins was measured using a protein concentration of 2 M; 
excitation wavelength was 295 nm and emission data were collected in the range of 305-
450 nm. The spectral slit-widths were set to 3 nm for both monochromators. Experiments 
were performed using a thermostated cell holder connected to a circulating water bath set 
at 20° C. Buffer was 20 mM Tris-HCl, 300 mM NaCl, 1mM EDTA,1 mM DTT, 15% glycerol, at 
pH 7.5. 
For ANS-binding experiments, proteiŶs ;ϱ μMͿ iŶ buffer 20 mM Tris-HCl, 300 mM NaCl, 
1mM EDTA,1 mM DTT, 15% glycerol, at pH 7.5 were incubated at room temperature (10 
ŵiŶͿ, ǁith ϱϬ μM of ANS ;ϴ-anilino-1-naphthalene sulfonic acid). Control samples consisting 
of ANS ;ϱϬ μMͿ iŶ ďuffer solutioŶ were prepared. As a positive control, ϱ μM BSA was also 
incubated with the dye in the same conditions. The excitation wavelength was 350 nm and 
the emission spectra were collected between 400 and 600 nm. The bandwidth used was 3.0 
nm for both excitation and emission. To estimate the concentration of the dye, the 
extinction coefficient M= 4,950 M−1 cm−1 at 350 nm was used.  
Equilibrium Unfolding Experiments 
Unfolding experiments (isothermal) were carried out incubating protein variants for 3 
hours at room temperature with 0 to 4.0 M GdmCl in a buffer 20 mM Tris-HCl, 300 mM 
NaCl, 1mM EDTA, 1mM DTT, 15% glycerol, at pH 7.5. Measurements were done at 20° C. 
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The unfolding process was followed by tryptophan fluorescence. To determine 
thermodynamic parameters, the free energy of unfolding and its dependence with 
denaturant concentration (GNU and mNU, respectively), we fitted a two-state unfolding 
model to the data, where only native (N) and unfolded (U) conformations existed in 
equilibrium (UN). Data were processed according to Santoro and Bolen [44]. All GdmCl 
concentrations were corroborated using a refractometer. Unfolding transitions as a function 
of temperature were monitored by the circular dichroism signal at 222 nm using a 
bandwidth of 2 nm. Experiments were carried out in 20 mM sodium phosphate, 100 mM 
NaCl at pH 7.5. Protein concentration was 1.5 μM. Teŵperature ǁas ǀaried froŵ 4 to 90° C, 
at a constant rate of 1° C min-1, sampling at 1° C intervals and a 1.0 cm cell path length was 
used.  
Determination of Cysteine Desulfurase Activity 
The enzymatic desulfurilation of cysteine to alanine and sulfide by NFS1/ISD11 complex 
was determined by the methylene blue method [45]. Reactions were carried out in a volume 
of Ϭ.ϰ ŵL, ĐoŶtaiŶiŶg ϭ μM of NFSϭ/ISDϭϭ, ϯ μM FXN aŶd ϯ μM ISCU. Saŵples were 
supplemented ǁith ϭϬ μM PLP, Ϯ ŵM DTT aŶd ϭ µM Fe+2 (final concentrations) and the 
reaction buffer was 50 mM Tris-HCl, 200 mM NaCl, 10% glycerol, at pH 8.0. The buffer was 
degassed using argon. The reaction was started by the addition of 1mM cysteine and 
samples were incubated at room temperature for 30-minute. Sulfide production was 
stopped ďǇ the additioŶ of ϱϬ μL of ϮϬ ŵM N,N-dimethyl p-phenylenediamine in 7.2 N HCl 
aŶd ϱϬ μL of ϯϬ ŵM FeCl3 were prepared in 1.2 N HCl. Under these conditions, methylene 
blue production took 20 minutes. After that, the samples were centrifuged for 5 minutes at 
12000g and supernatant was separated. Absorbance at 670 nm was measured.  
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FITC-Labeling His6-TAT-FXN1-210, Cell Culture and Protein Internalisation 
For FICT-labeling, His6-TAT-FXN1-210 or FXN90-210 proteins were incubated in the 
presence of FITC for 2 hours at 24 C in buffer 20 mM HEPES 300 mM NaCl, 1 mM EDTA, at 
pH 8.0. Protein and FITC concentrations were 0.38 and 0.038 g L-1, respectively. Reactions 
were stopped by the addition of 100 mM Tris-HCl (final concentration), at pH 7.6. After 
reaction, the free FITC was removed from protein solution by an extensive over-night 
dialysis at 4 C against a buffer of 20 mM Tris-HCl 300 mM NaCl, 1 mM EDTA, at pH 7.6. 
Proteins were centrifuged for 20 min at maximum speed using a refrigerated (4 C) 
Eppendorf centrifuge and maintained at 4 C until use.  
B104 cells (ATCC CRL 1887) were cultured in RPMI 1640, in the presence of 10% FBS, 
penicillin-streptamycin (10 U ml-1 each), glutamine (2 mM), up to a 50% of confluence, in 
sterile round cover slides in a 24-well culture microplate. FITC-labeled His6-TAT-FXN1-210 
was added to fresh culture medium at a concentration 20 g mL-1, and cells were incubated 
at 37º C and controlled pCO2 for 4 hours. The cover slides were then washed, fixed with ice-
cold methanol during 5 minutes, washed again and stained with Hoescht (10 g mL-1 during 
2 minutes). Cover slides were extensively washed, dried and mounted using mowiol. Finally, 
cells were observed by fluorescence microscope (Olympus BX50). Subcellular localisation 
was investigated by confocal fluorescence microscopy (CFM). Mitochondria were identified 
using a MitoRed indicator reagent (Abcam). Given that it was previously suggested that cell-
fixing processes can alter the distribution of proteins that include a TAT sequence (in 
particular, it was observed that part of TAT-including proteins seemed to appear in the 
nuclei, [46]), two different strategies were followed:  
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(i) Cells were incubated with His6-TAT-FXN1-210. After gentle washing, cells were 
incubated first with MitoRed (150 L, 0.1) for 30 min. After new washings, cells 
were incubated with Hoescht dye (20 L, 10 g mL-1) for 5 min.  Finally, cells were 
carefully washed and subsequently fixed (4% paraformaldehyde, 10 min) and 
mounted using mowiol;  
(ii) On the other hand, cells were grown in a 96-multiwell plate suitable for 
fluorescence microscopy, incubated in the same way, first with the FITC-labeled 
recombinant protein and then with fluorescent dyes; but in this latter case, cells 
were not fixed and MitoRed concentration was lower (0.015).  
 In all cases, cells were observed using a confocal microscope FV1000 instrument 
(Olympus) and a 60  immersion oil objective. In addition, a digital zoom (4 and 3, for 
fixed and not-fixed cells, respectively) was applied.  
 
Ethics Statement 
The use of laboratory animals in this study was in accordance with the relevant guidelines 
and institutional policies, and the protocol was approved by the Animal Care and Use 
Committee at the School of Pharmacy and Biochemistry of the University of Buenos Aires 
(Argentina). All efforts were made to minimise the animal distress. 
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Immune Response Measurements against TAT-His6-FXN1-210 
C57 male mice ranging from 8 to 12 weeks were used. The animals were kept in an 
environment with a constant temperature of 22° C and 12-h light–dark cycle (08:00–20:00), 
with food and water ad libitum. Mice were primed with His6-TAT-FXN1-210 at a low dose 
(0.05 nmol) or high dose (0.25 nmol), according to previous experiences with other proteins. 
Proteins were intraperitoneal injected in sterile PBS at a final volume of 200 l. Two control 
groups were included: one without protein and another one with adjuvant (0.04 g mL-1 of 
aluminum hydroxide and 0.04 g mL-1 of magnesium hydroxide). Animals were bled on days 
15, 30 and 45, and specific antibodies to His6-TAT-FXN1-210, FXN90-210 and FXN56-210 
were tested by ELISA. Briefly, microplates were coated with the corresponding antigen, 
blocked with non-fat milk (0.03 g mL-1 prepared in PBS) and then washed to remove non-
bound proteins. Sera were titrated in twofold dilutions starting at 1/100, and specific 
antibodies were detected using anti-mouse HRP labeled antibodies (Sigma Aldrich) at a final 
dilution of 1/5000. Peroxidase activity was detected using TMB substrate solution and the 
reaction was stopped with 4 N H2SO4. Absorbance was measured at 450 nm using a Tecan 
reader. 
In Vitro Ubiquitination Assay 
The in vitro ubiquitination assay was performed in a reaction mixture containing 100 nM 
of bacterially purified human recombinant His-tagged E1, 1.4 mM of a human recombinant 
untagged E2 UbcH5b and 200 nM of human purified recombinant glutathione S-transferase 
(GST)-RNF126 (E3) in a ubiquitination buffer as described by Benini and coworkers [40]. The 
human recombinant FXN1-210 protein expressed in E. coli was purchased from GenScript. 
Recombinant ubiquitin was purchased from Enzo Life Sciences. Human recombinant GST-
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RNF126 protein, purified using an in vitro wheat germ expression system, was purchased 
from Abnova. 1,10- Phenanthroline monohydrochloride monohydrate (1,10-
phenanthroline) was purchased from Sigma-Aldrich and, where indicated, was preincubated 
with RNF126 for 5 min before starting the assay. After incubation for 60 min at 30° C, the 
reactions were terminated by adding 4  Laemmli sample buffer, loaded on a 10% Mini-
Protean TGX Stain-Free Gel (Bio-Rad) and followed by Western blotting with a monoclonal 
anti-frataxin antibody (clone 18A5DB1, Abcam). 
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Figure Captions 
Figure 1. Hydrodynamic Behaviour of His6-TAT-FXN1-210. Protein (14 M) was run in a 
buffer of 20 mM Tris-HCl, 600 mM NaCl, 1mM EDTA, 1mM DTT, 10% glycerol, at pH 7.5 in a 
MALS-SEC-FPLC system, followed by absorbance at 280 nm. The dashed line indicates the 
theoretical molecular weight corresponding to the full-length His6-TAT-FXN1-210 variant. 
The inset shows the result of a SDS-PAGE stained with coomassie blue analysis. Molecular 
weight markers (M) are: BSA (66 kDa), HPRT (25 kDa) and FXN90-210 (13.5 kDa).  
 
Figure 2. Spectroscopic Analysis of His6-TAT-FXN1-210. (A) Far- and (B) Near-UV CD 
spectra. Spectra corresponding to the precursor and FXN90-210 are shown in black and 
blue, respectively. In addition, the spectra of the precursor calculated considering the length 
of the C-terminal domain (90-210) is included (orange); (C) Tryptophan fluorescence spectra 
were acquired for the precursor and FXN90-210 (black and blue, respectively), excitation 
was performed at 295 nm, and slits correspond to 4 nm. U (unfolded conditions) and N 
(native conditions) indicates the presence or absence of 5.0 M GdmCl, respectively; (D) ANS 
binding was evaluated for the precursor (black) and FXN90-210 (blue). As references, we 
evaluated binding of ANS to bovine serum albumin (BSA, in cyan) and variant FXN56-210 in 
two conformations, monomer and multimer, in green and red respectively; the buffer was 
20 mM Tris-HCl, 300 mM NaCl,1mM EDTA,1mM DTT, 15 % glycerol, at pH 7.5. All the 
experiments were carried out at 20 C. 
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Figure 3. Unfolding and Stability of FXN Variants. (A) Protein unfolding was followed by 
tryptophan fluorescence intensity at 310 nm. Excitation was performed at 295 nm. After 
GdmCl addition, proteins were incubated for three hours to guarantee equilibrium 
conditions. Native and unfolded fractions and mNU and GNU were calculated by fitting a 
two-state model to the data. The buffer was 20 mM Tris-HCl, 300 mM NaCl,1mM 
EDTA,1mM DTT, 15 % glycerol, at pH 7.5. (B) Aggregation tendency upon controlled heating. 
The fraction of soluble protein was quantified by SDS-PAGE and coomassie blue staining. 
Temperature unfolding/aggregation followed by CD at 222 nm in the absence (C) or in the 
presence (D) of 1.0M GdmCl.  
In temperature-unfolding experiments, the buffer was 20 mM sodium phosphate, 100 mM 
NaCl, 0.1 mM EDTA, 0.1 mM DTT, 15 % glycerol, at pH 7.5. CD signals obtained after 
temperature denaturation and a return to the initial temperature are shown in red and gray 
for FXN90-210 and His6-TAT-FXN1-210, respectively. 
 
Figure 4. Reversibility of the Temperature-Induced Unfolding of the Precursor as a 
Function of GdmCl Concentration. The recovery of the CD signal at 222 nm after returning 
to the initial temperature is quantified as the percentage of the starting CD signal, measured 
at 4 C before starting the temperature ramp (left). The CD signal recovery under urea (2.0 
M), NaCl (1.0 M) or the simultaneous addition of both at these concentrations is shown 
(right). The buffer was 20 mM sodium phosphate, 100 mM NaCl, 0.1 mM EDTA, 0.1 mM 
DTT, 15 % glycerol, at pH 7.5. In the left panel, GdmCl was added to the indicated final 
concentrations, whereas in the right panel the same buffer was used, but instead of GdmCl, 
it was supplemented with urea 2.0 M and/or NaCl to 1.0 M final concentration.  
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Figure 5. Sensitivity to Chymotrypsin of His6-TAT-FXN1-210. Variant FXN90-210 was 
included as a control. Incubation time (minutes) was indicated and the buffer was 20 mM 
Tris-HCl, 300 mM NaCl,1mM EDTA,1mM DTT, 15 % glycerol, at pH 7.5. For this experiment, a 
1:100 protease to protein mass ratio was used. 
 
Figure 6. Predictions of Disorder in the N-terminal Segment of His6-TAT-FXN1-210 
Precursor. Disorder predictions were carried out using a number of programmes: DiSOclust 
(red, [36]), Disopred3 (orange, [30]), Espritz (magenta, [31]), MFDp2 (blue, [34]), IUPRED 
(green, [35]), PrDOS (cyan,[33])  and DisCOP (dark-gray, [29]) Disorder probability is plotted 
and the dotted line shows the 0.5 threshold. In the lower panel, the prediction of secondary 
structure (Jpred4 [37]) content is plotted side by side with the secondary structure content 
obtained from the X-ray structure (PDB ID: 1EKG, [47]). The black arrow indicates the 
starting residue of the mature form of FXN (FXN81-210). Numbering corresponds to that of 
the precursor of FXN, for this reason His6-TAT-FXN1-210 starts at residue -19. 
 
Figure 7. Activation of NFS1/ISD11/ISCU by His6-TAT-FXN1-210. The reaction comprises 
the use of cysteine as a substrate, whereas in the presence of DTT the products are alanine 
and hydrogen sulfide. The detection of sulfide was carried out by the methylene blue 
method. The reaction was carried out in the presence of a combination of mouse 
NFS1/ISD11 (purified from E. coli) and human ISCU (purified from E. coli), and His6-TAT-
FXN1-210 or FXN90-210 as a control. The specific combination is indicated using symbols + 
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and – (presence and absence, respectively) and 10% of glycerol was added to the reaction 
buffer.  
 
Figure 8. FICT-Labeled His6-TAT-FXN1-210 Interaction with Cells. The translocation of the 
FXN precursor across the cytoplasmic membrane using B104 cells was evaluated by 
fluorescence microscopy. 20 g/mL of FICT-labeled His6-TAT-FXN1-210 (A, B and C) or FICT-
labeled FXN90-210 (D) were added to the fresh culture medium and, after a 4 hour-
incubation, cover slides were washed, fixed and stained with Hoescht. Subcellular 
localisation of the FICT-Labeled His6-TAT-FXN1-210 was investigated by CFM in fixed B104 
cells in 4% paraformaldehyde, 10 min (E-I) and non-fixed B104 cells (J-S). Panels show 
Hoescht (E, J and O), FITC (F, K and P) or MitoRed (G, L and Q) fluorescence and merge of 
the three snapshots (H, M and R). Cell structure was inferred applying differential 
interference contrast (DIC, I, N and S). A 60  immersion oil objective was used. Panels J-N 
and O-S correspond to two different fields. A digital zoom (4 for fixed and not-fixed cells) 
was applied. 
 
Figure 9. Immune Response against His6-TAT-FXN1-210. (A) Mice were primed with His6-
TAT-FXN1-210 at a low dose (LowD, 0.05 nmol) or high dose (HighD, 0.25 nmol), and sera 
were titrated for the detection of specific antibodies anti His6-TAT-FXN1-210. Two control 
groups were included: one without protein and another one with an adjuvant. (B) Specific 
antibodies to His6-TAT-FXN1-210, FXN90-210 and FXN56-210 were tested by ELISA.  
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Figure 10. Ubiquitination of His6-TAT-FXN1-210. An in vitro ubiquitination assay was carried 
out with purified recombinant human E1, UbcH5b as the E2 ubiquitin-conjugating enzyme, 
and GST- RNF126 as the E3 ubiquitin ligase, together with Ub, ATP, and recombinant human 
His6-TAT-FXN1-210 or FXN1-210 as a substrate. Where indicated, 10 mM 1,10-
phenanthroline, the Zn chelating agent, was added to the reaction. The reaction mixture 
was incubated for 60 min at 30º C. Reaction was stopped by the addition of a Laemli sample 
buffer. Proteins were separated on SDS-PAGE and analysed by Western blotting with an 
anti-frataxin antibody. The FXN precursor, monoubiquitinated FXN, and polyubiquitinated 
FXN are indicated by arrows.  
 
Supplementary Material 
Figure S1. Effect of 1.0M GdmCl Concentration on the Tertiary Structure of the C-Terminal 
Domain of His6-TAT-FXN1-210. CD spectra in the near-UV was acquired at 25 C in the 
absence (black) and in the presence (orange) of 1.0M GdmCl. The buffer was 20 mM sodium 
phosphate, 100 mM NaCl, 0.1 mM EDTA, 0.1 mM DTT, 15 % glycerol, at pH 7.5.  
 
Figure S2. Reversibility of the GdmCl-Induced Unfolding of the Precursor Followed by 
Tryptophan Fluorescence. Spectra corresponding to His6-TAT-FXN1-210 in the presence (- - 
) or in the absence () of GdmCl and spectra corresponding to a protein sample 
refolded by an over-night dialysis (------) are shown. The buffer was 20 mM sodium 
phosphate, 100 mM NaCl, 0.1 mM EDTA, 0.1 mM DTT, 15 % glycerol, at pH 7.5. Excitation 
was performed at 295 nm, and slits of 4 nm were used for both excitation and emission.  
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Figure S3. Reversibility of Temperature-Induced Unfolding of the Precursor as a Function 
of GdmCl Concentration. Denaturation profile (black) followed by a CD signal at 222 nm and 
the recovered CD signal (gray) after returning to the initial temperature (5 min) and 
starting the ramp again are shown. The buffer was 20 mM sodium phosphate, 100 mM 
NaCl, 0.1 mM EDTA, 0.1 mM DTT, 15% glycerol, at pH 7.5. Concentrations of 0, 0.125, 0.25, 
0.5 and 1.0 M GdmCl were added in A, B, C, D and E, respectively. 
 
Figure S4. Predictions of Disorder in the N-terminal Segment of FXN1-210 Precursor. 
Disorder predictions were carried out using a number of programmes: DiSOclust (red, [36]), 
Disopred3 (orange, [30]), Espritz (magenta, [31]), MFDp2 (blue, [34]), IUPRED (green, [35]), 
PrDOS (cyan,[33])  and DisCOP (dark-gray, [29]). Disorder probability is plotted and the 
dotted line shows the 0.5 threshold. In the lower panel, two different predictions of 
secondary structure (Jpred4 [37]) content are plotted side by side with the secondary 
structure content obtained from the X-ray structure (PDB ID: 1EKG, [47]). The black arrow 
indicates the starting residue of the mature form of FXN (FXN81-210). Numbering 
corresponds to that of the precursor of FXN, for this reason His6-TAT-FXN1-210 starts at 
residue -19. 
 
Figure S5. The N-terminal of FXN1-210 is not conserved along the evolution. LOGO 
corresponding to full-length human FXN (for clarity, only the 100 first residues are shown) 
was prepared using 50 sequences of >70% identity and >99% query covering. LOGO was 
created using Weblogo. 
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Figure S6. The N-terminal of FXN1-210 is not conserved. Sequences corresponding to the 
human (GenBank: AAH23633.1, up) and mouse (GenBank: AAB67778.1, down) FXN 
precursor are compared.  
 
Table 1. GdmCl-induced unfolding of FXN variants.1 
Variant ΔG° NU H2O (kcal mol-
1
) 
m NU (kcal mol
-1
 M
-1
) Cm (M) 
FXN 90-210 10.0 ± 0.5 3.9 ± 0.2 2.5 ± 0.3 
His6-TAT-FXN1-210 9.6 ± 0.7 3.8 ± 0.3 2.5 ± 0.5 
 
1Isothermal unfolding experiments were carried out in 20 mM Tris-HCl, 300 mM NaCl, 1mM 
EDTA, 1mM DTT, 15% glycerol, at pH 7.5. Measurements were done at 20° C. A two-state 
unfolding model was fitted to the data. 
 
 
 
A
cc
ep
te
d 
A
rt
ic
le
FEBS Open Bio (2018) © 2018 The Authors. Published by FEBS Press and John Wiley & 
Sons Ltd 
 
  
A
cc
ep
te
d 
A
rt
ic
le
FEBS Open Bio (2018) © 2018 The Authors. Published by FEBS Press and John Wiley & 
Sons Ltd 
 
  
A
cc
ep
te
d 
A
rt
ic
le
FEBS Open Bio (2018) © 2018 The Authors. Published by FEBS Press and John Wiley & 
Sons Ltd 
 
  
A
cc
ep
te
d 
A
rt
ic
le
FEBS Open Bio (2018) © 2018 The Authors. Published by FEBS Press and John Wiley & 
Sons Ltd 
 
 
A
cc
ep
te
d 
A
rt
ic
le
FEBS Open Bio (2018) © 2018 The Authors. Published by FEBS Press and John Wiley & 
Sons Ltd 
 
  
A
cc
ep
te
d 
A
rt
ic
le
FEBS Open Bio (2018) © 2018 The Authors. Published by FEBS Press and John Wiley & 
Sons Ltd 
 
  
A
cc
ep
te
d 
A
rt
ic
le
FEBS Open Bio (2018) © 2018 The Authors. Published by FEBS Press and John Wiley & 
Sons Ltd 
 
  
A
cc
ep
te
d 
A
rt
ic
le
FEBS Open Bio (2018) © 2018 The Authors. Published by FEBS Press and John Wiley & 
Sons Ltd 
 
  
A
cc
ep
te
d 
A
rt
ic
le
FEBS Open Bio (2018) © 2018 The Authors. Published by FEBS Press and John Wiley & 
Sons Ltd 
 
 
 
 
 
 
 
 
 
 
